STEM-Talk

Our guest today is Dr. John Newman, a geriatrician and researcher who is well-known for a 2017 study that found a ketogenic diet reduced the mid-life mortality of aging mice while also improving their memory and healthspan. John is an assistant professor at the Buck Institute for Research on Aging and a geriatrician in the Division of Geriatrics at the University of California, San Francisco. He also is a physician who works with older adults in the San Francisco VA Medical Center. At Buck, John studies the molecular details of how diet and fasting regulate the genes and pathways that control aging. He particularly focuses on the ketone body beta-hydroxybutyrate and how its molecular signaling activities involving epigenetics and inflammation regulate aging and memory in mice. Show notes: [00:02:51] Dawn opens the interview asking John what it was like growing up in Long Island. [00:04:20] Dawn mentions that John was described as a pretty geeky kid growing up, and asks him about his childhood. [00:05:40] Ken asks John if being the type of kid who would do all the homework in his textbooks in the first couple of months annoyed his classmates. [00:07:34] Dawn asks why John decided to go to Yale University. [00:08:45] Mentioning that Yale doesn’t have a pre-med program, Dawn asks what John decided to major in. [00:10:15] John explains how he met his wife at Yale. [00:11:28] Dawn asks John why he traveled across the country to the University of Washington after graduating from Yale. [00:12:26] Dawn asks why John decided to focus his graduate work on the progeroid Cockayne syndrome. [00:14:15] John discusses his decision to go to the University of California, San Francisco for his residency. [00:16:05] Dawn asks if John immediately joined the faculty at San Francisco after his residency. [00:17:03] Ken asks John about his work to improve the care of older adults and help them maintain their independence as they age. Ken asks for an overview of the work John and his colleagues do in this area at the Buck Institute [00:18:39] Ken mentions that a lot of John’s work focuses on the molecular details of how diet and fasting regulate the genes and pathways that control aging. Ken asks John to elaborate on this work. [00:20:04] Dawn asks what specifically attracted John to the idea of studying the ketogenic diet as an intervention in mid to later life as opposed to a diet consumed habitually throughout life. [00:23:12] Dawn mentions that John and Eric Verdin, who recruited John to the Buck institute, share an interest in looking at ketone bodies as signaling metabolites, a topic they have written about. [00:26:21] Ken talks about a conference he and Dawn attended on CBD and seizures, where Ken made the point that ketones are a metabolite of THC. [00:27:52] Ken asks John to go into more detail about how ketone bodies may link environmental cues such as diet to the regulation of aging. [00:29:08] Ken talks about how it seems clear that ketone bodies are emerging as crucial regulators of metabolic health and longevity via their ability to regulate HDAC (histone deacetylases) activity and thereby epigenetic gene regulation. He asks John to discuss how beta hydroxybutyrate may be an increasingly useful and important signaling molecule as we age. [00:34:24] Dawn mentions that John and his colleagues published paper in 2017 in Cell Metabolism titled “Ketogenic Diet Reduces Midlife Mortality and Improves Aging in Mice.” Dawn asks why John chose a cyclical rather than continuous ketogenic diet for this study. [00:37:56] Dawn asks why John decided to conduct the test of physiological function while the ketogenic diet group was off the diet, and on a standard high-carbohydrate diet. [00:40:02] Dawn mentions that Megan Roberts and her colleagues at theUniversity of California Davis were also conducting studies on the effects of a ketogenic diet on mice around the same time as John’s study, and that both were published in the same issue of Cell Metabolism. Dawn goes on to mention that Megan was recently interviewed on episode 92 of STEM-Talk where she discussed her paper, “A Ketogenic Diet Extends the Longevity and Healthspan in Adult Mice.” Dawn adds that both Megan’s and John’s studies had similar findings but that Megan’s had the added caveat that the ketogenic diet may also improve strength and coordination. Dawn asks what John’s takeaways were from Megan’s paper and how do the two papers differ? [00:44:50] Ken mentions that he is personally looking at the effect of the ketogenic diet as a way to avoid sarcopenia and other aspects of aging. [00:46:42] John discusses possible reasons why the ketogenic diet has such pleiotropic effects on people suffering from diseases such as type 2 diabetes, epilepsy, inflammation etc. [00:50:17] Dawn mentions that one of the most frequent criticisms of the diet comes from nutritionists who say “show me the five-year data,” she asks how John would respond to that. [00:54:25] Ken asks about the “

Our guest today is Dr. Emma Wilson, a researcher who has spent the past 15 years studying Toxoplasma gondii, a protozoan parasite that infects about a third of the world’s population. She is a native of Scotland and a professor of biomedical science at the University of California, Riverside. Toxoplasma gondii is a single-celled organism found in all mammals. The primary focus of Emma’s research is the immune response in the brain following Toxoplasma gondii infection. Her 2016 research paper in the online journal PLOS Pathogens connected the Toxoplasma gondii to brain dysfunction. Show notes: [00:03:05] Emma begins the interview taking about growing up was born in Glasgow with parents who were in the acting business. [00:03:38] Emma shares how her father advised her to keep all of her doors open, which lead her as a youth to pursue everything she found interesting. [00:04:30] Dawn asks if Emma decided to major in ecology in an effort to help save the rainforests. [00:05:28] Ken asks about Emma’s experience with a “proverbial crazy professor” who showed her a room full of rattlesnakes and how that experience led to Emma’s curiosity in immunology. [00:06:54] Ken asks whether if it’s that she was paid to stand out in the bush so that mosquitos could feast upon her during a research trip to Tanzania. [00:08:16] Ken asks if Emma’s experience in Africa was limited to mosquitos or if she was able to see some of the impressive wildlife there. [00:09:26] Emma discusses her experiences after her research trip to Africa and her decision to pursue work in immunology at Dr. William Harnett’s lab at the University of Strathclyde. [00:10:32] Dawn asks about the research Emma did in Harnett’s lab. [00:11:46] Dawn mentions that Emma had the opportunity to attend a conference in Philadelphia where she met many interesting people. She goes on to ask about the conference and how she ended up spending the next five and a half years at the University of Pennsylvania. [00:13:52] Dawn mentions another conference Emma was able to attend, this one in California, where she stood out for asking so many questions. Dawn asks about how this led her to go to work at University of California, Riverside. [00:16:50] Ken mentions that the primary focus of Emma’s research at Riverside is the immune response in the brain following Toxoplasma gondii infection, further mentioning that in an episode of the podcast “This Week in Parasitism” Dr. Dickson Despommier referred to Toxoplasma gondii as the most successful parasite on Earth. Ken asks Emma to give an overview of what Toxoplasma gondii is and does. [00:18:58] Dawn asks why Toxoplasma gondii has such a high infection rate in countries such as France and Brazil, where close to 80 percent of people are infected. In the U.S., only 15 to 30 percent of people are infected. [00:20:49] Ken mentions that Eskimos, who’s traditional diet is rich in raw meat, have an almost 100 percent infection rate. [00:21:19] Ken asks how the Toxoplasma parasite prevents digestion in the stomach. [00:23:12] Emma discusses how most cases of Toxoplasma in healthy adults present little to no consequences of infection, but that congenitally infected children or people who are immunocompromised can have serious consequences. [00:25:33] Ken asks how an immunocompetent individual keeps the infection at bay and if there is any risk associated with that constantly active immune response in the brain to this infection. [00:27:32] Ken explains that cats are the only definitive host of the toxoplasmosis parasite because it can only complete its sexual reproduction cycle in the gut of a cat. He goes on to explain that cats eat rats, and sometimes rats eat cat feces, which infects the rats with Toxoplasma gondii, When the cats eat these rats the cats perpetuate the cycle. Ken asks Emma to explain how the infection changes the fundamental fear response in rodents that they naturally have to cats. [30:48] Ken mentions amazing videos on the web showing infected mice approaching cats and rubbing up against them affectionately. [00:31:50] Dawn asks if vegetarians are safe from Toxoplasma gondii infection, given that humans typically contract the parasite via uncooked meat from intermediate hosts such as sheep, cows, goats, and pigs. [00:33:03] Dawn asks if the relationship between the toxoplasmosis parasite and their host can be mutually beneficial. [00:34:24] Dawn asks if seafood can lead to infection. [00:35:33] Ken mentions that there is presently no vaccine for Toxoplasma gondii; however, there are commonsense preventative measures such as pregnant women avoiding cat litter and wearing gloves while gardening. Ken goes on to ask if there are any other ways to reduce chances of infection. [00:37:42] Dawn mentions that Emma and her colleagues at Riverside had a 2016 paper in the journal PLOA Pathogensthat described how Toxoplasma infection leads to a disruption of neurotransmitters in the brain. Dawn goes on to mention that Emma post

Our guest today is Megan Roberts, a research scientist who conducted an interesting study that showeda ketogenic diet extended the longevity and healthspan of adult mice. This study has been discussed in several earlier episodes of STEM-Talk. Megan conducted her research while earning a master’s degree in nutritional biology at the University of California, Davis. Today, she is the scientific director at Nourish Balance Thrive, an online health-coaching company where Megan helps people optimize their heath and performance. Show notes: [00:02:53] Dawn begins the interview mentioning that Megan grew up in Northern California and asks Megan what she was like as a child. [00:03:20] Megan talks about how her interest in science started. [00:03:38] Dawn asks Megan how she became a martial arts instructor, teaching teen-agers as well as children as young as five years old. [00:04:02] Megan talks about her decision to attend the University of California, Davis. [00:04:16] Megan explains why she initially want to major in biochemistry, but decided toward the end of her freshman year to switch majors. [00:04:42] Ken asks Megan about her decision to stay at UC Davis to earn a master’s degree in nutritional biology. [00:05:08] Megan talks about the privilege of having open-minded professors and peers who were a part of her nutritional biology program at UC Davis. [00:06:07] Ken mentions that part of Megan’s thesis ended up in Cell Metabolism, in the form of a paper titeld, “A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice.”The paper, Ken points out, has been discussed in several episodes of STEM-Talk. He asks Megan about the motivations behind her study. [00:07:41] Megan describes the three different diets used for the mouse studies. [00:08:30] Dawn mentions that an important aspect of the study was that all of the mice were fed the same number of calories every day. She asks Megan to explain the significance of this parameter. [00:09:23] Megan describes the various markers of physiological function that were measured how the study yielded interesting results in terms of healthspan in the mice. [00:10:14] Dawn asks how the memories of the mice were tested. Dawn also asks Megan to go into detail on the finding that mice on the ketogenic diet were having their memories preserved for longer. [00:11:13] Ken asks Megan how she tested the grip strength of mice. [00:12:05] Megan talks about the two areas of healthspan that saw the most dramatic effects with the ketogenic diet: memory and the preservation of motor-function. [00:12:39] Ken asks if Megan and her colleagues were surprised by the finding that lifespan was increased by 14 percent in the mice fed a ketogenic diet. [00:13:08] Dawn mentions that the ketogenic diet came out on top in the study, followed by the low-carb diet. Dawn mentions that those mice on the low-carb diet, however, surprisingly gained weight asks Megan is she was surprised by this. [00:14:35] Ken asks what lead Megan to the idea of studying the ketogenic diet as an intervention in midlife, as opposed to being a habit throughout life. [00:15:27] Dawn asks how well Megan thinks these mouse models are likely to translate to humans. [00:17:05] Ken asks what experiments Megan would have done to extend her findings reported in the Cell Metabolism paper if she had managed to have more time, funding and resources. [00:17:52] Dawn mentions that Megan’s study suggests that the metabolic changes that accompany carbohydrate restriction might indeed help increase lifespan. However, Dawn asks Megan about ketone bodies themselves (AcAc and BhB) and their potential role in the extension of healthspan. [00:18:13] Ken asks about Megan’s findings in regards to a tissue dependent mTORC1 signaling, in the context of skeletal muscle and the ketogenic diet. [00:20:26] Dawn asks Megan for her take on the tissue specific effects of ketones that she observed in her work. [00:21:12] Megan explains the effects of the ketogenic diet on insulin sensitivity. In her study, the ketogenic diet did not impair insulin sensitivity while the low-carb diet did. [00:22:55] Megan explains the key differences in the design and interpretation of her study versus a similar paper from Eric Verdin’s group, which reported that a cyclical ketogenic diet, but not a consistent one, improved healthspan in older mice. [00:24:13] Dawn asks Megan about her thoughts on the enrichment of a standard diet with exogenous ketones, and if there could be healthspan benefits from that. [00:24:47] Ken mentions a recent paper by Poffé, which suggested that a ketone ester can help prevent some of the negative effects of “over-reaching” in endurance training. [00:25:55] Ken asks if exogenous ketones have their most important effects when taken post-exercise, rather than pre-exercise. [00:27:02] Dawn asks if there are other untapped uses of endogenous or exogenous ketosis that people may not be considering. [00:27:39] Dawn asks Megan what her thoughts

Our guests today are Drs. Irina and Michael Conboy of the Department of Bioengineering at the University of California Berkeley. In their lab at Berkeley, the Conboys investigate the process of tissue repair in the body in an effort to determine why damaged tissues do not productively repair as the body ages. In today’s interview, you will hear the Conboys talk about their early research and a fascinating technique they pioneered called heterochronic parabiosis, where the couple took a young mouse and an older mouse and sutured them together so the animals blood and organs. The Conboys found that the older mouse benefited from this fusion, its aged stem cells becoming rejuvenated and its muscle tissues becoming functionally younger. Since then, the Conboys’ follow-up research has provided fascinating insights into stem-cell niche engineering, tissue repair, and stem-cell aging and rejuvenation. In 2015, they published an important study showing that high levels of the protein TGF-β1 impaired the ability of stem cells to repair tissues. While their experiments also showed that giving old animals young blood appeared to have some benefit to old stem cells, the Conboys’ most recent work provides compelling evidence suggesting the more interesting benefits are instead produced by a dilution of harmful signals in old blood. The research coming out of the Conboy lab has profound implications in terms of postponing the onset of age-related diseases as well as the prevention of such degenerative conditions such as Parkinson’s, Alzheimer’s, osteoporosis and sarcopenia. Show notes: [00:03:23] Dawn opens the interview asking Irina about her time as a gymnast in the Soviet Union. [00:03:56] Irina talks about how she became interested in biology. [00:04:36] Michael describes how he was a bit of a nerd who spent a lot of time outdoors as a kid studying bugs. [00:05:29] Ken asks what Michael’s plans were when he started his education at Harvard. [00:06:00] Ken inquires as to what it was about lab work that attracted Michael to the point where he abandoned medical school and focused on research instead. [00:06:56] Irina tells the story of her first overseas visit to Boston and how a female friend of hers had set her up with multiple dates for her visit before her plane had even touched down in the states. [00:09:06] Michael recounts the story of his first time in Moscow, where he asked Irina if she wanted to hang out. [00:10:52] Dawn mentions that after graduating, Michael got a job as a lab tech at Harvard, but eventually moved to Philadelphia to join the lab a friend of his was starting. Michael goes on to explain how he and Irina eventually became professional lab rats together there. [00:13:44] Michael explains how he would likely still be a lab tech if it were not for Irina and her desire to study aging, and how that inspired him to pursue his doctorate at Stanford. [00:15:10] Dawn asks Irina about her pursuit of a Ph.D. at Stamford in auto-immunity in the lab of Patricia Jones. [00:18:30] Dawn asks Irina to explain her discovery that Notch Signaling had the potential to regenerate aged muscle, a discovery she made during her post-doc work at Stamford. [00:21:30] Dawn mentions that Irina finished her post-doc work before Michael did, which allowed her to get work at a competing laboratory. Dawn asks if working at a competing labs created tension between the two of them. [00:24:26] Ken asks Irina what led her to look into reactivating old stem cells and whether that might delay or even reverse the onset of aging. [00:26:00] Michael talks about his inspiration for the parabiosis experiment, which involved two mice, one old and one young, being statured together. [00:30:12] Ken asks what the results of the parabiosis experiment were. [00:31:57] Ken mentions that the 2005 paper in Nature, which documented the findings of the parabiosis experiment, sparked an interesting reaction from the media that included headlines about “baby boomer vampires.” Ken asks the Conboys if they were annoyed with the overly simplistic interpretations of their study’s findings. [00:33:27] Dawn asks about Michael and Irina’s research into finding an inhibitory compound in old blood that turned out to be transforming TGF Beta 1. [00:37:44] Ken brings up Michael and Irina’s 2016 paper, published in Nature Communications,in which they described a new, more definitive, experiment than the parabiosis experiment. This blood exchange experiment, aimed to distinguish whether there was a curative property of young blood, or an inhibitory compound being filtered out of old blood, exchanged only blood between the two animals, rather than all of their organ systems. [00:40:55] Michael explains that those experiments came at a time when funding was drying up for the Conboy’s lab. He talks about how discussions with Aubrey de Grey from the SENS Research Foundation aided him and Irina with their experiments. [00:45:23] Dawn asks why Michael and Irina about th

Ken and Dawn return in today’s podcast to answer more listener questions. Back at the beginning year, Ken and Dawn hosted their first Ask Me Anything episode. In that episode, they promised not to wait another three years and 83 episodes before once again addressing listeners’ questions. A steady stream of new questions have poured in since that first Ask Me Anything episode. Today, Ken and Dawn take turns answering questions about exogenous ketones, daily allowances of protein, healthy fats, black holes, long-duration space flights, decompression sickness, the future of AI, sloppy science, and much, much more. Show notes: [00:04:13] Dawn starts the episode with a listener question for Ken, which is in regards to the Valter Longo interview, episode 64,and the Stuart Phillips interview, episode 84.The listener became confused about protein intake because Longo said that more than 100 grams of protein a day accelerates aging, while Phillips said that the recommended daily allowance for protein is too low. After going online to get some clarification about the right intake of protein, the listener became even confused and asks if Ken could provide some insight and clarity on the issue. [00:08:40] A listener asks Dawn about her research on exogenous ketones. [00:09:44] A listener wonders if Ken has read the 2017 paper titled, “Is Sociopolitical Egalitarianism Related to Bodily and Facial Formidability in Men,”and if so, to share his thoughts on it. [00:11:52] Dawn reads another question addressed to Ken about the utility of a paper out of Harvard that appeared in February.That paper described an observational epidemiological study showing a strong association between the ability to do pushups and cardiovascular events. [00:14:49] A listener says he has read one of Dr. Ford’s papers criticizing the Turing Test, and wonders why he let Dr. Epstein off the hook during episode 89 of Stem-Talkwhen the topic came up. [00:16:02] Dawn asks another question on behalf of a listener who asks about Ken’s comments on the previous AMA episodewhere he expressed some reservations about canola oil. [00:19:27] Dawn follows up by asking Ken which oils he favors. [00:20:13] Another listener asks Ken about his recent appointment to the National Security Commission on Artificial Intelligence and wonders what the issues the commission is investigating. [00:20:54] A listener asks Ken about the so called “futurist” types who foreshadow a dark future where AI has a doom-and-gloom effect on humanity at large. The listener asks Ken to expand on his brighter and more hopeful vision of the future where AI and intelligent systems help humanity. [00:22:44] Dawn asks Ken about the data gathered by the European Space Agency (ESA) since the launching of the Gaia mission, which is cataloguing the composition, brightness, positions, and directions of stars in the Milky Way. [00:25:13] Dawn is asked about a paper published in late 2018 in the proceedings of the national academy of sciences that was titled, “Space Radiation Triggers Persistent Stress Response, Increases Senescent Signaling, and Decreases Cell Migration in Mouse Intestine.”The paper suggests that space radiation could pose a risk for the gastrointestinal tracts of astronauts [00:28:47] Ken asks Dawn a question about her involvement in a record-breaking freshwater-cave dive. [00:31:01] A listener, asking another diving questions of Dawn, wonders if there are any biological or genetic factors that might influence individual susceptibility to decompression sickness or the bends. [00:33:04] Dawn is asked for her thoughts on what the research community has learned since Gena Shaw’s 2015 landmark paper, “New Study Suggests Brain Is Connected to the Lymphatic System: What the Discovery Could Mean for Neurology.” [00:36:15] Ken asks Dawn if sleeping position has any effect on the ability of the brain’s lymphatic system to flush out metabolic waist. [00:37:02] A listener asks Dawn about a 2019 paper published in the proceedings of the national academy of sciences, titled “Brain Ventricular Changes Induced by Long-Duration Space Flight.” [00:38:16] Ken is asked by a listener to explain the process of photographing a black hole. [00:39:49] Another listener asks Ken, via Facebook, about the future of space exploration, as well as the future of human and machine teaming. [00:41:15] A listener writes to Dawn and asks about her involvement in the NASA and ESA 60-day bedrest study, and if she can explain what it entails. [00:43:53] Dawn asks Ken what he thinks the biggest problems with science are, which prompts Ken to cite Dr. John Ioannidis, who was interviews on episode 77.Ioannidis is a Stanford professor who has been described by “BMJ” as “the scourge of sloppy science.” [00:46:28] Ken is asked about modern technology’s effect on democracy, and if it is feasible to fix the issues that arising. Ken’s answer includes references to his interview with Dr. Robert Epstein, episode 89. [00:48:46] A lis

Our guest today is Dr. Robert Epstein, a psychologist, professor and journalist who is the former editor of Psychology Today. Robert is currently a co-founder and the senior research psychologist at the American Institute for Behavioral Research and Technology in Vista, California. He has had a distinguished career as a scientist and journalist researching and writing about advances in mental health, the behavioral sciences, and, most recently, the invisible influence that technology companies have on consumer and political behavior. Robert is the author of 15 books and has written more than 300 scientific and popular articles. He is the founder of the Cambridge Center for Behavioral Studies. He became well known early in his career for his work on creativity. Since then, he has conducted research on a diverse range of topics such as adolescent-and-adult competency, arranged marriages, sexual orientation, self-control and voter manipulation. He also has also developed a number of unique online competency tests which are annually taken by more than a million people. Show notes: [00:03:38] Dawn begins the interview asking Robert about growing up in Connecticut. [00:04:57] Dawn asks if Robert skipped a grade in school, given that he graduated from high school at 16. [00:06:16] Robert talks about his interest in computers in the 60’s, and how his high school was one of the first in the country to even have a computer. [00:07:27] Ken asks about what lead Robert to attend Trinity. [00:08:23] Dawn inquires as to whether Robert knew he was going to major in psychology when he first showed up at Trinity, or if he simply ended up gravitating toward the field. [00:10:14] Robert talks about collecting and analyzing the first ever campus-wide sex survey conducted at Trinity. [00:11:40] Robert explains what he did in the two years between obtaining his bachelor’s degree in 1976 and pursing graduate school. [00:13:07] Dawn asks about Robert’s experience at the University of Maryland Baltimore. [00:13:48] Robert tells the interesting story of how he ended up at Harvard, in part, thanks to the behaviorist B.F. Skinner. [00:15:40] Ken asks how Robert managed to be one of the few people who never had to write a dissertation while at Harvard to obtain his doctorate. [00:20:29] Dawn mentions how, at the time, Robert was becoming well known for his work with Skinner. She points out that many behaviorists at the time were working with chimpanzees and asks why Robert and Skinner were working with pigeons instead. [00:23:49] Dawn mentions that after his work with pigeons, Robert began to study creativity. He explains why he concluded that creativity is an orderly and predictable process that can be learned, rather than something one is simply born with. [00:27:34] Robert talks about how he founded the Cambridge Center for Behavioral Studies after his time at Harvard, and how he took on the role of executive director despite Skinner’s warning to never go into administrative work. [00:29:56] Ken asks about Robert’s time at the Cambridge Center and if all the papers he wrote during that time had a theme, or if they were just in general social-science communication. [00:31:28] Robert discusses his book “Cognition, Creativity and Behavior” which is a book of selected essays that he published in 1996. He discusses the various topics in the collection, ranging from creativity to parenting to artificial intelligence. [00:33:09] Ken asks why, after ten years at the Cambridge Center, Robert moved to the west coast. [00:35:40] Dawn asks about Robert’s research into arranged marriages and his finding that couples in arranged marriages developed a greater affection for each other than those who married for love. She asks him about his view that people can deliberately learn to love each other. [00:40:02] Robert discusses his time at the University of California San Diego where he gave students extra credit for participating in “affection building exercises.” He also explains what these were like and what he learned from them. [00:42:37] Ken asks about Robert’s work on psychological maturity, and his criticism of the “artificial extension of childhood” that is prevalent today. [00:47:43] Dawn asks about a study on sexual orientation that Robert published in 2007 that supported Freud’s position that bisexuality is the human norm. [00:50:53] Dawn mentions a book that Robert coedited called Parsing the Turing Test, which refers to Alan Turing’s philosophical test for machine intelligence in which a human judge engages in a three-way conversation between a machine and a person, and if the judge is unable to differentiate the two, then the machine is deemed intelligent. [00:55:53] Ken mentions that he, Clark Glymour and Pat Hayes provided a running commentary on Turing’s paper for Robert’s book, Parsing the Turing Test. Editor’s Note: Ken deems the Turing Test a silly goal for AI. See his paper published in Scientific American (with Pat Hayes) on thi

Our guest today is Dr. Duane Mitchell, the Phyllis Kottler Friedman Professor in the Department of Neurosurgery at the University of Florida College of Medicine. He’s also the co-director of the university’s Preston A. Wells Jr. Center for Brain Tumor Therapy and Director of the Brain Tumor Immunotherapy Program. Duane and Dawn have been friends since their days at Duke University where they served on the Institutional Review Board together. Duane got his medical degree and doctorate at Duke and then joined the faculty, where he spent the next decade before moving to the University of Florida in 2013. Duane and his team at Florida are among the world leaders in the uphill battle to find ways to treat glioblastoma, an aggressive form of brain cancer that affects about 13,000 Americans annually. It’s the disease that recently took the life of Senator John McCain. People who are diagnosed with glioblastoma typically live for less than two years. Show notes: [00:03:00] Duane explains the story behind his “quote of the week” tradition, where every Monday morning he share’s a quote with his colleagues in his research group. [00:03:43] Ken asks if it is true that one of Duane’s favorite quotes comes from Mark Twain: “I have never let my schooling interfere with my education.” [00:04:13] Dawn asks if it is true that by the sixth grade Duane had decided he was going to become a doctor. [00:04:52] Duane talks about his decision to attend Rutgers College. [00:05:37] Duane explains how reading Stephen Rosenberg’s book “The Transformed Cell” heavily impacted him during his time at Rutgers. [00:06:43] Dawn mentions that she and Duane met at Duke University, and how this almost didn’t happen because Duane was originally going to attend another university for med school. [00:07:55] Dawn explains that after receiving his MD and Ph.D. from Duke, Duane went on to serve in numerous faculty positions for the next 12 years. During this time, Duane became known as a trailblazer in the application and research of immunotherapy for cancer, particularly brain tumors. Dawn asks Duane for an overview of the role that immunotherapy plays in the treatment of brain tumors. [00:09:30] Duane explains how in 2013 he joined the faculty at the University of Florida and managed to bring his entire team from Duke with him. [00:10:47] Duane has acquired considerable clinical and translational research experience as a principle investigator on seven first-in-human protocols through FDA approved clinical trials. Dawn points out that at Florida, Duane and his team offer unique clinical options for adult and pediatric malignant brain tumor patients. She asks Duane to explain, in depth, the work that he and his do at Florida. [00:12:11] Duane gives an overview of the types of brain tumor and what some of the more common tumor types are. [00:14:09] Dawn asks why Duane chose to specialize in glioblastoma, or GBM, an aggressive form of brain cancer that kills 15,000 Americans eachyear. [00:15:16] Ken asks what characteristics of GBM make those particular types of tumors so difficult to treat. [00:16:17] Duane talks about the standard of care for these malignant brain tumors. [00:18:36] Dawn asks if immunotherapy is a stand-alone approach for treating brain tumors, or if it is administered in conjunction with standard therapy. She goes on to asks if changes to the immune system through radiation or chemotherapy have a negative effect on immunotherapy. [00:21:20] Dawn asks if recent findings about the nervous system’s immune system, and the new-found interconnectedness between the glymphatic system and the lymphatic system impact immunotherapy approaches for brain tumors. [00:23:02] Ken asks how the immune system is naturally equipped to fight cancer. [00:25:36] Dawn explains that the (PD)-1/PD-L1 pathway, otherwise known as Programmed Cell Death, is an immune resistance mechanism that tumor cells exhibit to dampen immune response. Dawn asks about the efficacy of a new class of immunotherapy drugs called immune checkpoint inhibitors that block these signals and allow immune cells to be more effective in fighting the tumor. [00:28:11] Dawn mentions that Duane is helping to lead a health-organized coalition known as the ReMission Alliance, which is a University of Florida initiative that brings together neuro-oncology experts from institutions across the U.S. and Canada. [00:29:32] Ken mentions stories, both anecdotal and found in the literature, of the ketogenic diet having a beneficial effect in fighting cancer. He asks if Duane has given thought to the role of HDAC, given that BHB is an HDAC inhibitor, and that perhaps in addition to the energetic effects of ketone bodies, another benefit of the ketogenic diet in cancer is its signaling effects. [00:31:17] Ken mentions a recent paper in Nature Communications that describes how Duane and his colleagues at Florida have discovered a new use of stem cells that could clear a revolutionary pathway to make immu

Dr. Dominic D’Agostino returns to STEM-Talk to give Ken and Dawn an update on his research into ketogenic nutrition. Dom was the guest on episode 14 back in 2016 when ketogenic diets didn’t even show up on a list of the top-10 diets that people Googled. Since then, the search term “ketogenic diet” has risen to the top of the list. In today’s episode, Dom talks about his past 10 years of research into ketogenic diets and what he is learning about the physiological benefits of nutritional ketosis. Dom is tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine.He also is a research scientist here at IHMC.Throughout his career, Dom has been a researcher with a diverse background in neuroscience, molecular pharmacology, nutrition and physiology. Show notes: [00:02:55] Dawn begins the interview mentioning that when she and Ken started hosting STEM-Talk, the ketogenic diet wasn’t on the list of the top-10 most Googled diets of 2015. Today, however, Dawn points that ketogenic diet is number one on the list. She asks Dom if he foresaw sudden mass interest in a ketogenic diet coming. [00:04:12] Ken asks Dom for his thoughts on how the ketogenic diet has went from being very obscure to becoming a household term. [00:06:04] Ken comments on the evolutionary component of the ketogenic diet and how our ancestors must have gone in and out of ketosis based on the availability of food. He also comments on the unique aspect of the ketogenic diet, being that it has an objective measurement, and asks Dom to talk about that. [00:06:59] Dawn comments on the cynicism regarding the ketogenic diet, particularly from nutritionists. She asks Dom to address the criticism and pushback that the ketogenic diet receives from so many nutritionists. [00:10:02] Ken mentions that some fields are resistant to change and new science due to the emotion behind established theories. Dom agrees and then talks about how people, even doctors, are resistant to new data and new science. [00:11:13] Dom talks about the most common misconceptions and overrepresentations of the ketogenic diet. [00:12:54] Ken discusses his dissatisfaction with the term “ketogenic diet” since the word diet implies the mandated consumption of certain food items. He goes on to say that if one is in ketosis, then, by definition, they are doing a ketogenic diet, even though they may be in ketosis because they have been fasting and haven’t eaten anything. Ken and Dom discuss how knowledge about ketogenic nutrition has changed over time and that it is certainly possible to eat an unhealthy ketogenic diet. [00:15:35] Dom and Ken talk about the results of a recent Megan Roberts paper, “A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice,”that showed a 13% increase in the lifespan of the mice along with remarkably improved healthspan. [00:20:26] Dom shares his thoughts on the potential of exogenous ketones in the context of blood glucose regulation. [00:27:07] Ken asks if Dom has been tracking Virta Health, which was founded by Dr. Jeff Volek who was interviewed in STEM-Talk episode 43. Virta Health has been publishing impressive results of its trials that show people reversing type-2 diabetes via a well-formulated ketogenic diet. [00:29:13] Ken adds that the reported numbers from Virta show 60% to 70% of their patients going off their insulin medication or greatly reducing their insulin levels. [00:30:55] Dawn asks about Dom’s experience going underwater for 10 days in participation of a NASA NEEMO mission. She asks him to talk about his personal experience as well as his background in hyperbaric physiology. [00:32:08] Dom discusses his group’s work replicating the experimental design of his original oxygen toxicity work in aged and obese rats. [00:33:35] Dawn briefly describes what oxygen toxicity is, and asks Dom about the first human studies, on which he is serving as a consultant, that are being conducted at Duke University to assess the effect of nutritional ketosis on oxygen toxicity and seizure risk. She points out that the studies that are being run by Dr. Bruce Derrick. [00:36:36] Dom discusses brain energy metabolism, and cerebral metabolism, in the context of ketone bodies. [00:39:23] Dom talks about his group’s research into kabuki syndrome, an epigenetic disorder that causes altered growth and cognitive dysfunction in children. [00:42:02] Dom elaborates on the difference between ketone esters and ketone salts. [00:44:00] Ken asks if there’s any evidence that people experience medical issues as a result of ketone esters or salts. [00:48:02] Dawn asks about the transition into ketosis for women, which appears to be more difficult than it is for men, and whether the use of exogenous ketones would be a good option for women. [00:49:43] Dawn asks if there are any more resources that have been generated on a vegetarian ketogenic diet, since the last time she and Dom discus

Our guest today is Dr. Matt Johnson, another colleague who works with Ken and Dawn at IHMC. Matt is a research scientist who joined the institute in 2002 after a 20-year career as Naval aviator. He focuses on human-machine teaming as it relates to technologies such as robotics, software agents and autonomous vehicles. These technologies are used in military responses and help first responders with disaster responses. They are used in space and aviation work as well. He also is part of an IHMC team developing humanoid behaviors and advanced interface concepts that will enable Boston Dynamics’ Atlas robot and NASA’s Valkyrie robot to do complex work. Matt was in the news recently for a project he’s doing with the police department here in Pensacola. He’s leading a team to develop specialized drones that police officers will be able to use in a number of areas ranging from search and rescue operations to disaster response. AI Magazineis running an article in its spring issue that Matt co-wrote with Alonso H. Vera, the chief of the Human Systems Integration Division at NASA Ames Research Center. Titled,“No AI Is An Island: The Case For Teaming Intelligence,”the article argues that artificial intelligence will only reach its full potential if it has enough teaming intelligence to work well with humans. Show notes: [00:02:52] Matt begins by discussing his upbringing in Long Island, New York, and his unusual family dynamics. [00:03:25] Dawn asks what lead Matt to attend the University of Notre Dame in Indiana and work on undergraduate degree in aerospace engineering. [00:03:59] Ken brings up that after obtaining his undergraduate degree, Matt went into the Navy as an aviator, and asks what motivated that transition. [00:04:44] Matt explains how he ended up at Texas A&M in Corpus Christi where he obtained his master’s degree in computer science. [00:05:45] Matt talks about his transition out of the Navy and how he came to live in Pensacola and work at IHMC. [00:07:02] Matt touches on how after a few years at IHMC, he began working on his Ph.D. through Delft University in the Netherlands. [00:10:03] Ken mentions that Matt’s research focuses on making technology more flexible and resilient through human-machine teamwork. He asks Matt to define what he means by human-machine teamwork. [00:11:51] Dawn brings up that Matt’s human-machine teamwork endeavors have led to a number of different projects in various fields, one of which is a partnership with the Pensacola Police Department to develop specialized drones for police use in a number of operations including search and rescue and disaster response. [00:14:05] Matt discusses his ongoing project to help develop humanoid behaviors and advanced interface concepts for robots. [00:15:53] Ken asks Matt to talk about an article Matt has with Alonso Vera of NASA Ames that’s appearing in the spring issue of AI Magazine. [00:17:03] Dawn talks about how machine intelligence is making inroads into our everyday world, citing a few examples such as self-driving cars and digital assistants like Siri and Alexa. Dawn asks Matt if he can use self-driving cars as a way to explain the gaps and challenges that intelligent technologies still face. [00:18:52] Matt talks about how humans are still far better at driving cars and that the technology for self-driving cars still has a long way to go before matching the safety record of humans. [00:20:11] Dawn describes how Elon Musk told a group of governors that they should adopt AI legislation before robots go rouge and start roaming the streets killing people. She asks Matt if he agrees with Musk, or if the notion of rouge robots is an over exaggeration. [00:21:23] Ken mentions that it seems natural to think of AI, and technology in general, as a means to compensate for human limitations. He goes on to mention that Matt’s article in AI Magazine warns people to be aware of misconceptions associated with this viewpoint, and asks Matt to talk about them. [00:24:16] Matt compares human-machine teamwork with a musician playing a duet to illustrate the idea of “teaming intelligence.” [00:25:47] Ken asks what “common ground” means in regards to the communication between humans and AI, given that “common ground” has a technical meaning in communication theory and is generally mentioned in regards to intelligent human beings who share an understanding or mental model of the world. [00:27:14] Ken asks Matt for his takeaways from the book “Digital Apollo” by David Mindell, which described tensions that existed between the engineers and astronauts during the Apollo years. [00:28:43] Dawn mentions that Matt was recently awarded a grant to work with on a NASA-related project to use machine-learning to optimize signal capture on a novel device being developed at CalTech lymphatic imaging. [00:29:08] Ken asks Matt what he does in his downtime. [00:29:34] Dawn asks Matt about his frequent humanitarian trips to Hatti, which he has been making over the pas

Today’s guest is Dr. David Geary, a cognitive developmental scientist whose wide-ranging interests are particularly focused on evolutionary psychology, sex differences and children’s mathematical development. He is a Curators’ Distinguished Professor and a Thomas Jefferson Fellow in the Department of Psychological Sciences and Interdisciplinary Neuroscience Program at the University of Missouri Columbia. David’s book, “Male, Female: The Evolution of Human Sex Differences,” has been described as a landmark text that provides a comprehensive evolutionary model to explain sex differences. His research on children’s mathematical development resulted in a MERIT award from the National Institutes of Health. In addition to authoring four books, he has published more than 300 articles and chapters across a diverse range of topics. David has served as a member of the President’s National Mathematics Advisory Panel and was appointed by President George W. Bush to the National Board of Directors for the Institute for Education Sciences. Show notes: [00:02:36] Dawn asks about David’s childhood, mentioning that his family moved around quite a bit before settling down in Northern California. [00:03:00] Dawn asks if David’s early struggles in elementary school were due to jumping around from classroom to classroom because of family moves. [00:03:43] David talks about how he first became interested in science. [00:04:15] Ken asks why David decided to go to Santa Clara University in Silicon Valley. [00:04:47] David explains how he ended up majoring in developmental psychology. [00:05:18] David recounts the story of how he went from working at an auto parts store to getting his master’s degree in clinical child and school psychology at California State University. [00:06:06] Dawn mentions that before David earned his master’s degree, he went to work as a school psychologist and counselor. She then asks what led him to decide to enter the Ph.D. program as the University of California Riverside. [00:07:05] After finishing his Ph.D., David had a number of university positions before landing at the University of Missouri in Columbia. Ken asks David about the school’s interdisciplinary evolution group, which was a key reason David was interested in the university. [00:08:12] Dawn asks how children’s mathematical development and evolutionary psychology became two of David’s primary research focuses. [00:10:04] David summarizes the factors that determine human intelligence. [00:11:11] David explains why the attempt to define intelligence has always been a controversial issue. [00:11:51] Ken asks about David’s research in the ‘90s that made a distinction between evolved forms of cognition, such as language, and other forms of cognition that are more dependent on schooling, such as reading and arithmetic. [00:14:44] David talks about his interest in Evolutionary Educational Psychology, and how that relates to the insights gleaned from his recent article that argued that there is built-in scaffolding that helps a child’s mind learn to talk, use tools, and play, but that there is nothing of the sort for learning how to read, write, or do math. [00:17:14] David has been investigating children’s mathematical cognition for nearly 25 years, including a 2015 paper on the numerical foundations of young children’s mathematical development.Dawn asks David to share his key takeaways from this research. [00:20:08] David gives an overview of the MU Math Study, which is supported by the National Institutes of Health and the National Science Foundation, and focuses on mathematical development from preschool all the way through high school. [00:22:32] David discusses his research into human sex differences, and human sexual selection. [00:23:46] Dawn asks about David’s paper that focused on human cognitive sex differences, which illustrated how sexual selection can result in sex differences in the brain and cognition. The paper also explored how these differences appear to be related to mitochondrial functioning, which led David propose a taxonomy of sex differences in human condition-dependent cognitive abilities. Dawn asks David to talk about these underlying brain systems and their development. [00:26:36] Ken asks how disease, premature birth, and pre- and postnatal exposure to toxins affect males and females differently. [00:28:56] Dawn mention’s David’s 2018 paper in “Psychological Review”that argued that the overall efficiency of mitochondrial functioning is critical to general health, brain development and functioning, as well as age-related changes in health and cognition. She goes on to ask David about his view that mitochondrial functioning provides a plausible basic biological mechanism that underlies the relations among all these phenomena. [00:32:10] Ken mentions Doug Wallace, one of the pioneers of mitochondrial research, who was interviewed on episode 67 of STEM-Talk, who has shown that mitochondrial haplotypes have adapted to t

Today’s guest is Joe Gomes, the former head strength and conditioning coach for the NFL’s Oakland Raiders, who today is IHMC’s new High Performance Director. Joe came to IHMC a little more than a year ago to be part of a new biological team that is searching for innovative ways to extend the capabilities and resilience of high-performing humans who operate in extreme environments. In today’s interview, you’ll hear Joe talk about a number of projects he’s working on, including his work with IHMC’s engineers and NASA to develop an exercise machine for long-duration space missions. Joe was with the Raiders for the 2016 season when Oakland won 12 games and went to the playoffs for the first time in 14 years. Although Joe has spent most of his career helping professional and amateur athletes, he also spent five years in North Carolina as a senior advisor and performance director for the United States Army Special Operations Command. Show notes: [00:03:43] Ken asks about Joe’s childhood and whether he played a lot of sports growing up. [00:04:14] Joe talks about being drawn to rugby because of the teamwork that’s involved. [00:05:27] Joe describes how he and a friend decided to take some time off from school and travel to Australia. [00:06:41] Joe discusses returning to London to go to back to school and major in sports science and rehabilitation. [00:07:37] Ken mentions that even as a young man Joe was very interested in the science of how the human body worked, and asks Joes how it came about that he started to question some of the basic training techniques offered by coaches. [00:08:40] Joe talks about working with John Allen, a physiotherapist who worked with the British track and field team, where he helped Allen set up a hydrotherapy program to assist injured athletes. He goes on to talk about how he also became involved in a program to screen elite athletes who were potential Olympic medalists. [00:11:36] Joe explains how he became interested in strength and conditioning. [00:12:52] Ken asks how a sports-medicine conference in Las Vegas led to Joe moving from London to Phoenix Arizona. [00:14:47] Joe tells of how he began working with the Argentinian national rugby team back in 2007. [00:16:36] Joe explains how his experience with the Argentinian rugby team helped him better understand that in addition to physical training, instilling a winning mindset is also important to get the best performance from athletes. [00:18:36] Joe talks about his passion for teaching athletes about self-accountability. [00:19:44] Ken asks Joe to talk about his biggest takeaways in terms of optimizing athletes’ performance after working with the Argentinian ruby team. [00:20:43] Joe gives an account of “his own world tour,” where he hopped around working with different national teams and governing bodies for three years after his experience with the Argentinians. [00:22:01] Ken asks for Joe to describe his time running the NFL annual scouting combine, where Joe helped train 35 first-round draft picks in a three-year period while working for EXOS as the director of performance. [00:24:16] Ken comments on how the NFL combine seems quite artificial, focused heavily on explosive power and strength. He notes that much of the training for the combine is designed to stiffen the tendons of the athletes for better power and strength transfer. He goes on to ask if this has resulted in the tendons being stiffer than the muscles are strong, and if there has been a higher injury rate in athletes who have attended the combine training. If so, Ken asks, does it come down to how their team handled them after the combine at the start of training camp. [00:26:54] Joe discusses how he came to work for the U.S. Army Special Operations Command at Fort Bragg. [00:28:13] Ken explains how impressed he was by the good work Joe was doing in facilitating the performance, and also preserving the health, of elite warfighters at Fort Bragg. Ken then asks about the similarities and differences between the training for the NFL as opposed to tier-1 military units. [00:30:13] Joe describes the work he did at Fort Bragg as the most important work of his career. [00:32:38] Joe tells the story of how he came to work with the Oakland Raiders. [00:33:44] After arriving in Oakland, Joe helped to plan and open a new state-of-the-art training facility for the Raiders. Ken asks what the process was like and what a state-of-the-art NFL training facility entails. [00:35:48] Ken asks Joe about the need for a personalized approach to optimize an NFL player’s performance. [00:37:53] With injuries in the NFL, and sports in general, being a common occurrence, Joe discusses how he uses technology and science to implement strategies for mitigating the risk of injury. [00:39:23] Ken asks whether coaches and staff fully appreciate the importance of good nutrition and exercise for their own health. [00:40:31] Joe discusses recommendations and strategies for the preservation of stre

It has only taken us nearly three years to get around to it, but we’re finally doing our first “Ask Me Anything” episode. It’s hard to believe, but Ken and Dawn sat down to interview their first STEM-Talk guest back in 2016. And during that time, listeners have been emailing us questions. So, in this episode, Dawn and Ken will be asking each other questions that listeners have directed their way. The show turned out to be a lot of fun and the chairman of the double-secret selection committee who chooses all the guests who appear on STEM-talk promises not to wait three years before getting around to do another Ask Me Anything episode. If you want to check out Ken and Dawn’s bios before you listen to today’s show, be sure to click on the links above, which will take you to their profile pages at ihmc.us. Also, links to papers mentioned in this episode can be found at the bottom of the show notes. Show notes: [00:02:31] Dawn asks about Ken’s time growing up in Guantanamo while his father was stationed there in the Navy. [00:02:59] Ken points out that Dawn spent part of her time growing up on a farm and asks her what that was like. [00:04:46] Dawn asks Ken about visiting Navy gyms when he was a kid. Ken then talks about how much he enjoyed those times, but that gyms have now become fitness centers. [00:05:43] Ken talks about his pet peeves during his workouts. [00:06:40] A listener writes in to say that he tried a ketogenic diet, but was never able to get over the “keto-flu.” He asks Ken to discuss this phenomenon and whether the ketogenic diet may not be for everyone. [00:07:44] Dawn follows up on the previous question and asks Ken for his thoughts on what constitutes a good diet if someone finds that the ketogenic diet isn’t right for them. [00:08:30] A listener asks Dawn about the APOE genotype, which has been mentioned on STEM-Talk several times. The listener asks about Dawn’s research into the genotype and what that research uncovered in regards to its relation to brain health. [00:11:09] Ken responds to a question about his views on the effectiveness of the ketogenic diet for older and middle-aged individuals, and why he thinks the diet might be considered an anti-aging diet. [00:14:39] A listener asks Ken to explain what the Mediterranean diet actually is, given the nebulous nature of the term. The listener goes on to write that they have never seen any noticeable weight loss benefit for people on the Mediterranean diet, unlike what the listener has seen for people adhered to the ketogenic and Paleo diets. [00:17:16] Dawn asks Ken how he would define the ketogenic diet, given that the Mediterranean diet is so ill-defined. [00:19:58] A listener asks Dawn if she has ever attempted a vegetarian ketogenic diet, given that Dawn is a vegetarian. In answering the question, Dawn mentions that Dom D’Agostino’s website lists resources for vegetarians and vegans who want to know more about ketogenic diets. [00:21:08] Dawn asks Ken for his thoughts on people on the ketogenic diet drastically limiting their protein intake. [00:22:57] Ken is asked about his thoughts on exogenous ketones, and he refers to a promising ketone ester developed by Oxford and NIH scientists. [00:24:34] Ken explains what sarcopenia is, and why people should want to avoid it. [00:26:17] Dawn mentions that Ken has said that the maintenance of skeletal muscle is contingent upon the balance between muscle protein synthesis and muscle breakdown. She goes on to ask what some of the factors are that drive this process in one direction or the other. [00:27:11] Ken discusses oxytocin, which is commonly thought of as the ‘trust’ or ‘bonding’ hormone and is important in reproduction. Dawn asks about the role of oxytocin in the context of the age-related loss of muscle mass and function. [00:28:22] Ken describes what oxytocin is and does. [00:28:50] Dawn comments on how Ken mentioned that Conboy’s group at UC Berkeley used subcutaneous injections of oxytocin, and asks about other forms of administration, such as intranasal. [00:29:36] Ken has received several questions along the lines of how oxytocin impacts weight loss, and gives his thoughts on the matter. [00:31:14] Ken lists off some natural ways of increasing oxytocin. [00:32:01] Ken closes his discussion on oxytocin with the aspects of the subject that interest him the most. [00:33:11] Dawn mentions how Ken, and other researchers in human performance, have touted the benefits of sauna. She asks if there are any new findings in this regard. [00:34:32] A listener asks Dawn why we never hear about free divers having the bends. [00:35:40] Ken asks Dawn if she experienced any changes from living under water during her NASA NEEMO mission the Atlantic. [00:38:33] Ken asks Dawn how she sees genetics and genomics fitting into undersea or other extreme environments in regards to a person’s resilience and performance. [00:38:39] A listener mentions an interesting blog post they read by William Dav

Our guest today Dr. Stuart Phillips, a professor of kinesiology at McMaster University in Ontario, Canada, who is best known for his research into muscle health and the benefits of dietary protein. Stu is the director of the McMaster Physical Activity Centre of Excellence, a state-of-the-art exercise research and training center. It is devoted to studying and improving the health and well-being of older adults as well as people with chronic diseases and disabilities. In addition to his work in the kinesiology department at McMaster, Stu is adjunct professor in the university’s School of Medicine. He is a fellow of the American College of Sports Medicine and the American College of Nutrition. He received the New Investigator Award from the Canadian Institutes for Health Research, the Ontario Premier’s Research Excellence Award, and the Young Investigator Award from Canadian Society for Exercise Physiology. In today’s interview we discuss: [00:08:19] Dawn introduces the importance of dietary protein and its role in muscle health, and tissue regeneration more generally, which makes it one of the only macro nutrients we need on a daily basis. [00:10:59] A recent study (2017) showed that whole eggs promoted a greater amount of muscle protein synthesis than egg whites, suggesting that there may be benefits to the extra nutrients found in the egg yolk. [00:12:53] Why Stu believes the recommended daily allowance for protein is too low. [00:14:06] The differences between animal and plant-based protein. [00:16:31] The phenomenon of muscle synthesis (anabolism) and catabolism. [00:17:54] Highlights of the recent findings coming out of Kevin Tipton’s group which indicates that the dose-response relationship may depend on the amount of muscle tissue that was recruited during exercise, with the ingestion of 40 g protein further increasing muscle protein. [00:20:43]A 2013 paper from Stu’s group titled, “Dose-dependent responses of myofibrillar protein synthesis with beef ingestion are enhanced with resistance exercise in middle-aged men.” [00:27:52] Stu’s thoughts on the recommendation of pre-sleep protein feeding. [00:37:52] An overview of the Physical Activity Centre of Excellence, a state-of-the-art, exercise research and training lab at McMaster. [00:43:37] The importance of maintaining healthy functional muscle mass and function as we move into middle and later life. [00:46:56] Stu’s paper, “Muscle Disuse as a Pivotal Problem in Sarcopenia-Related Muscle Loss and Dysfunction.” [00:50:25] The need to add more protein to our diets as we get older, which is something that Dr. Valter Longo discussed on episode 64 of STEM-Talk. [00:56:24 How fasting affects muscle protein turnover, which were topics covered in episode 7 of STEM-Talk, an interview with Mark Mattson, and episode 79, which was an interview with Satchin Panda, author of the “The Circadian Code.” [00:57:32] Whether a ketogenic diet with sufficient protein would in any way be detrimental to muscle mass. [01:05:47] Stu’s thoughts on a study that was conducted on behalf of the American College of Sports Medicine that found supplementation with HMB failed to enhance body composition to a greater extent than a placebo. Show notes [0:02:51] Stu talks about being born in the UK but growing up in Canada. [00:03:09] Dawn asks about Stu’s passions for all kinds of sports as a kid. [00:03:27] Stu recalls his high school science teacher, who was responsible for getting him interested in biology and chemistry. [00:03:44] Dawn asks what led Stu to choose McMaster University after high school. [00:04:19] Ken brings up that Stu was captain of the Ruby team his senior year, and while it looked as though he was headed to a great season, things didn’t turn out as planned. He asks how that season led to Stu’s decision to focus on nutritional biochemistry. [00:05:16] Stu explains how he ended up at Waterloo University to work on a doctorate in physiology. [00:06:01] Dawn asks Stu why he headed off to Texas after graduating from Waterloo. [00:06:36] Dawn asks if it is true that after three years in Texas, Stu moved back to Canada to get married. [00:07:18] Stu talks about why he went back to McMasters to study protein, exercise, and muscle synthetic versus catabolic dynamics, among other things. [00:08:19] Dawn asks how Stu first became interested in the process by which protein plays a role in regenerating muscle, making it one of the only macro nutrients we need on a daily basis, and to give listeners an overview on the importance of dietary protein. [00:09:49] Dawn asks Stu how much of his work has focused on muscle- protein turnover and if changes in muscle-protein turnover directly correlate with changes in muscle growth. [00:10:59] Ken mentions that many protein-intervention studies use supplementation in the form of whey, which has a clear benefit from a muscle standpoint given its high leucine content and convenience. He goes on to mention, however, that some research

Our guest today is Dr. Charles Brenner, the Roy J. Carver Chair of Biochemistry at the University of Iowa. Charles is one of the world’s leading experts on nicotinamide adenine dinucleotide, commonly referred to as NAD, which is an essential molecule found in every living cell. In 2004, he discovered the nicotinamide riboside kinase pathway, which leads to a special form of vitamin B3. We talk to Charles about his research into NAD and why he believes supplementation with NR could help people age better. In addition to his work at the University of Iowa, he is also the chief scientific advisor for ChromaDex, which markets the NR supplement Tru Niagen. Toward the end of our interview, Charles talks about dozens of exciting new papers and studies that are on the horizon. One of those papers – Maternal Nicotinamide Riboside Enhances Postpartum Weight Loss, Juvenile Offspring Development, and Neurogenesis of Adult Offspring– was published in Cell Reports on the same day as our interview with Charles went live. Also in today’s interview, we discuss: [00:06:29] How Charles became the first cancer biology graduate student in the biology department at Stanford University. [00:07:51] Charles’ research into nicotinamide adenine dinucleotide (NAD) during his time on the faculty at Thomas Jefferson University. [00:09:15] Charles’ discovery that nicotinamide riboside (NR) is a precursor of NAD. [00:19:47] Why Charles doesn’t use the term “anti-aging.” [00:25:52] The importance of nicotinamide adenine dinucleotide phosphate (NADPH) and its role as the central regulator of reactive oxygen species toxicity. [00:34:56] The circadian rhythms of NAD and the potential benefit of diurnal dosing. [00:38:45] Why skeletal muscle is one of the most sensitive target tissues for the anti-aging effects of NMN. [00:45:42] How the benefits of a ketogenic diet, intermittent fasting, time restricted eating could be related to NAD. [00:47:02] A recent human trial conducted by the University of Colorado that found Niagen increased NAD+ by 60 percent in healthy middle-aged and older adults after just six weeks. [00:49:19] The optimal dose of NR for humans. Show notes: [00:03:06] Charles talks about growing up as a kid who dreamed about becoming either a comedian or rabbi. [00:03:26] Charles describes his success on the math team in high school and how he also enjoyed playing tennis and running cross-country. [00:03:43] Charles reflects on his decision to attend Wesleyan University. [00:04:09] Although Charles decided to major in ecology, he found out upon arriving at Wesleyan that they did not have an ecology department. [00:05:05] Dawn mentions that after graduating with honors in biology, Charles traveled across the country to work in the Bay Area. She asks him what he did. [00:06:29] Charles talks about when and why he became interested in cancer research, and how he was the first cancer biology graduate student in the biology department at Stanford University. [00:07:51] Dawn asks about the work Charles did from 1996 to 2003 on nicotinamide adenine dinucleotide (NAD) during his time on the faculty at Thomas Jefferson University. [00:09:15] Ken brings up Charles’ research at Dartmouth, asking about his discovery that nicotinamide riboside (NR) is a precursor of NAD. [00:12:35] NAD is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a co-substrate for other enzymes. Charles gives an overview of the research into NAD and its relationship to overall health and age-related diseases. [00:19:47] Dawn asks Charles why he doesn’t use the term “anti-aging.” [00:20:54] Charles discusses how Verdin and numerous other investigators have reported that NADcontent declines with age in multiple organs, such as pancreas, adipose tissue, skeletal muscle, liver, skin, and brain, as well has his own hypothesis. [00:25:52] Charles gives an overview of nicotinamide adenine dinucleotide phosphate (NADPH), which is particularly important because of its role as the central regulator of reactive oxygen species toxicity. [00:29:19] Dawn asks about experiments Charles’ lab conducted on mice that looked at obesity and type-2 diabetes. [00:33:08] Dawn asks if there is an easy way someone can determine if their NAD levels are dysregulated. [00:34:56] Ken asks Charles about the circadian rhythms of NAD, and the potential benefit of twice a day dosing. [00:36:02] Charles discusses why one shouldn’t simply supplement directly with NMN, despite the findings of a 2016 Cell Metabolism paper. [00:38:45] According to the Cell Metabolism study (linked in the previous question), the authors suggest that skeletal muscle is one of the most sensitive target tissues for the anti-aging effects of NMN. Charles discusses his thoughts on this. [00:40:42] Some people are going the route of intravenous NAD infusions. Since it is believed that

Our guest today is Dr. Butler Hine, the Flight Project Manager and Chief Technologist for Engineering at the NASA Ames Research Center in Mountain View, California. Butler is also a senior research scientist and a colleague of Ken and Dawn at IHMC. Butler is currently the project manager for NASA’s Arcus mission, which is an X-ray observatory that has a possible launch date of 2023. The mission will include a high-resolution X-ray grating spectrometer that will study the hot gas that is the dominant component of the normal matter in the Universe, much of which has not yet been directly seen. In today’s interview, we discuss: [00:03:57] How Butler became interested in astronomy and started building telescopes as a youth. [00:08:37] How Butler wound up managing the robotics lab at NASA. [00:11:55] The challenges of trying to change the thinking of the science community about ways to adapt technology to science. [00:17:34] Artificial intelligence and data mining. [00:26:59] The Lunar Atmosphere and Dust Environment Explorer mission, also known as LADEE. [00:30:07] The concept of modularity in spacecraft design. [00:41:58] The scientific goals of NASA’s Arcus mission, which Butler is currently managing. [00:45:58 The complexity of developing a robotic platform for space or lunar exploration [00:51:24] The future of robotic space exploration. Show notes: [00:02:27] Butler begins the interview talking about moving around a lot as a youth because of his father’s career in the Army. [00:03:17] Butler talks about growing up as “classic nerd,” and the influence that the Apollo Moon landings had him. [00:03:57] Butler describes how he became interested in astronomy in junior high school started building telescopes. [00:05:49] Dawn asks what the difference is between science and science implementation, something Butler became interested in during graduate school. [00:06:40] Butler discusses going to NASA Ames Research Center for his post-doc work. [00:08:37] Butler talks about how he wound up managing the robotics lab at NASA. [00:09:29] During his time with the robotics lab, Butler worked on performing field-science investigations through remote mobile platforms in an attempt to approximate what a scientist does in the field. Ken asks what the primary challenges were in this work. [00:11:55] Butler describes the difficulty of trying to change the thinking of the science community about ways to adapt technology to science, such as getting people to buy into the usefulness of remote planetary rovers. [00:15:20] Butler talks about virtual-reality techniques for presenting complex information that he and his team at Ames developed, and how he left NASA to create a company to apply those techniques to other areas. [00:17:34] Dawn asks about a program Butler pushed for in the mid-to-late ’90s that focused on artificial intelligence and data mining. [00:20:11] Dawn asks about Butler’s days at NASA that overlapped with Ken’s time at the agency. [00:21:14] Ken asks how Butler become interested in developing low-cost, high-performance spacecraft designs. [00:26:59] Butler talks about becoming the project manager for the Lunar Atmosphere and Dust Environment Explorer mission, otherwise known as LADEE. [00:30:07] Ken asks if Butler thinks that the concept of modularity in spacecraft design is something that will be embraced in future missions. [00:32:16] Dawn asks what the scientific objectives of the LADEE mission were. [00:35:38] Butler talks about how LADEE was not only a science mission, but it also showcased several new technologies. [00:37:35] Butler discusses the trajectory of LADEE from launch to its impact into the backside of the moon. [00:41:58] Butler talks about the scientific goals of NASA’s Arcus mission, which he is currently managing. [00:44:30] Ken asks about the new technologies that are driving the Arcus mission. [00:45:58] Dawn asks about the complexity of developing a robotic platform for space or lunar exploration and what the makeup of Butler’s team at NASA Ames looks like for these missions. [00:48:30] Butler gives advice for young people interested in a science career and perhaps one day working at NASA. [00:51:24] Dawn asks what Butler sees as the exciting next steps in robotic space exploration. [00:54:45] Ken ends the interview asking Butler what he does with his free time. Links: Butler Hine bio NASA LADEE website Learn more about IHMC STEM-Talk homepage Ken Ford bio DawnKernagisbio

Dr. Satchin Panda is a professor and researcher at the Salk Institute who has become recognized as one of the world’s leading experts on circadian rhythm. In today’s wide-ranging interview, he discusses how the body’s natural day-night cycle can help us improve our health, get a better night’s sleep and lose weight. He also shares how adopting a lifestyle that is aligned with the body’s natural internal clock can even help us prevent and reverse disease. Satchin also has been generating significant attention for his research into the health benefits of time-restricted eating. He is the author of “The Circadian Code” and in today’s interview he shares how listeners can become involved in a research project he and his colleagues are conducting through a smartphone app called My Circadian Clock. In addition to his work at the Salk Institute, Satchin is also a founding executive member of the Center for Circadian Biology at the University of California, San Diego. Key topics covered in today’s interview include: [00:03:46] How a rapidly evolving modern society disrupts the interconnectedness of our biological rhythms. [00:13:41] How Satchin became interested in circadian rhythms and metabolism. [00:17:11] Satchin’s first mouse study on time-restricting feeding, which so surprised him that he ended up repeating the study three times. [00:21:37] The role of ketosis in time-restricted eating, particularly in regard to weight loss and potential health benefits. [00:25:01] Whether having black coffee signals the beginning of a person’s eating window. [00:27:31] The potential use of caffeine to treat jet lag induced by international time-zone travel. [00:29:31] Satchin’s mouse studies that looked at obesity and type-2 diabetes. [00:30:58] The dangers of shift work and the importance of sleep. [00:45:39] Satchin talks about the importance of darkness when it comes to sleep and our circadian rhythms. [00:48:42] Satchin’s 2017 paper in Aging Research Reviews titled “ Circadian rhythms, time-restricted feeding, and healthy aging.“ [00:51:59] Satchin’s recent paper in Cell Metabolism, “Time-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian Clock.” [01:00:19] The role of diet in people who lost weight during time-restricted feeding. [01:06:30] “My Circadian Clock,”an app Satchin and his lab at Salk Institute have developed. [01:20:02] Satchin discusses how he convinced his mother to try time-restricted eating. [01:25:32] What Satchin’s diet and eating window looks like on a typical day. Show notes: [00:03:05] Satchin begins the interview talking about being raised in India and his parents’ expectation that he would become a doctor or engineer. [00:03:46] Satchin talks about his book “The Circadian Code,” which is dedicated to his maternal and paternal grandparents. He touches on how a rapidly evolving modern society disrupts the interconnectedness of our biological rhythms. [00:06:14] Satchin shares how when he was a junior in high school, he lost his father in an accident with a truck driver. [00:07:21] Dawn asks Satchin to talk about how going to agricultural school like his father did cemented Satchin’s interest in science. [00:08:44] Dawn asks how Satchin ended up with a research job at a flavor and fragrance manufacturer in India after finishing his master’s degree. [00:10:10] Satchin talks about what led him to Canada and eventually the U.S. [00:11:21] Ken asks Satchin why he decided to pursue at Ph.D. in plant circadian rhythm. [00:13:41] The circadian rhythm field primarily focuses on understanding the timing mechanism in biological systems like plants, fruit flies, mice and humans. Satchin discusses how he took a different route and became interested in circadian rhythms and metabolism. [00:15:13] Dawn asks what it is like to work at the Salk institute, a place where Nobel laureates such as Francis Crick once worked. [00:17:11] Satchin talks about his first time-restricted feeding mouse study, which so surprised him that he repeated the study three times. [00:19:03] Ken asks Satchin what he was expecting to learn when he started the mouse studies. [00:20:06] Dawn asks about Satchin’s published findings of his experiments in 2012, which raised the question of whether eight hours was the magic number for time-restricted eating. [00:21:37] Knowing that people go into ketosis after 12 to 16 hours without food, Dawn asks if Satchin has looked at the role of ketosis in time-restricted eating, particularly in regard to weight loss and potential health benefits. [00:22:39] In the mouse studies, the mice that followed time-restricted eating also had an endurance benefit. Dawn asks if Satchin thinks this might also be related to ketosis. [00:25:01] Satchin says in his book, “The moment you eat breakfast, or have your first cup of coffee or tea, is the beginning of your eating window.” Dawn points out that Satchin also says in the book that water doesn’t signal the start of the eating win

SEO: Jeff Phillips, Naval Medical Research Unit, University of Alabama, F-22 Raptors, hypoxia, oxygen saturation measurement, arterial gas embolism, aircraft oxygen systems, physiologic episodes, Delores Etter Award, Ken Ford,Dawn Kernagis,Jon Clark,IHMC Today’s interview is with IHMC Research Scientist Dr. Jeff Phillips. Jeff joined IHMC a year ago after spending six years as a research psychologist at the Naval Medical Research Unit in Dayton, Ohio. He worked almost exclusively on hypoxia in tactical aviation and was part of team that was instrumental in getting the F-22 Raptors back into operation after a series of hypoxia-related episodes among jet pilots. In 2012, Jeff won the Dolores Etter Award, which the Department of Navy annually awards to its top performing scientists and engineers. Jeff is a University of Alabama graduate who earned his Ph.D. in experimental psychology. At IHMC, he works on research that ranges from physical and cognitive performance in extreme conditions to the role that ketone esters can play in protecting special operators from hypoxia, fatigue and other issues. Because Dawn Kernagis was in London giving a presentation when we conducted our interview with Jeff, IHMC Senior Researcher Jon Clark joined Ken Ford to co-host the episode. In today’s episode, we discuss: [00:15:45] Jeff’s participation on a team that investigated hypoxia-like episodes F-22 pilots in the Air Force were having. [00:17:02] The problems with aircraft oxygen systems (OBOGs) and the related physiologic episodes (PE) that extend beyond the F-22 to virtually all frontline tactical jet aircraft. [00:18:19] The physiological effects of hypoxia on the brain and the associated cognitive and perceptual performance deficits. [00:19:54] The most promising technologies for detecting a hypoxia event. [00:29:10] The challenge of understanding what may be a multifaceted phenomenon like OBOGS-related PE events. [00:32:30] Studies that have shown pure oxygen in the lungs causes the alveolar cells to collapse. [00:37:10] The possibility that increased breathing (hyperventilation) may be occurring in aircrew involved in PE events who develop rapid onset hypoxia-like symptoms. [00:48:36] The role that mindfulness plays in elite performance as well as day-to-day life. Show notes: [00:06:06] Jeff talks about growing up in Sandflat, Alabama. [00:06:57] Jon asks Jeff what he was like as a kid. [00:07:32] Jeff talks about the impact that reading Stephen Hawking’s “A Brief History of Time” had on him. [00:08:19] Jeff explains how he headed off to the University of Alabama expecting to become a newspaperman, but ended up switching his major to psychology. [00:09:50] Jon asks Jeff about his mentors at Alabama who encouraged him to purse a doctorate in experimental psychology. [00:11:50] Jeff talks about a paper he helped author on handshaking and how it generated so much attention that he was interviewed by the Associated Press and network news shows. [00:14:16] Jon asks Jeff how he ended up at the Naval Aerospace Medical Research Laboratory in Pensacola, Florida. [00:15:02] Ken asks Jeff to describe the work he did at the Pensacola lab. [00:15:45] Jeff talks about becoming part of a team that investigated hypoxia-like episodes F-22 pilots in the Air Force were having when the Pensacola lab relocated to Dayton, Ohio. [00:17:02] Ken points out that problems with aircraft oxygen systems (OBOGs) and the related physiologic episodes (PE) extended beyond the F-22 and affected virtually all frontline tactical jet aircraft. Ken asks Jeff to talk about the how the different military services approached the problem. [00:18:19] Ken asks Jeff about the physiological effects of hypoxia on the brain and the associated cognitive and perceptual performance deficits. [00:19:16] Jon asks Jeff about his participation in studies that assessed different oxygen saturation measurement techniques. [00:19:54] Ken asks Jeff about the most promising technologies for detecting a hypoxia event. [00:21:29] Jon points out that Jeff has been involved in studies that demonstrated a residual cognitive deficit that pilots had following a hypoxic exposure that was still present at two hours after recovering on room air. Jon asks Jeff if he knows why this deficit exists so far after hypoxic exposure. [00:23:41] Jon points out one possible cause of prolonged symptoms is arterial gas embolism causing bubbles in the brain. This is why US aircraft carriers have been recently fitted with hyperbaric chambers to treat aircrew for AGE. The suspected mechanism is sudden pressure fluctuations in the breathing system that is causing over-pressurization to the lungs that some aircrew have experienced. Jon asks Jeff if he thinks that this mechanism could account for prolonged symptoms. [00:024:52] Ken asks if there is a good return-to-duty marker or assessment tool for pilots following a hypoxic exposure. [00:26:14] Jeff gives an overview of the different laboratory-based simula

Our guest today is Dr. John Ioannidis, a Stanford professor who has been described by “BMJ” as “the scourge of sloppy science.” Atlantic magazine has gone so far as to refer to him as one of the world’s most influential scientists. John is renowned for his 2005 paper, “Why Most Published Research Findings Are False,” which has been viewed more than 2.5 million times and is the most citied article in the history of the journal PLoS Medicine. He has authored nearly a thousand academic papers and has served on the editorial board of 30 top-tier journals. At Stanford, John is a professor of medicine, of health research and policy, and of biomedical data science in the school of medicine as well as a professor of statistics in the school of humanities and sciences. He is the co-director of the university’s Meta-Research Innovation Center and the former director of the Stanford Prevention Research Center. In today’s wide-ranging interview, John talks about: [00:07:43] What led him to begin questioning the reliability of medical research during his residency at Harvard. [00:12:03] His 2005 paper, “Why Most Published Research Findings Are False.” [00:26:27] How a major issue facing science is a lack of replication. [00:30:51] Which studies are worse, nutritional studies or drug studies. [00:38:25] If it’s possible to remove sampling biases like the healthy user bias. [00:46:50] The need for scientists to disclose their personal dietary biases as well as their personal diets when publishing research findings. [00:52:40] His recent paper, “Evidence Based Medicine Has Been Hijacked,” which argues that vested interests have transformed clinical medicine into something that resembles finance-based medicine. [00:55:36] The impact that funding pressure is having on the veracity of research being done today. [01:08:42] The need for future research to be designed by scientists without vested interests. [01:14:58] The ways John would fix the system if he had magic wand. [01:18:42] And as a bonus, John reads an excerpt from his latest book. Show notes: [00:02:37] Dawn begins the interview asking John about being born in New York but raised in Athens. [00:03:54] John talks about how his parents were physicians and researchers and how they instilled in him a love for mathematics at an early age. [00:05:26] Dawn asks John about winning the Greek Mathematical Society’s national award when he was 19 years old. [00:06:23] John talks about his decision to go to medical school and to attend Harvard. [00:07:43] Ken mentions that John began questioning the reliability of medical school during his residency at Harvard, and asks John to talk about his interest in an “evidence-based medicine” movement that was gathering momentum at the time. [00:08:47] Dawn asks John about his work with the late Tom Chalmers, who played a major role in the development of randomized controlled trials. [00:09:58] John talks about returning to Greece to take a position at the University of Ioannina. [00:12:03] John talks about his 2005 paper “Why Most Published Research Findings Are False,” which became the single most-cited and downloaded paper in the history of the journal PLoS Medicine. [00:15:32] Dawn mentions that when the paper came out, it was theoretical model. She asks John to talk about how now there are a number of studies pointing out problems with preclinical research on drug targets. [00:17:34] Dawn asks John about his decision to leave the University of Ioannina to take a position at Stanford University. [00:21:02] Dawn asks John for his thoughts on ways to improve the peer-review process. [00:24:09] John talks about how he and his colleagues have found that most medical information that doctors rely on is flawed. [00:26:27] Dawn points out that a major issue facing science is a lack of replication. She talks about how funding for repeat studies is hard to come by and that many journals will reject data that replicates previously published work. She asks John for his thoughts about ways to change this. [00:29:14] Ken asks John if he sees interesting variations across disciplines. [00:30:51] Ken follows up with a question about which studies are typically worse: nutritional studies or drug studies? [00:31:28] John talks about the issues with nutritional epidemiology that stems from the often-implausible results arising from food frequency questionnaires. [00:33:04] Dawn mentions that John has talked about the importance of getting nutritional epidemiology right because people are dying from bad decisions. She asks John if we’re at a point where we should scrap all nutritional epidemiological findings. [00:36:20] Ken talks about how John has shown that almost all of the variables in nutritional epidemiology are connected, which partly explains multiple positive results. Ken asks John if there is a way to adjust for that. [00:38:25] Ken points out that many studies proclaim they have adequately adjusted for multiple known health risk factors such

Today’s episode features Dr. Dava Newman, the first female engineer to serve as NASA’s deputy administrator. Dava is currently the Apollo Professor of Astronautics at the Massachusetts Institute of Technology. For more than 20 years, she has worked passionately to figure out what it will take to put humans on Mars. She is perhaps best known, however, for developing a next-generation spacesuit called the BioSuit, a slim-fitting compression suit that’s designed to make it easier for astronauts to move around on lunar surfaces. Dava joined the faculty at MIT in 1993 and served as NASA’s deputy administrator from 2015 to 2017. She also is on the faculty of the Harvard–MIT Health, Sciences, and Technology department. As the director of MIT’s Technology and Policy Program from 2003 to 2015, she led the institute’s largest multidisciplinary graduate research program with more 1,200 alumni. She is the author of “Interactive Aerospace Engineering and Design,” an introductory engineering textbook, and has published more than 300 papers. Links to Dava’s book, papers and bio, as well as videos of the BioSuit, are included at the bottom of the show notes. In today’s interview with Dava, we discuss: [00:03:01] Her memories of watching the Apollo Moon landings as a child. [00:06:36] How Dava made the Notre Dame women’s varsity basketball team as a walk-on. [00:09:49] Her work over the past 20 years to get people on Mars. [00:11:19] Dava’s thinking behind the design of a slim-fitting spacesuit. 00:15:12] The physiological monitoring systems she would like to see incorporated into next-generation spacesuits. [00:26:00] How she thought the call from the White House about the NASA position was a prank. [00:27:06] Dava’s takeaways from her four space missions to measure astronaut performance in microgravity. [00:28:41] Her transition back to MIT after her stint as NASA deputy administrator. [00:38:42] Dava’s advice for today’s young aspiring scientists and engineers, a group she says will become known as the Mars generation. Show notes: [00:02:30] Dawn begins the interview by asking Dava to elaborate on comments she has made about having the best job in the world. [00:03:01] Dawn asks Dava about growing up in Montana during the Apollo years and watching the moon landings on TV. [00:03:43] Dava talks about her years in middle school and high school. [00:04:17] Ken asks Dava about her decision to attend Notre Dame. [00:05:40] Dava talks about how she was often the only women in her science and engineering classes back in the early 1980s. [00:06:36] Dawn asks Dava about making the Notre Dame women’s varsity basketball team as a walk-on. [00:08:30] Dawn asks Dava about her decision to write an introductory aerospace engineering textbook shortly after accepting a faculty position at MIT. [00:09:49] Dava talks about how her goal of getting people to Mars has been a passion of hers for the past 20 years. [00:11:19] Ken points out that Dava is perhaps best known for designing a slim-fitting spacesuit call the BioSuit. Ken asks Dava what motivated her to redesign spacesuits. [00:13:38] Dawn asks Dava what human bio-energetic requirements will look like for lunar surface operations and how they differ from current EVA operations? [00:15:12] Dawn asks Dava about the physiological monitoring systems she would like to see incorporated into next generation spacesuits. [00:17:09] Dava talks about how spacesuit design has faced significant biomedical challenges, particularly for women. [00:21:30] Ken mentions that Dava wrote the proposal for the BioSuit while on a sailing trip during a sabbatical, and follows up by asking her to tell the story of how she and her husband became stranded in the middle of the Pacific. [00:26:00] Dava explains that when she got a call from the White House about becoming the deputy administrator for NASA, she thought the phone call was a prank. [00:27:06] Dawn points out that Dava has flown four space experiments to measure astronaut performance in microgravity. Dawn asks Dava what stands out in terms of those experiences. [00:28:41] Dava talks about her transition back to MIT after her time as NASA deputy administrator. [00:31:09] Ken asks Dava for her thoughts on the Space Launch System, a space shuttle-derived super heavy-lift expendable launch vehicle. [00:32:21] Ken talks about InSight, a robotic lander that has been designed to study the interior of Mars and is expected to land on the planet in time for Thanksgiving. Ken asks Dava to give an overview of the mission and how it might lead to a new understanding of Mars. [00:35:05] Dava talks about how in addition to Mars, teaching is another one of her passions and that she is particularly interested in getting more women and people of color into science. [00:37:29] Dawn asks Dava about her role models who helped guide her career path. [00:38:42] Dava ends the interview talking about how young people today, especially teen-agers, will become known as the Mars

Today’s guest today is Rob Mueller, one of NASA’s senior technologists who is leading an effort to establish a base station on the Moon, and eventually Mars, as well as other destinations in the solar system. Rob is the senior technologist for the Advanced Projects Development at NASA Kennedy Space Center and a co-founder of Swamp Works, an innovation lab that has brought together NASA engineers, researchers and scientists to work on creating Spaceports across the solar system. As most of our listeners know, NASA has been working toward an eventual mission to Mars. But before venturing to Mars, NASA first plans to build a lunar base on the Moon. In announcing the agency’s decision to return to the Moon, NASA Administrator Jim Bridenstine said that this time the agency isn’t interested in just leaving flags and footprints on the lunar surface. “This time when we go, we’re going to go to stay,” he said. As part of this mission, Rob’s work is particularly focused on ways to excavate and mine the resources of space so that astronauts and eventually others will be able to live off the land in space. In today’s interview, Rob talks about his nearly 30-year career with NASA as well as the future of space exploration. Topics we cover include: [00:12:40] In order to survive and thrive in space, we need to be able to build things in space. [00:14:51] Rob’s lab at NASA called Swamp Works. [00:18:44] Swamp Works’ goal of expanding civilization into the solar system. [00:20:33] The Regolith Advanced Surface Systems Operations Robot project. [00:24:59] How there are billions and billions of times the resources in outer space than here on Earth, and our potential to excavate these materials. [00:30:41] The Lunar Orbital Platform-Gateway. [00:35:29] NASA’s decision to return to the Moon before venturing to Mars. [00:37:33] How new technologies being developed for Spaceflight could eventually have applications on Earth as well. [00:40:29] How to survive and thrive on the Moon and Mars, we will need to be able to build landing pads, habitats and roads. [00:49:03] A partnership Swamp Works has with Astrobotic to develop a micro-rover. [00:51:11] How the regolith of the Moon, Mars and other planets as well as asteroids contain valuable resources. [00:54:12] The future of space exploration. [00:57:16] How Rob responds to people who question the cost and relevance of going to the Moon and beyond. [01:02:13] And if people are a little less likely to take Rob’s phone call given that there’s a Robert Mueller in Washington who’s conducting a Russian investigation. Show notes: [00:03:26] Rob talks about growing up in Portugal and how Rob ended up with an international background as a kid because of his father’s work. [00:04:00] Dawn asks Rob if it’s true that as a 12-year-old he was a pioneer of surfing in Portugal. {00:04:40] Rob talks about how his interest in advanced technology led him to the states and the University of Miami after graduating from high school. [00:06:48} Rob describes how he graduated from Miami shortly after the Challenger accident and ended up applying for a job at NASA. [00:07:56} Ken points out that it was an O-ring on the Solid Rocket Boosters that failed to maintain a seal that led to the Challenger explosion. Ken asks Rob to talk about how he came to work on the Solid Rocket Boosters when NASA hired him in 1989. [00:10:09] Rob talks about he actually was more interested in robotics than space when he went to work at the Kennedy Space Center. [00:11:02] Dawn asks Rob about his decision to work on an MBA at the Florida Institute of Technology while he was working at NASA. [00:11:45] Dawn follows up with a question about how Rob ended up in the Netherlands studying for a master’s degree in internal space systems engineering. [00:12:40] Dawn points out that Rob has been at NASA for nearly 30 years and that he is often quoted as saying that if we are going to survive and thrive in space we need to be able to build things in space. She asks Rob to explain what he means by that. [00:14:51] Rob talks about his lab at NASA, called Swamp Works, and how the lab is trying to foster a more innovative environment at the space agency. [00:17:43] Dawn asks Rob how he came up with the name Swamp Works. [00:18:44] Rob mentions that a goal of Swamp Works is to expand civilization into the solar system. Dawns asks him to talk about what that means. [00:20:33] Ken points out the Rob is the lead technologist for the Regolith Advanced Surface Systems Operations Robot project, and asks Rob to talk about his work in this area. [00:24:59] Ken mentions that Carl Sagan was known to say that there are billions and billions of times the resources in outer space than here on Earth. Ken asks Rob to talk about the potential and possibilities that our ability to excavate these materials will provide. [00:27:56] Dawn talks about how we will need new technologies if we’re going to survive and thrive in space. She asks Rob about 3D printing,

Today’s guest is a science journalist and author who has written extensively about the pharmaceutical industry. Robert Whitaker is also the founder of Mad in America, a nonprofit organization that focuses on getting people to rethink psychiatric care in the United States. As you will learn in today’s episode, one in six Americans takes a psychiatric drug. More than 130,000 children under the age of five are taking addictive anti-anxiety drugs prescribed by doctors. Whitaker has spent most of his career focused on changing the current drug-based paradigm of psychiatric care in the U.S. He has written three books about the pharmaceutical industry and the psychiatric profession. He has looked at how drugs used for depression, bipolar disorder and schizophrenia are causing a spike in America’s disability numbers. He also has investigated the history of medications prescribed for these disorders, how they are marketed, and why they’ve grown in popularity. Discover magazine named Whitaker’s first book, “Mad in America,” one of the best science books of 2002. His second book, “Anatomy of an Epidemic,” won the 2010 Investigative Reporters and Editors book award for best investigative journalism. His third book, “Psychiatry Under the Influence,” is a textbook used in university classrooms around the country. In today’s interview, we discuss: [00:11:08] When Robert first became disillusioned with the pharmaceutical industry [00:16:53] How Robert’s investigation into schizophrenia in the U.S. led him to write his first book, “Mad In America.” [00:26:58] Why the U.S. has seen such a sharp increase in the number of disabled, mentally ill people since the advent of psychotropic medications. [00:45:10] How many drugs may have efficacy in clinical trials over the short term, but overwhelming evidence shows over the long term many medications actually increase a person’s risk of becoming chronically ill and functionally impaired. [01:00:43] Robert’s investigation into the FDA’s review of studies that looked at Prozac [01:03:38] Antidepressants and their side effects. [01:08:40] How concerns over ADHD have led to an alarming percentage of children, especially boys, being drugged for exhibiting what once considered normal or at least acceptable behavior. And much more. Show notes: [00:02:24] Robert talks about growing up in Denver and taking family vacations around the country. [00:03:48] Robert explains how in high school he was so convinced he was going to attend Stanford University that he didn’t bother to apply to another college. [00:05:48] Dawn mentions that Robert graduated with a degree in English literature and after college decided he wanted to lead a life of adventure. Dawn asks him where that career path took him. [00:07:11] Robert talks about abandoning his dream of becoming a novelist and taking a job at a small newspaper in upstate New York. [00:08:51] Dawn points out that Robert eventually went to work for a newspaper in Albany, N.Y., where he became a medical writer. She asks him about the year he spent as a Knight Science Journalism fellow at MIT. [00:09:50] Ken asks Robert about moving to Boston and becoming director of publications at Harvard Medical School. [00:11:08] Robert talks about co-founding CenterWatch, a publishing company focused on the business of clinical drug trials. He describes how he became disillusioned with the pharmaceutical industry because it seemed to him that clinical trials had become so commercialized that they were corrupting the testing of new drugs. [00:13:44] Ken mentions that during this period, Robert came upon information about abuses of psychiatric patients in research settings. Ken asks Robert to share how he took this information and went to the Boston Globe to propose a newspaper series. [00:16:53] Dawn describes how the work Robert did for this series in the Boston Globe led him to information that schizophrenics in the U.S. were faring worse than patients in the world’s poorest countries. Dawn asks Robert to talk about how this information led him to write his first book, “Mad In America.” [00:19:42] After “Mad In America,” Robert became convinced that much of the information medical professionals were sharing with the mainstream press was out of sync with the science. Robert describes a scene in the movie “A Beautiful Mind” that he says illustrates this sort of misinformation. [00:21:43] Ken asks Robert about the criticism he received after the publication of “Mad In America.” [00:23:30] Dawn mentions that even though Robert had decided not to write another book about psychiatry, he started looking at disability numbers and became curious as to why there was an extraordinary rise in the number of people in the U.S. going on disability. Dawns asks Robert about the book that came about because of that curiosity, “Anatomy of an Epidemic.” [00:26:58] Ken points out that the book investigates why the U.S. has seen such a sharp increase in the number of disabled, mentally

Nearly 60,000 Americans are diagnosed with Parkinson’s disease every year in the U.S. The disease is an incredibly complex disorder that affects more than 10 million people worldwide. Our guest today is Dr. Michael Okun, who is considered the world’s foremost authority on the treatment of Parkinson’s.He is the Adelaide Lackner Professor and Chair of Neurology at the University of Florida Health College of Medicine as well as the co-director of the university’s Fixel Center for Neurological Diseases. The center is known for its interdisciplinary faculty that provides a one-stop, patient-centered clinical research experience that attracts patients from around the world. Since 2006, Michael has been the National Medical Director for the Parkinson’s Foundation and works very closely with a wide range of organizations such as the Michael J. Fox Foundation. The American Society for Experimental Nuerotherapeutics recently awarded Michael the 2018 Presidential Award. In 2015, he was recognized during a White House ceremony by the Obama administration as a “Champion for Parkinson’s Disease.” Michael also is an accomplished writer with more than 400 peer-reviewed articles and even a book of poetry. In today’s episode, we discuss: [00:17:56]What Parkinson’s disease is and the wide range of symptoms that can arise as a result of the disease. [00:29:19] How Parkinson’s disease is diagnosed since there is no specific test that can diagnose the disease. [00:32:11] The common risk factors associated with neurodegenerative disease. [00:38:20] The actor Alan Alda’s recent announcement that he has been living with Parkinson’s for more than a year. [00:41:04] A UCSF study that looked at the prevalence of Parkinson’s among veterans who had experienced traumatic brain injury. [00:46:32] Treatments that are available for Parkinson’s. [00:55:57] The cognitive, behavioral and mood effects of deep-brain stimulation. [01:17:11] The potential use of brain prosthetics or orthotics in patients with neurological disease. [01:29:26] Whether Parkinson’s therapy is moving toward local, systemic or a combination of the therapies. [01:31:48] The relationship between metabolism and nutrition and the progression of Parkinson’s disease. And much more. Show notes: [00:02:53] Michael begins the interview taking about growing up in West Palm Beach, Florida, and his love of baseball and collecting baseball cards. [00:03:39] After high school, Michael decided to attend Florida State University and focus on a liberal arts education. Dawn asks Michael if it’s safe to assume he wasn’t thinking about medical school when he started college. [00:04:53] Dawn asks Michael how a history major ultimately decides to become an MD. [00:06:18] Ken asks Michael to elaborate on a funny story about how he ended up going to the University of Florida for medical school. [00:10:10] Michael talks about how went to med school thinking he wanted to be a black-back family practitioner, but became so interested in neurology that he changed his mind. [00:13:06] Ken mentions that during Michael’s time at Florida, he became fascinated by what was going on in the brain of people who had tremors. Ken asks Michael if that is what led him to focus on Parkinson’s disease during his postdoc at Emory? [00:17:56] Even though most people are familiar with images of people like Michael J. Fox and Mohammed Ali who have tremors, most people aren’t aware that Parkinson’s has a wide range of symptoms, which makes it an incredibly complex disease. Michael gives an overview of Parkinson’s and the various symptoms that can arise as result of the disease. [00:22:29] Since Parkinson’s is such a remarkably complex and multi-system disease, Ken asks Michael how he integrates the different clinical disciplines that are required to treat someone with Parkinson’s. [00:29:19] Ken mentions that there is no specific test to diagnose Parkinson’s, and asks Michael if the disease is primarily diagnosed by symptoms. [00:32:11] Dawn mentions that when people are diagnosed with Parkinson’s, it means they don’t have Alzheimer’s or ALS. However, neurodegenerative diseases often have common risk factors such as type 2 diabetes or environmental exposures or trauma, as well as a neuroinflammatory or oxidative stress component. Ken asks what makes these diseases different beyond the specific areas of brain anatomy that they affect, and why might somebody with a given set of risk factors get one rather than the other? [00:38:20] Dawn mentions that more than a million people in the U.S. have Parkinson’s, including actor Alan Alda, who announced in July that he has been living with the disease for more than a year. In announcing he had the disease, Alda stressed that he has been living a full and happy life. As the national medical director for the Parkinson’s Foundation, Michael often stresses that people with Parkinson’s can lead happy and healthy lives, and Dawn asks Michael to talk about that. [00:41:04] Ken mentio

Today’s episode features a timely interview with Google’s Director of Research, Peter Norvig. He is also the co-author of “Artificial Intelligence: A Modern Approach,” which is in its third edition and is a leading AI textbook. In today’s interview, we talk to Peter about fake news, trolls, self-driving cars, killer robots, the future of artificial intelligence, and a lot more. We also talk to Peter about digital privacy. Tech companies such as Google, Facebook, Twitter and others have been facing heavy criticism recently over the way they handle people’s digital data. In May, Europe began enforcing a new law that restricts how people’s online data is obtained and used. In June, California passed a privacy law that requires tech and information companies to share how they’re collecting people’s data and how they’re sharing that information. At the moment, Congress is considering a federal privacy law that also covers how personal digital data is handled. Ken and Peter have a history that goes back to their days at the NASA Ames Research Center in Silicon Valley. Ken was the center’s associate director at the time and recruited Peter to become the center’s chief of the Computational Sciences Division. In today’s episode, we discuss: How artificial intelligence has changed since the days when Peter first became a practicing AI professional. [00:19:20] How AI research is now increasingly driven by commercial interests rather than government grants. [00:23:39] What deep learning is and what the word “deep” means in this context. [00:27:48] The philosophical questions that surround AI, such as: “What does it mean to be intelligent?” and “Can a machine be conscious?” [00:36:58] Search function and privacy. [00:44:32] Google’s responsibility for the content posted on their platforms. [00:50:06] The problems that arise when tech companies police content. [00:51:17] Peter’s thoughts about a meeting Elon Musk had with U.S. governors where he urged them to adopt AI legislation before “robots start going down the street killing people.” [00:56:18] The meaning of “singularity” and whether Peter believes in it. [01:03:19] Peter’s advice for listeners who are interested in going to work for Google someday. [01:12:10] Show notes: [00:02:15] Dawn begins the interview asking Peter about an interview he did with FORBES magazine where he said, “I don’t care so much whether what we are building is real intelligence. We know how to build real intelligence. My wife and I did it twice, although she did a lot more of the work. We don’t need to duplicate humans, that’s why I focus on creating tools to help us rather than duplicating what we already know how to do. We want humans and machines to partner and do what humans and machines couldn’t do on their own.” Dawn asks Peter to expand on this belief and how it influenced his career. [00:03:23] Dawn asks Peter about growing up in Boston and his habit of writing the local newspaper to complain about innumeracy and the sloppy language in its science stories. [00:04:36] Ken mentions Peter’s father was a math professor and his mother an English literature professor. While in high school, even though teachers suggested a career in journalism, Peter decided to learn programming instead. Peter talks about how he also took a class in linguistics, which led him to start thinking about using computers to process natural language. [00:05:54] Dawn asks Peter about classes he took at Brown University that led him to start thinking about artificial intelligence. [00:07:00] Dawn mentions that Peter went to the University of California Berkeley for his Ph.D. and asks him what motivated him to enroll in the computer science department and research AI. [00:08:03] Dawn asks Peter about the research he did after receiving his Ph.D. and becoming an assistant professor at University of Southern California as a research faculty member. [00:08:36] Peter talks about the work he did in various labs during the early years of his career. [00:09:45] Peter talks about how Ken, while on leave from IHMC, recruited Peter in 1998 to become the division chief of the Computational Sciences Division at NASA Ames. [00:11:32] Ken and Peter recall a tag-team address they made at the 1999 conference of the Association for the Advancement of Artificial Intelligence. The talk was titled, “AI and Space Exploration: Where No Machine Has Gone Before”. [00:14:07] Dawn mentions that in 1996 a couple of Stanford students developed a search algorithm that was originally known as “Back Rub,” which eventually led to the formation of Google in 1998. Peter joined Google in 2001 and Dawns asks how that came about. [00:16:11] Dawn asks Peter to talk about the differences in the work cultures of Google and NASA. [00:17:41] Ken mentions that the textbook Peter co-wrote with Stuart Russell is now in its third edition since its original publication in 1995, and that it is considered one of the leading textbooks on artificial intelligence. Ke

Episode 71: Elizabeth Nance talks about using nanotechnology to understand and treat brain diseases SEO: Elizabeth Nance, Nance Lab, University of Washington, nanotechnology, autism, traumatic brain injury, epilepsy, nanoparticles, blood-brain barrier,diffusion,dendrimer-NAC conjugates,Einstein’s brain, chemical engineering,Ken Ford,Dawn Kernagis,IHMC Our guest today has been described by Forbes magazine as one of the “most disruptive, game-changing and innovating young personalities in science.” Dr. Elizabeth Nance is known for her passionate search to find ways to more efficiently connect resources and information across multiple scientific and engineering disciplines. Her research focuses on using nanotechnology to understand the movement of molecules in the brain. She is particularly focused on better ways to treat brain diseases like autism, stroke, traumatic brain injury and epilepsy. Elizabeth is the Clare Boothe Luce Assistant Professor of Chemical Engineering at the University of Washington. She also has an adjunct appointment in the school’s radiology department. Elizabeth and her lab, the Nance Lab, recently was awarded a $1.8-million-dollar grant from the National Institutes of Health to develop quantitative, high resolution imaging and analysis platforms to understand nanoparticle behavior, with a specific focus on the brain. In today’s episode, we discuss: The pushback Elizabeth received in college when she tried to apply chemical engineering to neurological diseases. [00:11:33] How Elizabeth developed the first nanoparticles that could penetrate deep within the brain. [00:13:52] The many potential applications of nanoparticle technology in the treatment of neurological disorders, diseases and injuries. [00:17:10] The structure, and unique functions of the blood-brain barrier. [00:28:11] The dendrimer-NAC conjugates, and how they increase intracellular glutathione to reduce injury in the inflamed brain. [00:35:01] How “disease directing engineering” has the potential to allow for the leveraging of common hallmarks of neurological disease to better deliver therapies. [00:40:19] How change in brain metabolism affects targeted therapeutic deliveries to a specific region of the brain. [00:52:14] Show notes: [00:03:31] Elizabeth talks about growing up in North Carolina and how her family goes back nine generations to the original homesteaders of Charlotte. [00:04:06] Dawn mentions that Elizabeth liked to spend a lot of time outdoors as a child and asks her if it is true that she was especially good at climbing trees. [00:05:12] Dawn asks Elizabeth about her hectic schedule in high school, which, in addition to her studies, included soccer, track and volleyball. [00:06:03] Ken asks Elizabeth when she became interested in science. [00:08:22] Dawn mentions how in North Carolina a person has to decide early on if they are a Chapel Hill fan or a North Carolina State fan. Dawn asks if this culture contributed to Elizabeth going to NC State. [00:09:28] Dawn asks Elizabeth about her decision to major in chemical engineering. [00:11:33] Dawn asks Elizabeth to discuss the pushback she received in college when she tried to apply chemical engineering to neurological diseases. [00:13:52] Ken mentions that Elizabeth developed the first nanoparticles that could penetrate deep within the brain. This was a major reason why Forbes named her one of its “30 Under 30 Disruptive Influencers in Science” back in 2015. He asks if she could talk about the work she did in developing that platform and how it changed the way we might think about delivering drugs in the brain. [00:17:10]Ken mentions that there are many potential applications of nanoparticle technology in the treatment of neurological disorders, diseases and injuries. He asks Elizabeth to describe the structure of a nanoparticle in general, and how it can accomplish targeted delivery of a therapeutic. [00:21:47] Ken comments on how after publishing her nanoparticle paper in “Science Translational Medicine” in 2012, one publication commented that they were worried about potential nefarious applications of such technology. [00:25:23] Dawn asks why research and development for drugs used to treat people with injured or diseased brains take about 35% longer to develop than drugs for any other type of disease. [00:28:11] Dawn asks Elizabeth to give some background on the structure, and unique functions of the blood-brain barrier. [00:29:57] Ken discusses how a lot of Elizabeth’s work involves the use of nanotechnology and its potential applications in both understanding and treating the injured brain. He asks about the use of nanoparticles as probes, and how that helps us better understand the human brain microenvironment. [00:32:11] Dawn comments on how much of Elizabeth’s post-doctoral work focused on the use of dendrimer-based nanoparticles in multiple different settings as a model for how to approach neurological disease treatment. Dawn asks Elizabeth how that ha

Peter Attia, who was our very first guest on STEM-Talk, describes David Sabatini’s discovery of mTOR as one of his two favorite science stories. Today, Dr. David Sabatini joins us and gives us a first-hand account of how his research into rapamycin in 1994 as a graduate student led him to the discovery of mTOR, which we now know is a critical regulator of cellular growth. Our interview with David delves into his continuing research into mTOR, which has led to promising opportunities for the development of new treatments for debilitating diseases such as cancer, diabetes and neurological disorders. He also discusses mTOR’s role in healthspan and lifespan. David is a molecular cell biologist who, according to Reuters News Service, is on the short list for a Nobel Prize. David is on the faculty at MIT and heads up the Sabatini Lab at the Whitehead Institute. In today’s episode, we discuss: • Rapamycin, a macrolide antibiotic discovered in the soil of Easter Island • David’s discovery of mTOR while a grad student at Johns Hopkins • mTOR’s role as one of the major growth pathways in the body • mTOR’s role as a nutrient sensor • How mTOR inhibiton has become one of the hottest topics in longevity research • mTOR’s role in diseases, especially its connection to cancer • The role of RAG GTPases as key mTOR mediators • Protein intake and downstream mTOR activation • Research into ketogenic diets effect on longevity and healthspan • Whether David would take rapamycin as a means to enhance his longevity • And much, much more Show notes: [00:03:32] David talks about growing up in New York and having parents who immigrated to the United States from Argentina. [00:04:00] Dawn asks what David was like as a kid. [00:04:59] Dawn asks David about his decision to attend Brown University. [00:05:56] David talks about his decision to become a scientist and the time he spent in the lab of Al Dahlberg [00:06:53] Ken mentions that after his time at Brown, David headed off for Johns Hopkins to work in Sol Snyder’s lab, a professor known particularly for the work he and his colleagues did on the opioid receptor. Ken asks what drew David to Sol’s lab. [00:08:25] David talks about how as graduate student at Johns Hopkins in the M.D./Ph.D. program, he began trying to understand the molecular mechanism of rapamycin, a macrolide antibiotic discovered in the soil of Easter Island. Rapamycin was known as a potent antifungal, immunosuppressive with anti-tumorigenic properties. That research led David to the major discovery in 1994 of the protein to which rapamycin binds, now referred to as the mechanistic target of rapamycin, or mTOR. [00:11:46] Dawn asks David to give a high-level definition and overview of what mTOR does. [00:13:44] Dawn asks why the “m” in mTOR went from standing for “mammalian” to “mechanistic.” [00:14:11] Ken mentions that we now know mTOR is one of the major growth pathways in the body that is responsible for growth in both a positive sense and a pathologic sense. He goes on to mention that mTOR acts as a major switch between catabolism and anabolism, and asks David to explain why both of these processes are essential for survival. [00:16:10] Dawn asks how the two different mTOR protein complexes, mTORC1 and mTORC2, differ with regards to their activation and downstream function. [00:17:40] Dawn asks David about his decision to join the faculty atMIT and embark on a research-focused career there, starting his own lab at the Whitehead Institute rather than following the clinical path arising from his M.D. [00:20:50] Ken asks about how nutrients and other inputs are sensed and integrated by the mTOR complexes, given how one of the most fascinating aspects about mTORC1 is its role as a nutrient sensor. [00:23:46] Ken asks why both nutrients and growth factors are required to activate mTORC1. [00:25:54] Dawn mentions her interest in the connection of mTOR to aging, mentioning that mTOR inhibition through rapamycin or its analogues is currently one of the hottest topics in longevity research. She asks why mTOR inhibition appears to be life-extending? [00:30:38] Ken asks what the risks are of excess catabolism, when inhibiting mTOR pharmacologically, in terms of both health and longevity. [00:32:09] Dawn asks if there is data in humans suggesting that suppressing mTOR will extend longevity and healthspan, either pharmacologically, genetically or through diet and fasting. [00:34:23] Dawn asks where mTOR is made, both in terms of the individual cell, as well as specific tissues in the body. [00:35:02] Ken asks if there is a significant difference between the mTOR signaling in organs like the liver, skeletal muscle, and the brain. [00:37:07] Ken asks if tissue specific inhibition of mTOR is possible. [00:38:29] Dawnmentions how it is becoming clear that mTOR plays a role in a number of diseases, most notably is its connection to cancer. She goes on to say that in 2008, David’s team published a highly-cited paper in Science tha

Dr. David LeMay is a sports medicine and rehabilitation physician who is a consultant for the NBA’s Washington Wizards, the NFL’s Oakland Raiders and the National Hockey League’s Washington Capitals, which won the Stanley Cup this year, their first in the franchise history. Dave is also a neighbor of ours in Pensacola who has a practice called Lifestyle and Performance Medicine that is located just a few blocks from IHMC. Dave and his practice partner provide personalized preventative care that helps people reduce the effects of stress on the body and mind to maximize function and health. In his practice, Dave works with a lot of athletes as well as retired and active military members, particularly people in special-ops, who have inflammation as a result of persistent injuries and traumas. Dave often recommends specialized pro-resolving mediators, also known as SPMs, which help promote the natural termination of the inflammation process and allow a person to avoid anti-inflammatory drugs. We will especially be talking with Dave about this rather new way of treatment in today’s interview. Some other topics we cover in Dave’s interview: Neuroendocrine dysfunction, especially among military veterans. The role of inflammation in concussions and traumatic brain injuries. Dave’s work with the NFL Players Association Trust. The role of specialized pro-resolving mediators in an aging population. The proper dosage of SPMs for subacute inflammation. Dave’s efforts to improve the diets of former NFL players. The key components of keeping athletes healthy through an entire season. The correlation between heath-rate variability and athletic performance. Proper sideline protocols for players who sustain head injuries. Optimal treatment for people who suffer TBI and concussions. Establishing baselines for a person’s neuroendocrine function. The role of DHA and EPA consumption for maintaining optimal brain health. And much, much more. Show notes: [00:04:18] Dave begins the interview talking about growing up in Reno, Nevada, and playing sports non-stop as a kid. [00:4:35] Dawn comments on how Dave’s love of sports lead to some injuries, including a few broken fingers and torn ligaments, and says she understands that this is how Dave first became interested in science. [00:05:31] Dawn asks Dave about his decision to head to California after high school to attend Azusa Pacific University. [00:06:37] Dawn asks what lead Dave back home to attend med school at the University of Reno. [00:07:13] Ken asks Dave at what point he decided to specialize in physical medicine and rehabilitation. [00:08:33] Dawn mentions that the University of Texas Health Science Center has one of the best physical medicine and rehab programs in the country. She asks Dave if this was the reason he decided to go there for his residency. [00:09:21] Ken comments on how after Dave’s residency, he stayed in Austin for almost a year. But then Dave moved Pensacola and Ken asks how that came about. [00:11:04] Dawn asks about Dave’s private practice, called Lifestyle and Performance Medicine, which he and his partner opened in 2013 after their time at the Andrews Institute. [00:11:27] Ken points out that veterans, and some active-duty folks, particularly those with special operations backgrounds, comprise about half of Dave’s practice. Ken says he understands Dave has seen a great deal of neuroendocrine dysfunction in this group, and asks Dave for his observations. [00:12:56] Ken mentions that Dave is the medical director for a program that is run through the NFL Players Association Trust. He asks Dave to describe the type of rehab that this program provides the former NFL players. [00:14:54] Dawn comments on the concept of inflammation being a unifying component of many diseases that afflict Western Civilization, and how it is also a major contributor to the magnitude and persistence of different sports injuries and traumas. She asks Dave to talk about inflammation, and specifically its role in concussion and TBI, as well as give a brief overview of what inflammation is. [00:17:51] Dawn mentions how Dave has been looking at how targeting inflammation may serve as a therapeutic way to also treat fear- and anxiety-based disorders. [00:20:34] Ken asks if the process of EPA and DHA conversion into SPM’s through an enzymatic process diminishes in its efficiency as one ages. [00:21:18] Ken asks if Dave thinks there is a role for exogenous SPM’s for the aging population. [00:22:13] Ken asks if there is a particular SPM brand, or collection of brands, that Dave finds to be the most interesting or efficacious. [00:23:01] Ken asks what dosage would Dave suggest for subacute inflammation, and what would be proper for an acute inflammation stage. He goes on to ask about those people who experience a constant, mildly inflamed state. [00:24:52] Ken asks how Dave wound up working as a consultant for the NBA’s Washington Wizards, the NFL’s Oakland Raiders, and the National Hock

What’s the best way to eat and the right way to exercise to ensure a healthy lifespan? Our guest today is Dr. Stephen Anton, a psychologist who has spent his career researching how lifestyle factors can influence not only obesity, but also cardiovascular disease and other metabolic conditions. Steve is an associate professor and the chief of the Clinical Research Division in the Department of Aging and Geriatric Research at the University of Florida. In today’s episode, we talk to Steve about his work in developing lifestyle interventions designed to modify people’s eating and exercise behaviors in an effort to improve their healthspan and lifespan. One of Steve’s best-known papers appeared in the Obesity Journal titled “Flipping the Metabolic Switch.” The study looked at intermittent fasting and suggested that the metabolic switch into ketosis represents an evolutionary conserved trigger point that has the potential to improve body composition in overweight individuals. Topics we cover in today’s interview include: The increasing prevalence of metabolic syndrome associated with aging. Why so many hospital health and wellness programs fail. How fasting and intermittent energy restriction promote autophagy. The relationship between muscle quality, body fat and health. How age-related loss of muscle function and mass leads to sarcopenia. Effects, risks and benefits of testosterone supplementation in older men. Optimal exercise methods for long-term health. Therapeutic approaches that potentially can help avert systemic inflammation associated with aging. Steve’s study that looked at the effects of popular diets on weight loss. Controversies surrounded calorie restriction as a strategy to enhance longevity. Show notes: 2:30: Steve talks about growing up in Tampa and playing sports as a kid. 3:53: Dawn asks Steve about his decision to attend Florida State after high school. 4:17: Dawn comments on how Steve bounced between medicine, business, and psychology before finally deciding to major in psychology. She asks if having two parents who were also psychologists played a role in his decision. 5:24: Ken asks about Steven’s experience pursuing his Ph.D. at the University of Florida. 6:28: Dawn brings up that Steve became a fellow of behavioral medicine at the Pennington Biomedical Research Center in Baton Rouge, La. She mentions that Pennington has one of the nation’s premier programs in obesity metabolism and diabetes. She asks if that was the reason he decided on Pennington. 9:33: Dawn asks what prompted Steve to return to the University of Florida. 10:08: Ken asks what is driving the increased prevalence of metabolic syndrome that’s associated with advanced age. 11:19: Dawn brings up how hospitals have tried to promote health and wellness programs for decades, but notes how hospitals are designed to treat people who are sick and injured rather than delivering lifestyle interventions. She asks if Steve can give a summary of what he has learned in looking at ways to deliver interventions. 13:23: Dawn mentions that the traditional treatment and management approaches for type 2 diabetes are relatively ineffective and only reverse the disease in about one percent of the cases. 15:02: Ken mentions that Jeff Volek, STEM-Talk Guest on episode 43, has been a pioneer in researching type 2 diabetes. 16:49: Dawn points out that she and Ken had an in-depth conversation with Dr. Mark Matson about autophagy on episode seven of STEM-Talk. Matson also discussed fasting, and intermittent energy restriction and how it promotes autophagy, which is often described as the body’s innate recycling system. Dawn asks if Steve can elaborate a little on this process. 18:02: Dawn mentions that Steve has written about muscle quality and body composition and the risk of metabolic diseases and functional decline. She asks about the relationship between muscle quality, body fat and health. 19:17: Dawn asks if Steve can talk about how the age-related loss of muscle function and mass often lead to sarcopenia, and how this condition effects the individual and society. 20:31: Ken asks for Steve’s thoughts on the group of people who could be classified as having “pre-sarcopenia.” Ken mentions his interest in this group given that dietary and exercise intervention can still make a huge difference in their lives. 21:35: Dawn brings up the point of how testosterone tends to decline as men age, which is associated with a number of adverse health problems, including: cardiovascular and metabolic disease, sexual dysfunction, and mood disorders. Dawn asks about Steve’s study on the effects of testosterone supplementation in older men, and about the risks and benefits of supplementation. 24:12: Dawn asks if Steve can describe the difference between muscle quality and quantity, and if there is an easy way we can track and measure muscle quality. 25:28: Ken asks how we should be thinking about pharmaceutical therapies in these conditions as the field goes fo

Today’s guest is Dr. Douglas Wallace, the director of the Center for Mitochondrial and Epigenomic Medicine at Children’s Hospital of Philadelphia. He is internationally known as the founder of mitochondrial genetics. Mitochondria are tiny structures within cells that produce 90 percent of a person’s energy and play an essential role in health and disease. Dr. Wallace’s groundbreaking research in the 1970s defined the genetics of DNA within the mitochondria, as distinct from DNA in a cell’s nucleus. His research has shown that mitochondrial DNA is inherited exclusively from the mother and that genetic alterations in the mitochondrial DNA can result in a wide range of metabolic and degenerative diseases. One of Dr. Wallace’s seminal contributions has been to use a mitochondrial DNA variation to reconstruct human origins and the ancient migrations of women. These studies revealed that humans arose in Africa approximately 200,000 years ago, and that women as well as men left Africa about 65,000 years ago to colonize Eurasia. Dr. Wallace was inducted last year into the Italian Academy of Sciences during the academy’s 234th annual meeting in Rome. Founded in 1782, membership in the academy is limited to 40 Italian scientists and 25 foreign members. Over the years, the academy has seen such notable members as Albert Einstein, Benjamin Franklin, Louis Pasteur and Rita Levi-Montalcini. Links: Dr. Wallace’s Children’s Hospital of Philadelphia bio: https://www.chop.edu/doctors/wallace-douglas-c Mitochondrial DNA Variation in Human Radiation and Disease Wallace Cell Perspective 9-26-15 Mitochondrial DNA Mutation Associated with Leber’s Hereditary Optic Neuropathy Wallace LHON 11778 Science 1988 A Mitochondrial Bioenergetic Etiology of Disease Wallace JCI Wallace JAMA Psychiatry2017 Association Between Mitochondrial DNA Haplogroup Variation and Autism Disorders Chalkia_jamapsychiatry_2017 Maternal Inheritance of Human Mitochondrial DNA Giles Maternal Inheritance 1980 Show notes: 3:32: Dawn opens the interview by mentioning that Doug grew up exploring the woods outside his neighborhood in the suburbs of Annapolis, Maryland. Dawn asks if his time outdoors sparked his interest in science when he was young. 4:14: Dawn asks Doug what led him to attend Cornell University after graduating from high school. 5:15: Doug talks about his decision to focus on genetics in school. 6:21: Dawn asks Doug how he selected Yale for his graduate studies. 7:49: Ken mentions that mitochondria can be considered bacterial “power-pack” organelles that generate the majority of a cell’s energy, as well as much else. He goes on to say that mitochondria account for about 30 percent of our bodyweight, and that there are roughly 500 trillion of them. He finally points out that despite all this that they are surprisingly under attended to and asks Doug to give listeners a brief mitochondria 101. 13:37: Ken mentions how he’s glad Doug answered the question of how mitochondria ended up losing 99 percent of their original genes, considering that mitochondria used to be free living bacteria with roughly 1,500 genes. 15:25: Dawn points out that Doug and his colleagues are credited with founding the field of human mitochondrial genetics more than 40 years ago. She then asks if anyone else was doing similar research when Doug started working on human mitochondrial genetics during his post-doc. 17:55: Following his post-doc at Yale, Doug spent seven years at Stanford University School of Medicine. Dawn asks Doug about his work during this time. 22:01: Dawn mentions that in 1983 Doug became the professor of biochemistry, anthropology and pediatrics at Emory University in Atlanta. During this time, he also was chairperson and senior editor of the Mitochondrial DNA Locus-Specific Database for the Human Genome Organization. Dawn asks what that work entailed. 24:11: Ken asks Doug about accepting a professorship of molecular genetics at the University of California, Irvine where he founded the Center for Molecular and Mitochondrial Medicine and Genetics. 26:25: Dawn mentions that in 2010 Doug moved to Philadelphia to become professor of pathology and laboratory medicine at the University of Pennsylvania. Going on to mention that he also became the founding director of the Center for Mitochondrial and Epigenomic Medicine at the Children’s Hospital of Philadelphia (CHOP). She asks what took Doug to CHOP what sort of work goes on at the center. 28:07: Dawn asks Doug to expand on the work he and his colleagues have done that shows that mitochondrial DNA is inherited exclusively from maternal linage, and that genetic alterations to mitochondrial DNA can result in a wide range of metabolic and degenerative diseases. 31:34: Ken brings up that Doug often talks about how Western medicine has generally approached most diseases from a primarily anatomical and Mendelian perspective, and how it seems that our bioenergetics inheritance has been largel

In today’s episode, Ken and Dawn interview their colleague Dr. Peter Neuhaus, a senior research scientist here at IHMC. Peter is an engineer well-known for his work on wearable robotic devices. In particular, Peter has focused on lower extremity exoskeleton devices and their applications for mobility assistance for paraplegics and other people with disabilities or partial paralysis. In 2016, Peter lead an IHMC team that won a silver medal in the international Cybathlon, a competition conducted in Zurich in which people with disabilities used advanced assistive devices, including robotic technologies, to compete against each other. In today’s interview, Peter talks about IHMC’s humanoid robotic efforts as well as his work with NASA designing an exercise machine for a human mission to Mars or other missions beyond low earth orbit. Peter also describes the work he is doing with IHMC High-Performance Director Joe Gomes, the former Oakland Raiders strength and conditioning coach. Peter and Joe as well as others at IHMC are designing exercise technologies to extend the resilience of high-performing humans, such as astronauts and elite warfighters. Many of these technologies will eventually be able to be utilized by the general public. Links: Peter Neuhaus IHMC page: https://www.ihmc.us/groups/pneuhaus/ DARPA Robotics Challenge videos: http://robots.ihmc.us/drc/ Cybathlon videos: http://robots.ihmc.us/cybathlon/ IEEE Robotics and Automation Magazine article about Cybathlon: https://arxiv.org/pdf/1702.08656.pdf IHMC newsletter article about Cybathlon: https://www.ihmc.us/wp-content/uploads/2015/08/IHMCNewslettervol10iss3.pdf IHMC newsletter article about DARPA Robotics Challenge: https://www.ihmc.us/wp-content/uploads/2017/07/IHMCnewslettervol13iss1.pdf Show notes: 3:03: Dawn asks Peter about growing up in New York City. 3:33: Ken mentions that after high-school, Peter enrolled at MIT. Ken asks Peter what led him there. 4:04: Ken asks why Peter decided to major in mechanical engineering. 4:35: Dawn asks Peter what led him to travel across the country to attend the University of California, Berkeley for graduate school after he graduated from MIT. 5:10: Dawn asks what it was like for Peter to teach science to 5th– and 6th-graders as well as high-schoolers in Brooklyn after he received his master’s degree from Berkeley. 6:23: Peter talks about how after two years of teaching, he decided his window of opportunity to get a doctorate was shrinking and that it was essentially “now or never,” which led him back to Berkeley. 7:02: Dawn mentions that once Peter finished his doctorate, he went to work for a startup as a mechanical engineer. She asks what sort of work he did there. 7:47: Dawn talks about how a year and a half after getting his doctorate Peter met his future wife, who eventually led him to Pensacola, and in a roundabout way, to IHMC. She asks if he could share how that all came about. 9:22: Ken comments on how since joining IHMC in 2003, Peter has focused on wearable robotics systems and legged robots. Ken further mentions that Peter was one of the lead IHMC researchers participating in the DARPA Learning Locomotion project, where he helped develop quadrupedal locomotion algorithms for the Little Dog robot. Ken asks if Peter could talk about his work on this project? 11:08: Dawn, continuing with the discussion about DARPA projects, mentions that Peter played an important role in both the development of technology and in the management of IHMC’s humanoid robotics effort for the DARPA Robotics Challenge that was held between 2013 and 2015. IHMC placed second and brought home $1 million in prize money. Dawn asks what that experience was like. 12:10: Ken mentions there were three competitions that were part of the robotics challenge, and asks Peter to talk about IHMC’s performance in each of the competitions. 12:57: Dawn mentions that for more than a decade, Peter has been working on exoskeletons, wearable robotic devices that assist people with paralysis and other disabilities. She asks Peter how he got interested in this, and if he could give an overview of what is involved in the development of exoskeletons. 14:39: Ken comments on how wearables are a challenging application for robotics. He asks if Peter could elaborate on some of the specific technical challenges that go along with it. 15:27: Dawn changes the topic to the Cybathlon, a competition, held in Zurich, Switzerland for people with disabilities who are supported by modern assistive technology. IHMC won another silver medal in that competition and Dawn asks about the IHMC team’s preparation for the Cybathlon. 18:18: Ken mentions that a key factor that set IHMC’s exoskeleton apart from the rest at the Cybathlon was the incorporation of powered ankles, which improved mobility. Ken asks Peter to talk about the importance of this feature that the team added to the exoskeleton. 20:05: Dawn asks whether the balancing algorithms that are used in humanoi

Dr. Brendan Egan is an Associate Professor of Sport and Exercise Physiology at Dublin City University who is well known for research that shows resistance training can improve strength, muscle mass, reduce falls in older people, and perhaps even extend lifespans. In addition to being a first-class researcher, Brendan is also a stand-out player in Ireland’s national sport, Gaelic football. His current research is exploring the synergy between nutrition and exercise interventions to optimize performance in athletes and the elderly. Current projects also involve protein hydrolysates in recovery and glycemic management; leucine and n-3 PUFAs in the elderly; and exogenous ketones and athletic performance. Links: Brendan Egan’s faculty page: https://dcu.academic.ie/live/!W_VALOCAL_DCU_PORTAL.PROFILE?WPBPRSN=1631629 Brendan Egan’s Researchgate profile https://www.researchgate.net/profile/Brendan_Egan2/contributions Brendan Egan’s TEDx talk: https://youtu.be/LkXwfTsqQgQ Exercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation https://www.sciencedirect.com/science/article/pii/S1550413112005037 Metabolism of ketone bodies during exercise and training: https://physoc.onlinelibrary.wiley.com/doi/epdf/10.1113/JP273185 Fueling performance: Ketones Enter the Mix: https://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30438-7 Does Strength-Promoting Exercise Confer Unique Health Benefits? https://academic.oup.com/aje/article-abstract/187/5/1102/4582884?redirectedFrom=fulltext Does Strength-Promoting Exercise Confer Unique Health Benefits? https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/JP275938 Show notes: 2:46: Dawn opens by mentioning that Brendan was born in Detroit, and that his Irish father moved the family to Ireland when Brendan was 3 years old. Dawn asks if Brendan’s mother was American. 4:09: Dawn comments on how Brendan was very athletic as a child and played Gaelic football, which is Ireland’s national sport, and asks if he could explain how this game is played. 6:02: Ken, following up on the last question, asks what Brendan’s training is like for this sport, and how he manages to fit it into his busy schedule as a professor. 7:41: Dawn asks if it is true that even though Brendan’s best grades were in math and physics, he never considered a career in science while he was in high school. 8:37: Dawn mentions that Brendan ended up at the University of Limerick after graduating, asking what made him decide to attend Limerick as well as what prompted him to major in sports and exercise science. 9:46: Dawn asks about two people, Phil Jakeman and John Kirwan, who played a big role in shaping Brendan’s education at Limerick. 11:58: Dawn comments on how after completing his bachelor’s of science degree, Brendan went to work on his master’s, heading to the UK and attending Loughborough University where he graduated with distinction in sports exercise and nutrition. Dawn asks what made him decide to attend Loughborough, and what stood out about his time there. 13:33: Dawn mentions that Brendan returned to Ireland in 2004 to start his doctoral studies under the supervision of Dr. Donal J O’Gorman at Dublin City University. Dawn asks what that experience was like. 15:06: Ken asks what Brendan learned from his research with Dr. O’Gorman, which focused on skeletal muscle adaptation to exercise and, in particular, continuity between acute molecular responses to individual bouts of exercise and the adaptations in skeletal muscle induced by exercise training. 18:30: Dawn asks what took Brendan to Karolinska Institute in Stockholm. 19:51: Brendan talks about his work at Karolinska using animal intravenous cell systems, and his research into transcriptional regulation of skeletal muscle insulin resistance and type 2 diabetes utilizing small non-coding RNA’s. 23:39: Ken mentions that Brendan’s first faculty position was at the University College Dublin in 2011, where he spent five years establishing his own independent research group. He then moved to Dublin City University in 2016. Ken asks how Brendan developed his research group, and what kind of work the group does now. 25:44: Dawn asks Brendan to discuss the prevalence of the age-related loss of muscle function and mass, which often leads to sarcopenia. She also asks about its effects on individuals as well as its impact on society. 27:45: Ken mentions that the heavy use of Prednisone, which a lot of older people are put on for long periods of time, rapidly diminishes their muscle mass. 29:35: Ken mentions that falls are a huge issue, seemingly associated with the loss of fast-twitch muscle as we age, and that falls are more a result of loss of power than loss of strength and mass. He proposes that this is a major, yet overlooked, driver of the prevalence of falling in the older population. 31:11: Ken comments on how there are complex and interacting causes of this loss of mass, strength and power which are not completely understood yet.

Today’s episode features Dr. Valter Longo, director of the Longevity Institute at the University of Southern California. Valter is best known for his research on stem cells and aging as well as his fasting-mimicking diet. Often referred to as FMD, the diet is intended to avoid the downsides of fasting while reaping the health benefits of a calorie-restrictive diet. Over a 25-year career, Valter has published numerous papers about the ways specific diets can activate stem cells and promote regeneration and rejuvenation in multiple organs to reduce the risk for diabetes, cancer, Alzheimer’s and heart disease. He writes about this research and diet in a book that was released earlier this year, “The Longevity Diet: Discover the New Science Behind Stem Cell Activation and Regeneration to Slow Aging, Fight Disease and Optimizer Weight.” The book details an easy-to-follow everyday diet that is combined with short periods of the fasting-mimicking diet. Valter says the diet has the potential to help people live healthier and longer lives. Valter is a native of Genoa, Italy and moved Chicago when he was 16. He received his bachelor’s of science degree at the University of North Texas in 1992 and his Ph.D. at UCLA in 1997. Links: Longevity Center website: http://longevityinstitute.usc.edu Longo’s USC faculty page: http://gero.usc.edu/faculty/longo/ “The Longevity Diet”: https://amzn.to/2s1fcky A periodic diet that mimics fasting promotes multi-system regeneration: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509734/ Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration: https://www.cell.com/cell/fulltext/S0092-8674(17)30130-7 Fasting-mimicking diet and markers/risk factors for aging: http://stm.sciencemag.org/content/9/377/eaai8700 Prolon FMD website: https://prolonfmd.com/fasting-mimicking-diet/?doing_wp_cron=1526216346.5062971115112304687500 Show notes: 2:24: Dawn opens the interview by mentioning that Valter was born and raised in Genoa, Italy, the hometown of Christopher Columbus. She asks if reports of him driving his neighbors mad playing Dire Straits, Jimmy Hendricks and Pink Floyd on his electric guitar as a youth are accurate. 2:43: Dawn asks Valter what his parents said when he tried to talk them into letting him go to London to be a rock star when he was 12 years old? 3:10: Valter left home when he was 16 to go visit an aunt in Chicago, but ended up staying in Chicago to go to school and play music. Dawn asks what that was like? 3:49: Dawn comments on how in addition to being exposed to some of the best blues music in the world, Valter also was exposed to some of the unhealthiest food in the world. Valter then talks about what he refers to as “the heart-attack diet.” 4:48: Dawn asks what lead Valter to attend the University of North Texas College of Music. 5:30: Valter joined the Army Reserve to help pay for college and ended up assigned to a battalion of Army tankers. Ken asks Valter what that was like. 6:15: Dawn asks if it’s true that the idea of directing a marching band lead Valter to switch majors as a sophomore. 7:07: Dawn comments on how not many jazz performance majors, who have never taken a biology course, decide to switch their major to biochemistry. She asks Valter what the people in the biochemistry department had to say about that. 8:04: Dawn mentions that when Valter was five years old, he saw his ailing grandfather pass away. She asks him to talk about that experience and the role it played in his decision to study aging. 9:14: Dawn mentions that after switching over to biochemistry and graduating from college in 1992, Valter headed to UCLA, which at the time was one of the world’s leading centers of longevity research. She asks Valter how that opportunity came about. 10:22: Ken brings up Valter’s work at UCLA in the lab of the pathologist, Roy Walford. Valter studied the effects of caloric restriction in the lab and Ken asks Valter to talk about what he learned. 11:25: Dawn comments that while in Walford’s lab, Valter made two important discoveries using a method that he invented. Dawns asks him to describe the discoveries. 13:20: Dawn asks Valter what led him to do his post-doc work at the University of Southern California, and what the focus of his research was at USC. 14:04: Dawn asks what it was like to study in a community of dwarves in Ecuador, a group of people who lack the receptor for the growth hormone, which is known as Laron syndrome. Valter talks what he learned from that experience. 16:08: Ken notes that these dwarves seem to be nearly immune to cancer and diabetes. Accidents, convulsive disorders and alcohol deaths, however, account for 50 percent of their mortality. Among non-dwarf relatives, these same causes of mortality account for just three percent of deaths. Ken asks Valter what causes this big disparity. 17:54: Dawn recounts that Valter went on to become a professor of gerontology and biological sciences at USC, and that in 2011 he became the director of

Dr. Keith Baar joins Ken and Dawn today for the second of his two-part interview for STEM-Talk. Keith is a renowned scientist in the emerging field of molecular exercise physiology who has made fundamental discoveries on how muscles grow bigger, stronger, and more fatigue resistant. He is the head of the Functional Molecular Biology Laboratory in the Department of Neurobiology, Physiology, and Behavior at the University of California, Davis. In his lab, he leads a team of researchers attempting to develop ways to improve muscle, tendon and ligament function. Part one of our interview, episode 62, covered Keith’s childhood in Canada and his undergrad years at the University of Michigan as well as his time at the University of California, Berkeley, where he earned a master’s degree in human biophysics. We talked about Keith’s work at the University of Illinois, where he received a doctorate in physiology and biophysics. We also covered Keith’s time in the lab of John Holloszy, who is known as the father of exercise research in the United States, as well as the five years Keith spent at the University of Dundee in Scotland. Episode 63 picks up with Keith explaining his decision to return to the states and join the faculty at the University of California, Davis. Ken and Dawn then talk to Keith about his most recent research, some of which is looking at how to determine the best way to train, as well as what types of foods compliment training to decrease tendon and ligament injury and accelerate return to play. This work has the potential to improve muscle function not only in athletes, but also improve people’s quality of life as they age. Another key topic covered in part two of our interview is the research Keith is doing on a ketogenic diet and its potential to reduce cancer rates and improve cognition. Keith also provides his thoughts on what optimal workouts and nutrition should look like. Links: Baar’s UC Davis physiology department bio: https://www.ucdmc.ucdavis.edu/physiology/faculty/baar.html Baar’s UC Davis biology department bio: https://biology.ucdavis.edu/people/keith-baar Functional Molecular Biology Lab website: http://www.fmblab.com/ Molecular brakes regulating mTORC1 activation in skeletal muscle paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137116/ Age-related Differences in Dystrophin article: https://www.ncbi.nlm.nih.gov/pubmed/27382038 Show notes: 2:54: Dawn begins part 2 of our interview by mentioning that for the past eight years, Keith has been working at the University of California Davis. She asks Keith what prompted him to return to the U.S. from Scotland and join the faculty at UC Davis. 3:37: Dawn points out that Keith’s Functional Molecular Biology Lab conducts research across a range of related topics, including musculoskeletal development and adaptation as well as methods for engineering functional musculoskeletal tissues in vitro. She asks Keith to give a high-level overview of some of that research. 4:16: Dawn comments that some of Keith’s recent work has shown that we can use specific nutrition and training strategies to optimize injury recovery and prevention. She goes on to say that musculoskeletal injuries are among the most common problems that active people have. 8:45: Ken talks about how Keith has noted that tendon stiffness is dependent upon collagen content, and the amount of crosslinks within. He goes on to mention that Keith has developed various training modalities, as well as nutritional protocols, that can increase and decrease tendon stiffness. Ken begins this line of inquiry by asking about the training methods for this purpose. 12:04: Following up on the previous question, Ken asks whether anyone has looked at how blood flow restriction training, which is increasing in popularity, affects tendon stiffness. 13:32: Dawn moves on to asking about nutrition. She mentions that Keith’s lab has done a great deal of groundbreaking work on the use of gelatin and a small amount of vitamin C to augment collagen synthesis in tendons, ligaments, cartilage, and bone. She asks if he could talk about this nutrition protocol and its effects, particularly when combined with jumping rope. 17:52: Ken mentions that this work is not only interesting scientifically, but it has an immediate, practical application that people can use in their life. Ken goes on to say that those suffering from stress fractures or a variety of other ailments could benefit from this. 21:09: Ken mentions that there are several different forms of collagen, asking if there is any particularly efficacious form, or if they function equally. 22:40: Ken comments that it is not just lower body weakness and injuries in tendons, but also tendonitis that is found in the shoulders and elbows. He asks if there is a variant of Keith’s protocol that is suited for this sort of tendonitis as well. 24:37: Ken asks a question submitted by friends in the special ops community. He mentions that one of their biggest issu

Today’s episode is the first of a two-part interview with Dr. Keith Baar, the head of the Functional Molecular Biology Laboratory in the Department of Neurobiology, Physiology, and Behavior at the University of California, Davis. In his capacity as a researcher, Keith has made fundamental discoveries on how muscle grows bigger, stronger, and more fatigue resistant. He is a renowned scientist in the emerging field of molecular exercise physiology, and is leading a team of researchers attempting to develop ways to improve muscle, tendon and ligament function. Part one of our interview features our conversation with Keith about his background and his time time in the lab of John Holloszy, who is known as the father of exercise research in the United States. Episode 63 of STEM-Talk has Dawn and Ken talking to Keith about his most recent research, which is looking at how to determine the best way to train, as well as what types of foods compliment training to decrease tendon and ligament injury and accelerate return to play. This work has the potential to improve muscle function and people’s quality of life, especially as they age. Ken and Dawn also have a conversation with Keith about the research he is doing on a ketogenic diet and its potential to reduce cancer rates and improve cognition. Links: UC Davis physiology department bio: https://www.ucdmc.ucdavis.edu/physiology/faculty/baar.html UC Davis biology department bio” https://biology.ucdavis.edu/people/keith-baar Functional Molecular Biology Lab website: http://www.fmblab.com Molecular brakes regulating mTORC1 activation in skeletal muscle paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137116/ Age-related Differences in Dystrophin article: https://www.ncbi.nlm.nih.gov/pubmed/27382038 Show notes: 3:14: Dawn opens the interview by mentioning that Keith grew up in Canada, and asks what he was like as a child. 4:02: Dawn asks if Keith was interested in science as a kid. 4:53: Dawn comments that after high school, Keith came to the U.S. to attend the University of Michigan, where he earned a bachelor’s degree in kinesiology. She Keith if Michigan was where he first became interested in the science of how muscles work. 7:54: Dawn asks Keith if he played any sports at Michigan. 8:34: Dawn asks what lead Keith to attend the University of California, Berkeley to pursue a master’s degree in human biophysics. 9:39: Dawn mentions that after his time at Berkeley, Keith returned to the Midwest to attend the University of Illinois where he received his doctorate in physiology and biophysics. She asks why he decided on Illinois for his doctoral work. 11:12: Ken mentions that Keith’s Ph.D. work focused on the effect of resistance exercise on specific molecular markers that are related to muscle growth. He goes on to say that Keith identified that mTOR complex 1 was activated in response to resistance exercise and that the activation was proportional to the load across the muscle. He asks Keith to talk about this work and its significance. 16:20: Ken comments how surprising that discovery must have been. 17:33: Ken asks Keith to explain the two basic ways of activating mTORC1 in skeletal muscle. Ken also asks whether these two are merely additive, or if together they elicit a greater muscle protein response than either would independently. 29:49: Dawn mentions that after Illinois, Keith went to work in the lab of John Holloszy at Washington University in St. Louis, a professor of medicine who is known as the father of exercise research in the United States. Dawn asks if is Holloszy is the one who discovered that when people do endurance exercise that their muscles accumulate more mitochondria. 32:24: Ken asks about the role of PGC-1a. 38:43: Ken comments that we know most sports require a combination of strength and endurance for optimal performance, bringing up the topic of concurrent training. 48:02: Ken asks if we know which form of AMPK is activated by things such as Metformin or the ketogenic diet. 49:24: Dawn comments that Keith eventually accepted a position at Michigan where he worked with Bob Denis, who figured out how to engineer muscles as well as ligaments. She asks Keith to share some things about the research they did together. 50:41: Dawn mentions that after Michigan, Keith accepted a position at the University of Dundee in Scotland, where he worked for 5 years. Dawn asks what that experience was like. 55:20: Ken mentions that from looking at the literature, it seems as though Keith discovered that the non-contractile portion of the muscle plays a key role in the transfer of force, and that this is nearly as important as the size of the muscle fiber itself. He asks Keith to elaborate on this finding. 58:45: Ken asks if Keith’s work has elucidated a potential countermeasure to the loss of dystrophin, for both the aging population and cancer patients. Keith then talks about research at the University of California, San Diego, that has shown the beneficia

More than 90 Americans a day are dying from opioid abuse. Today’s guest, Dr. Christopher McCurdy, is at the forefront of research designed to help the U.S. deal with this drug overdose crisis. Chris is a medicinal chemist and behavioral pharmacologist at the University of Florida who is internationally known as an expert on kratom, a botanical mixture that has been shown to help people struggling with addiction. He recently became president of the American Association of Pharmaceutical Scientists, and has spent his career focusing on the design, synthesis and development of drugs to treat pain and drug abuse. Chris earned his bachelor of science degree in pharmacy from Ohio Northern University, and a Ph.D. in medicinal chemistry from the University of Georgia College of Pharmacy in 1998. He did his postdoctoral work at the University of Minnesota where he focused on opiate chemistry in relation to drug abuse and drug addiction. He joined the faculty at the University of Mississippi in 2001 where much of his research was successful in discovering unique and selective tools for sigma receptors, NPFF receptors and opioid receptors. Dr. McCurdy accepted a post as a professor of medicinal chemistry at Florida in 2017 and became the director of the university’s Translational Drug Development Core. Links: Christopher McCurdy UF faculty page: http://pharmacy.ufl.edu/faculty/christopher-mccurdy/ American Association of Pharmaceutical Scientists: https://www.aaps.org/home Translational Drug Development Core: https://www.ctsi.ufl.edu/research/laboratory-services/translational-drug-development-core/ Suspected Adulteration of Commercial Kratom Products with Hydroxymitragyine: https://www.ncbi.nlm.nih.gov/pubmed/27752985 Self-treatment of Opioid Withdrawal Using Kratom: https://www.ncbi.nlm.nih.gov/pubmed/18482427 Herbal Medicines for the Management of Opioid Addiction: https://www.ncbi.nlm.nih.gov/pubmed/22133323 Show notes: 2:58: Ken opens by asking Chris if he ever dreamed of becoming a professional athlete as a result of growing up in Pittsburg during the hay-day of the Stealers and the Pirates. 3:28: Dawn mentions that Chris’s father was a pharmacist, and his mother, a science teacher. She further mentions that in addition to being interested in sports, that Chris also was interested in science, and she asks what role his parents played in that. 4:45: Dawn mentions that Chris moved to a suburb of Youngstown Ohio just as he was starting high school. Chris talks about playing basketball, being part of a competitive swim team, and his reputation as a fairly straight-laced kid. 5:27: Ken mentions that Chris headed to Ohio Northern University after he graduated from high-school and initially pursued a double major in pharmacy and music. Ken asks what prompted that particular combination. 6:39: Ken talks about how at Ohio Northern, Chris’s first real mentor in science noted his talent for research, and suggested that Chris should head to the University of Georgia for the summer to get acquainted with research. Chris talks about how that eventually led to him attend Georgia for his doctorate. 10:39: Ken asks Chris to talk about his doctoral research into Native American Tobacco. 13:28: Dawn comments on how there weren’t too many post-doc opportunities available at the time he finished his studies at Georgia, but that she understands there is an apparent pattern in his life of being at the right place at the right time. She asks if it was this pattern that lead him to the University of Minnesota. 17:05: Dawn inquires as to what got Chris interested in working on the natural product called Salvinorin A (Magic Mint), and what became of that research. 20:40: Dawn mentions that because of his work on salvia divinorum, Chris was invited by the National Institute of Drug Abuse to give a talk in 2004, which is where he first learned about kratom. 23:08: As context, Ken asks if Chris could expound upon kratom’s history, the different types of kratom, and the varying effects they have on users. 32:10: Ken brings up the debate surrounding whether kratom is properly construed as an opioid. Chris goes on to talk about the differences between kratom and classic opioids. 37:33: Following up on the previous question, Ken mentions that the distinction between opioid and opiate is quite important, given that when people talk of opioids they are generally thinking of opiates specifically. Given that respiratory depression is a major issue for those on opiates, Ken asks how many lives could be saved by moving people off opiates. 40:32: Shifting the conversation, Ken asks about the use of kratom among athletes. 43:10: Ken, following up on the last question, mentions that the primary use of kratom among athletes is not for performance enhancement, but rather recovery, and coping with the pain. One frequently hears of kratom use among athletes, especially those engaged in sports such as wrestling, mix martial arts, bodybuilding, and football to

Why is it that modern marine concrete structures crumble and corrode within decades, but 2,000-year-old Roman piers and breakwaters endure to this day? Episode 60 of STEM-Talk features Dr. Marie Jackson, a scientist who has spent the past two decades figuring out the answer to that and other questions about the durability of ancient Roman mortars and concretes. Marie is a research associate professor in the department of geology and geophysics at the University of Utah. She is known for her investigations in pyroclastic volcanism, mineralogy, materials science, and archaeological science that are breaking new ground in understanding the durability and specialty properties in ancient Roman mortars and concretes. She is particularly focused on deciphering Roman methods and materials in the hope of producing innovative, environmentally friendly cementitious masonry products and nuclear waste storage materials that would benefit the modern world. She was the lead principal investigator of a drilling project in the summer of 2017 on the Surtsey Volcano, which is on a small isolated island off the coast of Iceland. The volcano is growing the same mineral cements as Roman marine cement and the drilling project is helping provide extraordinary insights into the materials and processes the Romans used. She is particularly focused on deciphering Roman methods and materials in the hope of producing innovative, environmentally friendly cementitious masonry products and nuclear waste storage materials that would benefit the modern world. She was the lead principle investigator of a drilling project in the summer of 2017 on the Surtsey Volcano, which is on a small isolated island off the coast of Iceland. The volcano is growing the same mineral cements as Roman marine cement and the drilling project is helping provide extraordinary insights into the materials and processes the Romans used. After receiving her bachelor of science in earth sciences from the University of California Santa Cruz, Marie traveled overseas and received a doctorate from the Universite de Nantes in France. She returned stateside and received a doctor of philosophy from John Hopkins University as well as a Ph.D. in earth and planetary sciences. Marie then went to work as a research geoscientist for the U.S. Geological Survey. After taking time off to raise a family, Marie joined the department of civil and environmental engineering at the University of California, Berkeley, as a project scientist. She stepped into her current position at the University of Utah in 2016. Links: Mechanical resilience and cementitious processes in Imperial Roman architectural mortar: https://www.researchgate.net/publication/270161645_Mechanical_resilience_and_cementitious_processes_in_Imperial_Roman_architectural_mortar Marie Jackson ResearchGate profile: https://www.researchgate.net/profile/Marie_Jackson Surtsey blogspace: https://surtsey50years.utah.edu Show notes: 4:06: Dawn begins interview by mentioning Marie’s love of the outdoors as a child and asks her to talk about those days. 4:38: Dawn asks if Marie’s father, who was a geologist, contributed to her love of the outdoors. 5:11: Dawn asks what topics Marie was interested in while in high school. 5:44: Dawn mentions that when Marie went to college, she never envisioned herself as a scientist, but this changed in her junior year, when her interest in earth sciences took root. Dawn asks Marie to elaborate on how that happened. 6:27: Ken asks Marie what role, if any, her family’s ranch played in motivating her interest in geology. 7:22: Dawn mentions that after college Marie worked for a mining company for a few years, which enabled her to save enough money to travel to France, where she worked on a doctorate. She asks if this is how Marie ended up in northern Corsica, in the Italian Alps. 9:39: Ken asks about her transition back to the United States, where she attended John Hopkins University after spending 3 years in France. 10:23: Ken mentions Marie’s reputation at John Hopkins for being a “desert rat” in Utah’s Henry mountains. He asks her to elaborate on her experiences in that area. 12:06: Dawn comments on how after Marie got her PhD in 1987, she went to work for the U.S. Geological Survey, and that she ended up doing a structural study of the seismically active Kaoiki fault zone on the southeast flank of the Mauna Loa Volcano in Hawaii. Dawn asks Marie to talk about that. 13:44: Dawn comments on how Marie didn’t know much about Rome until she spent a year there in 1995. Marie talks about her experience. 14:17: Ken mentions that Marie’s priority for many years was to raise her children, but Ken asks what else she did in those days. 15:05: Dawn comments on how during this period, Marie was writing papers and working with scientists who were nearing retirement. Dawn asks what that was like. 17:55: Dawn asks about the work Marie did after she started, in 2011, working at UC Berkley’s Department of Civil and Envi

Nearly five million people in the United States have Alzheimer’s disease. In 30 years, that number is estimated to be 16 million In today’s episode, Ken and Dawn interview Dr. Stephen Cunnane, a Canadian physiologist whose extensive research into Alzheimer’s disease is showing how ketones can be used as part of a prevention approach that helps delay or slow down the onset of Alzheimer’s. Cunnane is a metabolic physiologist at the University of Sherbrooke in Sherbrooke, Quebec. He is the author of five books, including” Survival of the Fattest: The Key to Human Brain Evolution,” which was published in 2005, and “Human Brain Evolution: Influence of Fresh and Coastal Food Resources,” which was published in 2010. He earned his Ph.D. in Physiology at McGill University in 1980 and did post-doctoral research on nutrition and brain development in Aberdeen, Scotland, London, and Nova Scotia. From 1986 to 2003, he was a faculty member in the Department of Nutritional Sciences at the University of Toronto where his research focused on the role of omega-3 fatty acids in brain development and human health. He also did research on the relation between ketones and a high-fat ketogenic diet on brain development. In 2003, Dr. Cunnane was awarded a senior Canada Research Chair at the Research Center on Aging and became a full professor at the University of Sherbrooke. He has published more than 280 peer-reviewed research papers and was elected to the French National Academy of Medicine in 2009. Links: Lower Brain 18F-Fluorodeoxyglucose Uptake: Castellano et al AD dPET J Alz Dis 2015 Brain glucose and acetoacetate metabolism: Nugent et al dPET YE Neurobiol Aging 2014 Energetic and nutritional constraints on infant brain development: Cunnane & Crawford J Human Evol 2014 Inverse relationship between brain glucose and ketone metabolism in adults: Courchesne-Loyer et al PET KD JCBFM 2016 A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults: Croteau et al. AD MCI CMR Exper Gerontol 2017 A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer’s Disease: Castellano et al. exercise ketones JAD 2017 Show notes: 3:33: Dawn mentions that Stephen was born in London but that his family emigrated to Canada when he was an infant. She asks him about growing up in a suburb of Montreal. 4:02: Ken mentions that he has been told by a reliable source that as soon as Stephen got into high school he spent a lot of time in the chemistry lab, where sometimes created mischief. 4:58: Dawn asks if it is true that Stephen nearly flunked out of college when he first started. 5:16: Dawn comments that Stephen got his PHD in physiology at McGill University which is when his interest in science really caught on and asks how that came about. 5:55: Stephen talks about communicating with Desmond Morris while Stephen was working on his post-doc. 8:03: Dawn asks about Stephen’s post-doctoral research, for which he traveled to Aberdeen London and Nova Scotia; as well as what prompted his interest in nutrition in the brain. 9:01: Dawn mentions that in 1986 Stephen became a faculty member in the department of nutritional sciences at the University of Toronto. She asks how he ended up teaching nutrition when he didn’t have a degree in nutrition. 10:33: Stephen talks about accepting a senior Canada Research Chair at the Research Center of Aging and a full professorship at the University of Sherbrooke. 11:57: Ken talks about Stephen’s interest in human evolution how it eventually led him to research the nutritional importance of shore-based foods and omega-3 fatty acid in particular in the development of human’s brains. He asks Stephen to talk about his work leading up to the hypothesis that humans evolved near the water. 16:32: Dawn asks which of the various forms and sources of omega-3 are optimal for overall wellness and brain health, and what are the differences between them. 18:50: Dawn asks Stephen if there was any pushback against his research into the importance of ketones and fat in the brain development of infants? Dawn points out that Stephen was working on this during the middle of the low-fat craze in the U.S. and Canada. 20:33: Dawn mentions that there is evidence that intermittent fasting improves cognition, and asks if there is any evolutionary basis for that? 21:49: Dawn asks if it was Stephen’s research into the metabolism of omega-3 fatty acids and the importance of ketones that lead him to write his book Survival of the Fattest? 23:04: Dawn notes that it seems as if ketones are at the core of Stephen’s way of thinking about infant brain development. She asks him to elaborate on this. 24:15: Dawn asks Stephen to talk about what it’s going to take to transition to the therapeutic use of ketones. 26:06: Ken mentions how Stephen has noted the importance of ketosis in postnatal life for a number of reasons, including brain development and survival and early breast milk av

Today’s episode features one of the nation’s leading physicians and researchers who has spent years studying and treating traumatic brain injuries. Dr. Flora Hammond is a professor and chair of the Department of Physical Medicine and Rehabilitation at Indiana University School of Medicine. She also is the Chief of Medical Affairs and Medical Director at the Rehabilitation Hospital of Indiana. She has been a project director for the Traumatic Brain Injury Model System since 1998. Shortly before we conducted this interview with Dr. Hammond, she and a team of physicians and scientists at Indiana University received a $2.1 million grant to continue research into people who suffer traumatic brain injuries and how these injuries affect the lives of patients as well as their families. Dr. Hammond is a Pensacola, Florida, native who graduated from the Tulane University School of Medicine in 1990 and completed her residency in Physical Medicine and Rehabilitation at the Baylor College of Medicine in Houston. She also completed a brain injury medicine fellowship at Wayne State University School of Medicine in Detroit. Her research in the area of brain injury includes studying the prediction of outcome, aging with brain injury, causes of and treatments for irritability, and quality of relationships. In 2016 she received the Robert L. Moody Prize, which is the nation’s highest honor reserved for individuals who had made exceptional and sustained contributions to the lives of individuals with brain injuries. Prior to the 2016 Robert L. Moody Prize, Dr. Hammond received local and national awards for her teaching, clinical care and research, including the 2001 Association of Academic Physiatrists Young Academician Award, the 2011 Brain Injury Association of America William Caveness Award, and the 2013 Baylor College of Medicine Distinguished Alumnus Award. In 2011, 2012, and 2013, Dr. Hammond led the Galveston Brain Injury Conferences which focused on changing the view of brain injury as an incident with limited short-term treatment to a chronic condition that must be proactively managed over the course of life. She co-chairs the American Congress of Rehabilitation Medicine Chronic Brain Injury Task Force, and serves on Journal of Head Trauma Rehabilitation editorial board. She has authored more than 140 peer-reviewed publications. Links: Flora Hamond faculty profile: https://medicine.iu.edu/faculty/20302/hammond-flora/ “Potential Impact of Amantadine on Aggression” study https://www.ncbi.nlm.nih.gov/pubmed/28891908 Show notes: 4:08: Interview begins. 4:38: Dawn says it’s her understanding that Flora dreamed of becoming a physician ever since middle school. Dawn asks what inspired her at such an early age to become a doctor. 5:02: Flora talks about also wanting to become a teacher, but worried that she would have to give up teaching to become a doctor. 5:40: Continuing with Flora’s history, Dawn mentions that after high school Flora traveled to New Orleans to attend Tulane University. Dawn asks if it’s true that Flora’s grandmother was her landlord while she was in college and med school. 6:20: Ken mentions that Flora’s mother was a dietician and that her father was a pathologist. He asks Flora what specifically inspired her to specialize in brain injury rehabilitation and research. 8:36: Dawn comments on how before Flora accepted a positon at Indiana, she was in the Carolinas, and asks about her work there. 9:30: Dawn asks how Flora ended up at the Indiana University School of Medicine. 10:23: Ken mentions that Flora’s lecture at IHMC attracted a lot of interest and a full-house. He follows up by asking Flora what she thinks is driving the interest in brain injuries. 11:34: Dawn talks about how Flora and a team of physicians and scientists at Indiana have spent years studying and treating TBI (Traumatic Brain Injury) and the effects of TBI on the lives of patients and their families. She goes on to mention that Indiana recently was awarded a $2.1 million grant to continue those studies for the next five years. Dawns asks Flora to talk about the scope of the work she will be doing as a result of the grant. 12:57: Ken mentions that Flora has pushed to have a national approach to the treatment of TBI, where patients and physicians continuously track the injury and continue treatments. He asks her to expand on her thoughts on such a program and how more people and organizations can start working toward an integrated approach. 13:48: Dawn asks for Flora to explain the different types of brain injury, and to clarify that TBI is not merely one singular disease or type of injury process. Flora goes on to explain the difference between mild, moderate and severe injuries, and then describes how the treatments differ. 14:50: Dawn asks Flora how she diagnoses the severity of TBI, and if there are any biomarkers that are currently in use. 16:01: Dawn asks what common issues patients struggle with after a traumatic brain i

Today’s interview features Dr. Lauren Jackson, a nationally known expert in the field of tumor and normal-tissue radiobiology. She is especially recognized for her expertise in medical countermeasure development for acute radiation sickness and delayed effects of acute radiation exposure. Lauren is the deputy director of the Division of Translational Radiation Sciences within the Department of Radiation Oncology at the University of Maryland School of Medicine. Lauren, who also goes by Isabel, received her bachelors in science in microbiology from North Carolina State University in 2006, and her PhD in pathology from Duke University in 2012. She currently is a principal or collaborating investigator on a number of industry and federally sponsored contracts and research grants. She has published extensively on the characterization and refinement of animal models of radiation-induced normal tissue injury that recapitulate the response in humans. Models developed in Lauren’s laboratory have gone on to receive FDA concurrence as appropriate for use in medical countermeasure screens. Lauren is a senior associate editor for Advances in Radiation Oncology, a journal of the American Society of Therapeutic Radiation Oncology, and serves as an ad hoc reviewer for several peer-reviewed journals. She also is the author of several book chapters on normal tissue tolerance to radiation, mechanisms of injury, and potential therapeutic interventions. Links: Jackson’s University of Maryland web page: http://www.medschool.umaryland.edu/profiles/Jackson-Isabel/ Radiation Emergency Medical Management website: https://www.remm.nlm.gov Centers for Disease Control website: https://www.emergency.cdc.gov/radiation/index.asp BARDA website: https://www.phe.gov/about/BARDA/Pages/default.aspx NIAID website: https://www.niaid.nih.gov Show notes: 5:06: Dawn begins interview by asking Lauren about her childhood and if it’s true that she was one of those children who was always asking questions? 5:39: Lauren talks about how she was more interested in history and the humanities in high school and wanted nothing to do with science. 5:59: Dawn asks Lauren about her decision to attend the University of Georgia to major in journalism and political science. 6:28: Ken comments on how even though Lauren was just 18 at the time, she was one of two students picked to represent the University of Georgia at the Center for the Presidency in Washington, D.C. Lauren then talks about how thanks to that experience, she decided journalism and political science weren’t the right majors for her. 7:38: Dawn points out that when Lauren first went to college, she took the minimum number of science classes. Lauren goes on to talk about how after spending time in D.C., she ended up applying to North Carolina State University and switching her major to microbiology. 8:52: While at N.C. State, Lauren worked for Dr. Hosni Hassan, an expert on Oxidative Stress. Dawn asks Lauren about the focus of her research with Dr. Hassan. 9:58 Dawn talks about how when Lauren was an undergrad at N.C. State, she became interested in tumors and cancer treatment, and found a professor down the road at Duke University who was doing interesting work in that area. Dawn asks Lauren if that’s why she ended up going to Duke for her doctorate. 10:52 Dawn asks Lauren to elaborate on how her background in journalism and political science connected her towards the path of radiation countermeasure research. 11:42 Dawn points out that as a graduate student at Duke, Lauren took part in projects that looked at radiation injury. Dawn asks Lauren to give an overview of what sort of work was involved in the projects. 12:46 Ken asks Lauren to explain the difference between clinical radiation exposure and radiation that someone would experience as a consequence of a nuclear attack. 13:59: Ken shifts the conversation to human space flight, asking Lauren to discuss the radiation astronauts will experience outside the protection of the Earth’s magnetosphere, such as galactic cosmic radiation and solar particle events. He also asks how they relate to the other previously mentioned clinical- and weapons-based radiation. 14:52: Ken asks Lauren to describe what the lifetime limits are for radiation exposure, how they are produced, and what is the biggest source of radiation exposure for the average person. 16:06: Dawn asks if it’s possible to translate the findings in clinical radiation to these other types of radiation exposures, such as nuclear weapons and space radiation. 16:40: Dawn asks if clinical radiation research is playing a role in the work that’s being done in space research as well as research into the effects of nuclear-weapons attack. 17:27: Ken asks Lauren to explain how radiation doses are defined. 18:28: Ken mentions that Lauren’s work has focused on both the acute and chronic effects of radiation exposure, then asks her to give an overview on how the body would respond at the cellular and ph

Today’s episode is the second of a two-part interview with IHMC Senior Scientist Dr. Jonathan Clark, a six-time Space Shuttle crew surgeon who has served in numerous roles for both NASA and the Navy. Part one of our interview, episode 55, ended with Jon talking about the tragic death of his wife, astronaut Laurel Clark. She died along with six fellow crew members in the Space Shuttle Columbia disaster in 2003. February marks the 15th anniversary of the disaster. Today’s episode picks up with Jon talking about becoming part of a NASA team that investigated the Columbia disaster. Ken and Dawn also talk to Jon about the extensive research he has been doing on the neurologic effects of extreme environments, and also about the instrumental work he has been doing in developing new protocols to benefit future aviators and astronauts. Jon received his Bachelor of Science from Texas A&M University, and medical degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He is board certified in neurology and aerospace medicine. Jon headed the Spatial Orientation Systems Department at the Naval Aerospace Medical Research Laboratory in Pensacola. He also held other top positions in the Navy and qualified as a Naval flight officer, Naval flight surgeon, Navy diver and Special Forces freefall parachutist. Jon’s service as a Space Shuttle crew surgeon was part of an eight-year tenure at NASA, where he was also chief of the Medical Operations Branch and an FAA senior aviation medical examiner for the NASA Johnson Space Center Flight Medicine Clinic. He additionally served as a Department of Defense Space Shuttle Support flight surgeon covering two shuttle missions. In addition to his new role as a senior research scientist at IHMC, Jon is an associate professor of Neurology and Space Medicine at Baylor College of Medicine and teaches operation space medicine at Baylor’s Center for Space Medicine. He also is the space medicine advisor for the National Space Biomedical Research Institute, and is a clinical assistant professor at the University of Texas Medical Branch in Galveston where he teaches at the Aerospace Medicine Residency. Links: Jon Clark’s NASA bio: https://www.nasa.gov/offices/nesc/academy/Clark-Jonathan-Bio.html Jon Clark You Tube Channel: https://www.youtube.com/playlist?list=PLZLZ5yKgXJR0L1xZzhdTY_dUzo5ZLILxS Jon Clark Red Bull Stratos page: http://www.redbullstratos.com/the-team/jonathan-clark/index.html Part one of Jon Clark STEM-Talk interview: http://www.ihmc.us/stemtalk/episode-55/ Show Notes: 4:07: Ken comments that Jon was part of the NASA team that studied every detail of the Columbia disaster. When the team’s report came out, Jon said, “You have to find ways to turn badness into goodness. You have to. It’s the only way you get through this.” Ken then asks Jon to talk about some of the lessons NASA learned. 7:27: Dawn says that on October 14, 2012, Jon was part of a team that successfully accomplished the highest stratospheric free fall jump from 128,100 feet. Dawn asks Jon how he became involved in this record-breaking jump. 9:37: Dawn asks Jon what his support team looked like for the jump. 11:15: Ken asks Jon what kind of preparation he and the team went through for the jump, and how long the preparatory period was. 12:46: Dawn asks Jon what the medical concerns for the jump were. 16:54 Dawn comments that when Jon discusses the medical team, he talks a lot about continuous physiological monitoring in the research world. She then asks Jon what kind of monitoring he was doing before, during, and after the jump. 22:58: Dawn asks Jon to discuss research he has done around neurological issues, specifically when it comes to space exposure. 23:31: Ken comments that intermittent artificial gravity has been discussed over the years, as a way to potentially mitigate some of the medical risk factors associated with long duration space missions. Ken then asks Jon how this may be accomplished in space and what we know about the effects of intermittent gravity. 30:30: Dawn says that NASA recently released a report describing an increased incidence of white matter hyper intensities in astronauts. She then asks Jon why we are seeing these lesions now and not in earlier crew. 34:01: Dawn comments that the DOD communities are also interested in the issue of white matter hyper intensities. Dawn then says that she and Jon are on a NASA Translational Research Institute project that is looking at the effect of simulated microgravity on brain lymphatic outflow. She then asks Jon to talk more about this study. 38:24: Dawn says that trying to perform effective aeromedical research with either aviators or astronauts can be difficult due to a fear of participating in studies whose findings might affect their flight status. She then asks Jon how he addresses these concerns. 41:02: Ken says that Jon has been extensively involved in previous investigations focused on physiological episo

Today’s episode is the first of two-part interview with IHMC Senior Scientist Dr. Jonathan Clark, a six-time Space Shuttle crew surgeon who has served in numerous roles for both NASA and the Navy. In a wide-ranging conversation with Ken and Dawn, Jon talks about his 26-year career in the Navy, his extensive research on the neurologic effects of extreme environments on humans, and the tragic death of his wife, astronaut Laurel Clark, who died along with six fellow crew members in the Space Shuttle Columbia disaster in 2003. Jon received his Bachelor of Science from Texas A&M University, and medical degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He is board certified in neurology and aerospace medicine. Jon headed the Spatial Orientation Systems Department at the Naval Aerospace Medical Research Laboratory in Pensacola. He also held other top positions in the Navy and qualified as a Naval flight officer, Naval flight surgeon, Navy diver and Special Forces freefall parachutist. Jon’s service as a Space Shuttle crew surgeon was part of an eight-year tenure at NASA, where he was also chief of the Medical Operations Branch and an FAA senior aviation medical examiner for the NASA Johnson Space Center Flight Medicine Clinic. He additionally served as a Department of Defense Space Shuttle Support flight surgeon covering two shuttle missions. In addition to his new role as a senior research scientist at IHMC, Jon is an associate professor of Neurology and Space Medicine at Baylor College of Medicine and teaches operation space medicine at Baylor’s Center for Space Medicine. He also is the space medicine advisor for the National Space Biomedical Research Institute, and is a clinical assistant professor at the University of Texas Medical Branch in Galveston where he teaches at the Aerospace Medicine Residency. Links: Jon Clark’s NASA bio: https://www.nasa.gov/offices/nesc/academy/Clark-Jonathan-Bio.html Jon Clark’s YouTube channel: https://www.youtube.com/playlist?list=PLZLZ5yKgXJR0L1xZzhdTY_dUzo5ZLILxS Show Notes: 4:32: Ken and Dawn welcome Jon to the show. 4:47: Dawn comments that Jon was the son of an army officer, and as a result, he grew up all over the world. Dawn then asks Jon what it was like to move so frequently to different army bases as a youth. 5:24: Dawn says that Jon is known as a fairly frugal person and asks him to tell the story of a piece of burnt toast in Germany that contributed to his frugality. 6:39: Ken asks Jon to share the story of how he learned how to fly planes in Germany as a teen-ager. 9:43: Dawn comments that Jon had aquariums in his bedroom as a child. She then asks Jon what drew him to marine biology. 13:53: Dawn asks why Jon chose Texas A&M for college after leaving Germany. 15:36: Jon talks about how he was accepted into medical school during his senior year of college, and how he was disappointed that the Navy sent him to flight school instead. 18:46: Ken says that after flight school, Jon ended up going to medical school after all. Ken asks Jon to talk about what happened. 20:09: Dawn asks Jon what it was like transitioning from being an officer in the Navy to a student in medical school. 21:24: Dawn comments that Jon was three years into his neurosurgery residency when his plans shifted. She asks Jon what happened. 24:52: Dawn says that Jon spent 26 years on active duty with the Navy, qualifying as a Naval Flight Officer, Naval Flight Surgeon, Navy Diver, U.S. Army Parachutist, and Special Forces Military Free Fall Parachutist. She asks Jon if it is fair to say that he has an appetite to try new things. 26:35: Ken comments that he and Jon met in Bruce Dunn’s lab at the University of West Florida in the late 1980s while Jon was in Pensacola working at the Naval Aerospace Medical Institute. Ken says that he recalls Jon working with Bruce on electrophysiology studies. Ken then asks Jon how he and Bruce met. 30:36: Ken says that Jon met his wife, Laurel, while he was in the Navy Dive School in Panama City. 35:34: STEM-TALK BLURB 36:00: Dawn asks Jon to share his experiences with the Marines in Desert Storm. 38:44 Dawn comments that Jon ended up back in Pensacola in the mid-1990s as the department head of the Naval Aerospace Medical Research Laboratory. During this time, Jon looked into the low-frequency active sonar, which was injuring both marine life and divers. Dawn then asks Jon to discuss this project. 41:14: Dawn asks Jon to discuss the Bug Springs project. 44:32: Ken comments that in 1996, Laurel was selected as a NASA astronaut, and she moved to Houston to begin astronaut candidate training. During this time, Jon was still in the Navy. Ken then asks Jon how he ended up working at NASA in Houston. 50:07: Ken asks Jon to discuss the transition at NASA. 53:02: Dawn asks Jon what his responsibilities were as a NASA flight surgeon. 55:00: Ken comments that it must have been an extremely tough experience when Lau

Late in 2017, a San Francisco startup company brought one of the commercial ketone esters to market. Today’s episode features an interview with a scientist and world-class athlete who has spent the past year helping develop and rollout HVMN Ketone, an FDA-approved drink that promises increased athletic ability as well as heightened focus and energy. Dr. Brianna Stubbs earned her PhD in biochemical physiology from Oxford University in 2016 where she researched the effects of ketone drinks on elite athletes. During Brianna’s collegiate athletic career, she won two gold medals while representing Great Britain at the World Rowing Championships. She first made international news when as a 12-year-old she became the youngest person ever to row across the British Channel. Brianna graduated from Oxford’s Pembroke College with a BA in preclinical sciences with the idea of becoming an MD. But after spending a year working as a research assistant helping to investigate the effect of exogenous ketones on human performance, she decided instead to pursue her doctorate in biochemical physiology and investigate how ketone compounds might be applied in a sporting and healthcare setting in the future. While at Oxford, she worked alongside Dr. Kieran Clarke to develop a novel ketone monoester that has been shown to improve exercise performance in endurance athletes. She also was a member of the Great Britain Rowing Team and in 2016 become the World Champion in the lightweight guadruple sculls. Brianna’s time at Oxford gave her a unique opportunity to combine her scientific interest in sports physiology and metabolism while also competing at an international level. Brianna moved to the United States in June of 2017 to work at HVMN and help bring the company’s ketone ester to market. Links: HVMN website: https://hvmn.com/ketone Mark Mattson STEM-Talk: http://www.ihmc.us/stemtalk/episode007/ Wikipedia: https://www.youtube.com/watch?v=hNhuJ4JiK40 Mice and ketones cognition: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102124/#!po=10.1064 Owen and Cahill: https://www.ncbi.nlm.nih.gov/pubmed/6061736 Oxford ketone study: https://www.ncbi.nlm.nih.gov/pubmed/27475046 Glycogen re-synthesi and ketones: https://www.ncbi.nlm.nih.gov/pubmed/28398950 Ketones, glycogen and mTOR: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440563/ Caryn Zinn: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506682/ Ketone esters vs ketone salts: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670148/ Acetoacetate paper: https://www.frontiersin.org/articles/10.3389/fphys.2017.00806/full HVMN online fasting community: https://www.facebook.com/groups/136348456816447/ Show notes: 3:52: Ken and Dawn welcome Brianna to the show. 4:07: Dawn congratulates Brianna on bringing one of the first ketone esters to the commercial market, and asks Brianna to provide some background that led to the ketone ester launch. 5:31: Ken comments that the HBMN ester has been approved by the FDA as “generally recognized as safe,” or GRAS. He then asks her to expand on what this means in terms of human use and to expand on the value of the GRAS status. 6:31: Dawn asks Brianna what sparked her interest in science. 7:18: Ken comments that he heard Brianna was seven years old when she ran her first race, and that she ran so hard, she made herself sick. He asks if this is true. 8:16: Ken says that Brianna’s father was the one who got her interested in rowing, and when she was six years old, he signed her up for the first rowing race across the Atlantic Ocean. Ken asks if it’s true that he had never rowed before. 10:21: Dawn comments that Brianna used to run and row with her father as he trained for these races, and then when she was 12 years old she rowed across the English Channel, becoming the youngest person to ever do so. Dawn asks how this came about. 11:59: Dawn asks what Brianna’s mother was doing while she and her father were off rowing across the English Channel. 12:41: Dawn says that Brianna won her first international rowing event when she was 16, and then at 18 she won a silver medal at the junior world championships. She then asks Brianna’s to describe her training schedule as a teenager. 13:44: Ken asks Brianna what it feels like to be the best in the world at something after winning a gold medal in rowing at the 2013 and 2016 world championships. 16:32: Ken says that as a rower, Brianna mainly competed as a lightweight. He then asks what this meant in terms of preparing for competition from both a nutritional and training standpoint. 18:18: Dawn comments that the problems associated with excess training stress and inappropriate energy balance in female athletes were previously called the female athlete triad, but it has now been renamed relative energy deficiency in sport (RED-S). She then asks if Brianna experienced any physiological issues associated with competing as a lightweight athlete and if she saw this in any of her male colleagues. 20:35: Dawn asks Brianna if she has

Today’s interview is with Dr. Brian Caulfield, the dean of physiotherapy at the University College Dublin, where he also is one of the directors of Ireland’s largest research center, the INSIGHT Center for Data Analytics. Brian is especially known for the work he is doing with wearable and mobile sensing technologies and how their use is opening new avenues for human performance evaluation and enhancement in areas like elite sports to rehabilitation medicine to gerontology. He also is a leader in the use of electrical muscle stimulation, also known as EMS, which is being used in health and sports. Brian also is the principal investigator in Ireland’s industry-led Connected Health Technology Center and is the overall project coordinator for the Connected Health Early Stage Researcher Support System, which is Europe’s first networked Connected Health PhD training program. Brian graduated with a bachelor’s Degree in Physiotherapy, a master’s in Medical Science, and a PhD in Medicine from the University College of Dublin. He has co-authored more than 180 research publications and six patents. He also has supervised more than 30 master’s of science graduate research and PhD projects to completion. Brian was the recent recipient of the prestigious 2017 University College Dublin Innovation Award, which recognized his work in the development of a connected health ecosystem in Ireland. Links: https://www.insight-centre.org/users/brian-caulfield https://www.researchgate.net/profile/Brian_Caulfield https://www.powerdot.com Electrical stimulation counteracts muscle decline in seniors Show notes: 3:52: Brian talks about growing up in Dublin and how he dreamed of becoming a professional athlete rather than a scientist. 4:35: Brian explains that as a kid he started noticing on TV how a couple of therapists would run onto the soccer field whenever a player was injured. That’s what first gave him the idea of going into physical therapy. 6:08: After receiving his physical therapy degree from the University College of Dublin, Brian tells the story of how he was about to leave for a job in Chicago when the director of the university lab offered Brian a job as a research assistant, which led him to stay in school and pursue a master’s degree. 8:02: Dawn asks Brian what it was like as a 21-year-old to work in a lab side by side with biomedical engineers and scientists on a project that looked at how reflex excitability is modulated throughout the different phases of the walking cycle in stroke patients when compared to patients who have a healthy gait. 11:45: Ken asks Brian what it was like to work in the United States after receiving his master’s degree. 13:30: Dawn asks Brian about returning to Dublin to work on a doctorate and his decision to focus his research on ankle sprains, which is one of the most common non-contact injuries suffered across all sports. 18:04: Brian talks about the limitations of studying athletes in the laboratory and how accelerometers made it possible to do research in the field. 20:57: Dawn asks Brian to expand on how his collaboration with biomedical engineers and computer scientists enabled them to develop wearable accelerometers and sensors to measure human movement. 23:34: Ken asks how this technology, which was developed to improve athletic performance, led to other technologies that were applied to accessing older adults who are at risk of falls. 27:24: Dawn points out that it was this research that led Brian to be named the University College Dublin’s site director for the Insight Center, which is one of Europe’s largest data analytics research organizations with more than 450 researchers. Dawn asks Brian to talk about Insight and its structure and purpose. 29:26: Dawn talks about how much fun it was using inertial measurement units, known as IMUs, during an undersea mission with NASA to assess the technology’s future use in looking at astronaut vestibular function on return to Earth. She then asks Brian to talk about other potential clinical and fitness applications when using IMU technology? 32:11: Dawn asks Brian to talk about his recently published study investigating whether the addition of inertial sensor data can provide additional insight into the nature of postural stability deficits for post-concussion monitoring protocol. 34:34: STEM-Talk blurb 35:02: Dawn asks how it’s possible that a measure of motor performance can help predict that a player is more likely to sustain a contact injury, which, Dawn points out, seems counterintuitive. 37:02: Ken asks Brian if his work on reducing the number of concussions among rugby players could have applications in a sport like American football. 38:25: Ken asks Brian to provide an overview of the different types of electrical muscle stimulation, also known as EMS, that are being used in health and sports today. 41:08: Ken asks how popular systems such as Compex and PowerDot fit into this spectrum of devices? 41:51: Dawn talks about h

Investigative journalist Nina Teicholz joined Ken and Dawn remotely from a studio in New York City in mid-September for a fascinating discussion about the history and pitfalls of nutrition science. Teicholz is the author of the international bestseller, “The Big Fat Surprise: Why Butter, Meat & Cheese Belong in a Healthy Diet.” The Economist named it the number one science book of 2014 and the Journal of Clinical Nutrition wrote, “This book should be read by every scientist and every nutritional science professional.” Nina began her journalism career as a reporter for National Public Radio. She went on to write for many publications, including the Wall Street Journal, New York Times, Washington Post, The New Yorker, and The Economist. She attended Yale University and Stanford University where she studied biology and majored in American Studies. She has a master’s degree from Oxford University and served as associate director of the Center for Globalization and Sustainable Development at Columbia University. “The Big Fat Surprise” is credited with upending the conventional wisdom on dietary fat. It challenged the very core of America’s nutrition policy by explaining the politics, personalities, and history of how we came to believe that dietary fat is bad for health. Her book was the first mainstream publication to make the full argument for why saturated fats – the kind found in dairy, meat and eggs – belong in a healthy diet. The Wall Street Journal, Forbes, Mother Jones, the Library Journal and Kirkus Review named “The Big Fat Surprise” one of the best books of 2014. The Economist described Nina’s book as a “nutrition thriller.” Links: — Nina Teicholz blog — Amazon: “Big Fat Surprise” http://amzn.to/2iQemXc — BMJ: “The scientific report guiding the US dietary guidelines: is it scientific?” — “A Review of the Dietary Guidelines by the National Academy of Medicine” — STEM-Talk with Gary Taubes — “Statistical Review of US Macronutrient Consumption date, 1965-2011” — “What if Bad Fat is Actually Good for You?” Show notes: 4:10: Interview begins with Nina talking about how her father, an engineer who also enjoyed computer science, sparked her interest in science. 5:41: Dawn asks Nina if she would share the story about her failed fruit-fly experiment in high school. 8:07: Nina talks about how an assignment to do a story on trans fats led her to become friends with journalist Gary Taubes, the author of “Good Calories, Bad Calories,” whom Dawn and Ken interviewed on episode 37 of STEM-Talk. 11:40: Dawn talks about an article Nina wrote for Men’s Health Magazine titled, “What If Bad Fat Is Actually Good for You?” It’s the article where Nina first laid out her case that saturated fats may not be bad for people’s health and might actually be good for people. Dawn asks Nina if she got pushback on that article. 14:07: Dawn asks about a paper Nina published in BMJ titled, “The Scientific Report Guiding the US Dietary Guidelines: Is It Scientific?” Dawn asks Nina to describe what happened when 180 scientists wrote a letter asking BMJ to retract the paper. 19:52: Dawn comments about how the pushback to the article seemed to violate the very process that science is supposed to follow. 21:30: Ken comments about the orchestrated effort to make Nina look bad, which leads Nina to highlight the support she received from BMJ and its editor Fiona Godlee. 22:55: Nina talks about the difficulty a journalist faces when challenging the work of scientists from institutions like Harvard and Yale. 24:16: Ken mentions how we’re seeing more and more dogma dressed up as science, which that leads to a discussion between Ken, Dawn and Nina about the shortcomings of nutrition science. 30:32: Dawn comments that Nina has been quoted as saying that institutionalized science is an oxymoron, and once institutions started adopting the principle that saturated fat caused heart disease, the scientists who knew better were silenced. Dawn asks Nina to expand on this. 35:42: STEM-Talk blurb. 36:12: Nina talks about a review of the dietary guidelines by the National Academy of Medicine that came out just the day before her interview with Ken and Dawn in September. The report concluded that the scientific rigor used for the dietary guidelines was not up to par. 39:05: With a population that is genetically and environmentally diverse, and in the current age of information where individuals can increasingly access data to personalize their own approach to health, Ken asks Nina if there is still an important role for a standardized set of national dietary guidelines? 40:52: Ken comments that he doesn’t really want the government telling him what to eat or what color to paint his house, and Nina responds that at the very least the government should stop making Americans fat and sick. 41:47: Nina comments that we don’t really know what kind of diet is optimal for the longest life, which leads to a discussion about

Today’s episode features field biologist Roger Smith, the founder and chair of the Teton Raptor Center, a rehabilitation facility in Jackson Hole, Wyoming, that annually cares for more than 130 injured birds. Roger and his wife, Margaret Creel, who also is a field biologist, established the Teton Raptor Center in 1997 as a facility committed to rehabilitating birds of prey. Both Ken and Dawn have visited the center, which has an education outreach program that reached nearly 37,000 people in 2016. “For our listeners who have never been to the Teton Raptor Center, I can honestly say that a visit to the center and the Grand Teton National Park would be well worth your time,” says Ken at the end of episode 51. Roger has spent his entire professional career in the natural sciences and environmental education. After high school, he headed off to the University of Montana and started his life as a field biologist researching grizzly bears in northwestern Montana in 1977. He continued to study grizzly and black bears in Alaska, Maine and Colorado before completing his secondary science degree in 1984. After teaching high school science in Montana, he moved to Jackson Hole in 1985 and joined the resident faculty at the Teton Science School. At the school, he designed and implemented a field-oriented natural science curriculum for adults and children. In 1987, he joined the field staff at the National Outdoor Leadership School and led courses in Wyoming, Texas, Mexico and Kenya. In 1994, Roger completed his Master’s degree in Wildlife Biology and Physiology at the University of Wyoming. Roger’s research has focused on raptors and ravens of the Grand Teton National Park. His research and papers have been published in a number of peer-reviewed professional journals. In 1994, he helped initiate and manage the professional residency in environmental education program at the Teton Science School, and was on the faculty there until 1999. He managed all aspects of independent research, including grant and proposal writing. Roger founded the Teton Raptor Center in 1996 and became the Resident Naturalist at 3Creek Ranch in 2002. Links: Teton Raptor Center: http://tetonraptorcenter.org Raptor Center video: https://www.youtube.com/watch?v=MdTB9hcF02k Roger’s IHMC Ocala lecture: http://www.ihmc.us/lectures/20170308/ Show Notes: 4:26: Ken and Dawn welcome Roger to the show. 4:40: Dawn asks Roger where he grew up and what kind of childhood he had. 6:56: Dawn discusses how Roger went to the University of Montana to study wildlife biology and as a freshman volunteered for a grizzly bear project, where he spent time in the wild analyzing grizzly bear scat. 8:54: Ken recalls a story Roger told him about him working on a black-bear project in 1979, which involved trapping and tagging bears in northern Maine. Ken comments on how this was an interesting time to be in the Maine woods as a young person. Ken then asks Roger if there are any adventures he would like to share from his time in northern Maine. 12:46: Ken comments on how bears are also found in the Tetons and throughout the Yellowstone ecosystem. He discusses how we often see warning signs posted to alert hikers and campers in areas where bears have been active. Ken then asks Roger if we have seen changes in activity in recent times, and if so, what drives those changes. 15:15: Ken discusses how he read a story about a grizzly bear breaking into someone’s garage to eat an elk carcass. 16:22: Dawn says that the grizzly bear is a reclusive animal and asks Roger what we know about its lifecycle. 18:07: Dawn comments that bears are opportunistic omnivores, eating a lot of berries and plants. She then asks Roger to discuss a grizzly’s diet. 20:18: Ken asks Roger to discuss bear hibernation and how it is different than other hibernators. 24:43: Ken discusses his amazement with the management of waste and kidney function, with respect to hibernation. 25:56: Ken discusses how both he and Dawn were at a meeting looking at hibernators, with respect to clues and ideas that may facilitate long duration human spaceflight. 27:31: Dawn comments on how she read that grizzlies can deposit as much as three and a half pounds of fat per day while preparing for hibernation. She then asks Roger what we know about hibernation preparation and physical adaptation in bears. 30:08: Ken asks if the bears came out this past winter when it was particularly cold. 30:34: Dawn asks what changes help bears transition back into normal activity after hibernation. 32:15: Dawn discusses how grizzlies are considered to be keystone predators and asks Roger to explain what this means and what their impact is on the surrounding ecology. 35:22: Ken comments that grizzly bears have recently become more common on the arctic islands and that we have seen grizzly bear-polar bear hybrids. He then asks Roger if we are seeing a breakdown of the species barrier here. 36:58: Dawn asks Roger to talk about how he became an a

Today’s episode features the second of Dawn Kernagis’ two-part interview with her STEM-Talk co-host and IHMC Director Ken Ford. This episode marks a milestone for STEM-Talk. It’s our 50th episode and follows Ken’s formal induction into the Florida Inventor’s Hall of Fame. In part one of Dawn’s interview, listeners learned about Ken’s childhood and his years as a rock and roll promoter back in the ‘70s. Ken even shared an interesting story about how he went from being a philosophy major to a computer scientist. He also talked about his work in AI and the creation of IHMC and the pioneering work underway at the institute. If you missed episode 49, be sure to check it out. Part two of Ken’s interview focuses more on his research and personal experience with the ketogenic diet, ketone esters, exercise and ways to extend health span and perhaps longevity. Dawn and Ken also discuss the nature of technical progress As listeners learned in part one, Ken has a varied background. He is a co-founder of IHMC, which has grown into one of the nation’s premier research organizations with world-class scientists and engineers investigating a broad range of topics. He also is the author of hundreds of scientific papers and six books. He received his Ph.D. in Computer Science from Tulane University. He is a Fellow of the Association for the Advancement of Artificial Intelligence, a charter Fellow of the National Academy of Inventors, and a member of the Association for Computing Machinery, the IEEE Computer Society, and the National Association of Scholars. In 2012, Tulane University named Ford its Outstanding Alumnus in the School of Science and Engineering. The Association for the Advancement of Artificial Intelligence named Dr. Ford the recipient of the 2015 Distinguished Service Award. Also in 2015, Dr. Ford was elected as Fellow of the American Association for the Advancement of Science. In January 1997, Dr. Ford was asked by NASA to develop and direct its new Center of Excellence in Information Technology at the Ames Research Center in Silicon Valley, where he also served as Associate Center Director. In July 1999, Dr. Ford was awarded the NASA Outstanding Leadership Medal. That same year, Ford returned to private life in Florida and to IHMC. In October 2002, President George W. Bush nominated Dr. Ford to serve on the National Science Board (NSB). In 2005, Dr. Ford was appointed and sworn in as a member of the Air Force Scientific Advisory Board. In 2007, he became a member of the NASA Advisory Council and on October 16, 2008, Dr. Ford was named as chairman – a capacity in which he served until October 201l. In August 2010, Dr. Ford was awarded NASA’s Distinguished Public Service Medal – the highest honor the agency confers. In February 2012, Dr. Ford was named to a two-year term on the Defense Science Board and in 2013, he became a member of the Advanced Technology Board which supports the Office of the Director of National Intelligence. Links: IHMC website: http://www.ihmc.us Ken Ford web page: http://www.ihmc.us/groups/kford/ Florida Inventors Hall of Fame website: http://www.floridainvents.org Outside magazine story on Ken Ford and ketogenic diet: https://www.outsideonline.com/2113406/high-carb-low-fat-ketone-diet Blood Flow Restriction Device. 15% discount code: IHMC https://www.gobstrong.com/what-is-b-strong/ BhB Ketone Ester https://hvmn.com Powerdot Muscle Stimulator https://www.powerdot.com/products/powerdot-muscle-stimulator Papers: Suppression of Oxidative Stress by b-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor http://www.ihmc.us/wp-content/uploads/2017/10/Verdin_2013.pdf Ketone Bodies as Signaling Metabolites http://www.ihmc.us/wp-content/uploads/2017/10/TEM-Ketone-bodies-as-signaling-metabolites-2014.pdf Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice http://www.ihmc.us/wp-content/uploads/2017/10/Verdin-Ketogenic-Mouse-Longevity-Cell-Metab-9-17-1.pdf A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice http://www.ihmc.us/wp-content/uploads/2017/10/Ramsey-Mouse-Longevity-Cell-Metab-9-17.pdf Ketone Bodies Mimic the Life Span Extending Properties of Caloric Restriction http://www.ihmc.us/wp-content/uploads/2017/11/Ketone-bodies-mimic-lifespan-extending-properties-of-CR_Veech_Review_2017.pdf Show notes: 7:06: Dawn begins part two of her interview with Ken by pointing out that some of the work IHMC is doing in terms of human performance is focused on nutritional approaches, including ketogenic diets and ketone esters. Dawn mentions that Ken was an early adopter of the ketogenic diet and that some people even refer to him as “the keto guy.” She then asks him when he first embraced a ketogenic diet and what attracted him to it. 8:06: Ken Talks about his long experience with the ketogenic diet and its effect on body composition. 10:30: Ken discusses how he became interested in ketone esters. 12:34: Dawn asks about research that seems to show that elevated level

On the eve of Ken Ford’s induction into the Florida Inventor’s Hall of Fame, co-host Dawn Kernagis convinced IHMC’s director and CEO that it was the perfect time to have the chairman of STEM-Talk’s double secret selection committee take a turn as a guest on the podcast. Today’s show features part one of Dawn’s two-part interview with her STEM-Talk co-host Ken Ford. Listeners will learn about Ken’s childhood and background; his early work in computer science and research into AI; as well as the creation of IHMC, which, as our regular listeners know, is a “not-for-profit research lab pioneering groundbreaking technologies aimed at leveraging and extending human cognition, perception, locomotion and resilience.” In this episode, Ken will share some of the pioneering work underway at IHMC. Dawn also asks Ken about highly vocal critics of AI such as Elon Musk. Episode 50, the second part of Dawn’s interview with Ken, will transition to a conversation about Ken and IHMC’s research into human performance. Their conversation will cover exercise, the ketogenic diet and ketone esters with the goal of extending health span and perhaps longevity. In terms of background, Dr. Ken Ford is a co-founder of IHMC, which has grown into one of the nation’s premier research organizations with world-class scientists and engineers investigating a broad range of topics. Ken is the author of hundreds of scientific papers and six books. He received his Ph.D. in Computer Science from Tulane University. He is a Fellow of the Association for the Advancement of Artificial Intelligence, a charter Fellow of the National Academy of Inventors, and a member of the Association for Computing Machinery, the IEEE Computer Society, and the National Association of Scholars. In 2012, Tulane University named Ford its Outstanding Alumnus in the School of Science and Engineering. The Association for the Advancement of Artificial Intelligence named Dr. Ford the recipient of the 2015 Distinguished Service Award. Also in 2015, Dr. Ford was elected as a Fellow of the American Association for the Advancement of Science. In January 1997, Dr. Ford was asked by NASA to develop and direct its new Center of Excellence in Information Technology at the Ames Research Center in Silicon Valley, where he also served as Associate Center Director. In July 1999, Dr. Ford was awarded the NASA Outstanding Leadership Medal. That same year, Ford returned to private life in Florida and to IHMC. In October 2002, President George W. Bush nominated Dr. Ford to serve on the National Science Board (NSB). In 2005, Dr. Ford was appointed and sworn in as a member of the Air Force Scientific Advisory Board. In 2007, he became a member of the NASA Advisory Council and on October 16, 2008, Dr. Ford was named as chairman – a capacity in which he served until October 201l. In August 2010, Dr. Ford was awarded NASA’s Distinguished Public Service Medal – the highest honor the agency confers. In February 2012, Dr. Ford was named to a two-year term on the Defense Science Board and in 2013, he became a member of the Advanced Technology Board which supports the Office of the Director of National Intelligence. Links: IHMC website: http://www.ihmc.us Ken Ford web page: http://www.ihmc.us/groups/kford/ Florida Inventors Hall of Fame website: http://www.floridainvents.org Outside magazine story on Ken Ford and ketogenic diet: https://www.outsideonline.com/2113406/high-carb-low-fat-ketone-diet Cognitive Orthoses PDF Bulletin Atomic Scientists 2014 Show notes: 6:41: Dawn welcomes Ken to the show. 7:04: Dawn asks Ken to talk about his childhood 8:12: Dawn points out that Ken moved around a lot because his father was in the Navy and asks him what that was like. 8:20: Dawn mentions that Ken lived in Guantanamo, also known as GITMO. She asks him what it was like to live there as a young child. 8:56: Dawn talks about how when Ken started high school, he became passionate about wrestling and began shaving off weight by cutting back on carbs. She asks Ken what drew him to wrestling in the first place. 9:48: Dawn asks Ken to discuss the mental aspect of wrestling. 10:33: Dawn asks Ken if he was always interested in science. 11:15: Dawn asks Ken if he had any influential teachers in high school. 13:56: Dawn discusses how before Ken became a scientist, he was a rock and roll promoter. She then asks Ken how this happened. 16:06: Dawn asks Ken if it was during this time that he met Jeff “Skunk” Baxter, previously interviewed on STEM-Talk. 16:37: Dawn shares a funny story about how her sister used to work with Richard “Paco” Zimmer, one of the best in the business. 17:25: Dawn discusses how Ken enlisted in the Navy after promoting rock and roll. She goes on to say how this is what led to Ken becoming interested in computer science, even though he thought computers were about the most “unfun thing that the Navy could assign him to do.” She then asks Ken to talk about how the Navy pushed him into computer science.

Today’s episode features the second of our two-part interview with Dr. Tommy Wood, a U.K. trained MD/PhD who now lives in the U.S. Part one covered Tommy’ background and education and what led him spend most of his academic career studying multiple sclerosis and ways to treat babies with brain injuries. Part two of our interview focuses on Tommy’s other passions: nutritional approaches to sports performance and metabolic disease. But before we get into Tommy’s background, we want to take a moment to thank our listeners for helping STEM-Talk win first place in the science category of the 12th Annual People’s Choice Podcast Awards. The international competition featured more than 2,000 nominees in 20 categories. STEM-Talk also was a runner-up in the People’s Choice Award, the grand prize of the competition. As we mentioned earlier, Tommy is U.K. trained MD/PhD who received an undergraduate degree in biochemistry from the University of Cambridge before attending medical school at the University of Oxford. He recently completed a PhD in physiology and neonatal brain metabolism at the University of Washington. He is now a senior fellow at the university researching neonatal brain injury. In part one of his STEM-Talk interview, Tommy also talked about how he is the incoming president of the Physicians for Ancestral Health, an international organization of physicians, healthcare professionals and medical students that specializes in ancestral health principles for the prevention and treatment of illness. Tommy’s interest sports performance stems from his background as an experienced rowing, endurance, and strength coach who combines evolutionary principles with modern biochemical techniques to optimize performance. He primarily performs this work with Nourish Balance Thrive, a functional medicine clinic based in California that works largely with athletes, where he is the chief medical officer. Links: Physicians for Ancestral Health – http://ancestraldoctors.org Physicians for Ancestral Health – http://ancestraldoctors.org Nourish Balance Thrive – http://www.nourishbalancethrive.com NBT automated performance analysis: http://nbt.ai Primal Endurance podcast (ketogenic diets, athletic longevity, etc.): http://primalendurance.libsyn.com/101-dr-tommy-wood 2) High Intensity Health podcast (ketogenic diets and gut health): http://highintensityhealth.com/tommy-wood-keto-diet-endotoxin-gut-health-bacterial-diversity/ Show notes: 3:37: The interview resumes. 3:43: Ken discusses how many, perhaps even most, adults are now insulin resistant to some degree, which negatively impacts many aspects of both health and performance, and is associated with most modern chronic diseases. Ken then asks Tommy if there are any underlying processes that he can see that tie these diseases together. 7:27: Ken comments on how in 1927 they had the sensible practice of starting a diabetic patient on a low-carb diet, which is still not current practice now in many places. 8:04: Tommy discusses how it is good to have symptom control with diabetes. Ken and Tommy discuss the many advantages of donating blood. 10:16: Ken asks Tommy if he has any issues giving blood in the United States given that he is from the UK which experienced mad-cow disease. 11:40: Ken asks Tommy if he checks his athletes’ ferritin levels and tries and keep them in a certain range, and if so, if he has a preferred range. 12:17: Dawn discusses how in addition to Tommy’s academic work at the University of Washington, he is also very active as the Chief Scientific Officer of Nourish Balance Thrive (NBT), an online company using advanced biochemical testing to optimize performance in athletes. Dawn asks Tommy to discuss Nourish Balance Thrive, and how the company works to optimize the health and performance of athletes. 14:41: Ken comments on how Tommy has a relatively homogeneous population if he is focused on endurance athletes, making it particularly interesting because people often confuse athletic performance with health. 15:37: Dawn mentions how Chris at NBT has been training machine-learning algorithms to predict biochemical patterns in athletes. She then asks Tommy to talk about how this fits in with his current work and why he thinks it is an important approach for the future of medicine in general. 17:52: Ken comments on how Chris is using XG Boost, a well-regarded open-source software library, as the machine learning tool. Ken mentions that XG Boost is an implementation of gradient boosting which is a form of supervised learning which has enjoyed broad success. Another nice feature of XG Boost is that its open source, allowing one to integrate it with a variety of other software packages. 19:25: Ken says how a sensible next step may be to identify another relatively homogeneous population and do it again. 20:48: Dawn comments on how over-training, under-recovery, nutrient deficiencies, or hormonal imbalances seem to be much more prevalent today. She then asks Tom

Dr. Tommy Wood is a U.K. trained MD/PhD who now lives in the U.S. He has spent most of his academic career studying ways to treat babies with brain injuries, but has also published papers on multiple sclerosis, as well as nutritional approaches to sports performance and metabolic disease. Today’s conversation is the first of a two-part interview we did with Tommy. Part two will upload to iTunes on Oct. 10. Tommy received an undergraduate degree in biochemistry from the University of Cambridge before attending medical school at the University of Oxford. He recently completed a PhD in physiology and neonatal brain metabolism at the University of Washington. He is now a Senior Fellow at the university researching neonatal brain injury. He also is the incoming president of the Physicians for Ancestral Health, an international organization of physicians, healthcare professionals and medical students that specializes in ancestral health principles for the prevention and treatment of illness. Tommy is also an experienced rowing, endurance, and strength coach who combines evolutionary principles with modern biochemical techniques to optimize performance. He primarily performs this work with Nourish Balance Thrive, a functional medicine clinic based in California that works largely with athletes, where he is the Chief Medical Officer. Links: Physicians for Ancestral Health – http://ancestraldoctors.org Nourish Balance Thrive – http://www.nourishbalancethrive.com NBT automated performance analysis: http://nbt.ai Primal Endurance podcast (ketogenic diets, athletic longevity etc): http://primalendurance.libsyn.com/101-dr-tommy-wood 2) High Intensity Health podcast (ketogenic diets and gut health): http://highintensityhealth.com/tommy-wood-keto-diet-endotoxin-gut-health-bacterial-diversity/ Show notes: 03:30: Ken and Dawn welcome Tommy to the show. 03:48: Tommy talks about growing up in the U.K. and also spending time in Iceland, Germany and France. 04:43: Ken asks Tommy if he was more interested in science or sports as a youth. 05:48: Tommy talks about his time the captain of a rowing club and how he became interested in ultra-endurance sports and Crossfit training. 07:33: Dawn points out that Tommy follows a Paleo style diet, but understands that wasn’t the case when he was on a rowing team at Cambridge. She asks Tommy what caused him to change his diet. 09:51: Tommy worked as junior doctor in central London for two years after medical school before moving to Norway to get a PhD in physiology and neuroscience at the University of Oslo. Dawn asks Tommy what motivated him to change his field of work? 11:39: Dawn asks Tommy why he has devoted so much of his research looking into multiple sclerosis. 13:23: Dawn mentions that Tommy is the incoming president of Physicians for Ancestral Health and asks him how he came involved with the organization. 15:40: Physicians for Ancestral Health work to identify natural dietary, nutritional and environmental interventions that complement standard medical therapies. Dawn asks Tommy to describe examples of natural interventions. 17:11: Tommy’s PhD focused on the physiology of hypoxic-ischemic brain injury in newborn babies using a rat model. Kens asks Tommy to talk about the disease and how it is studied in the lab. 19:25: Dawn points out that the current treatment for infants with brain injuries is therapeutic hypothermia. Dawns asks Tommy to talk about the treatment and how it works. 23:00: STEM-Talk blurb. 23:24: Considering that hypothermia was already standard of care by the time Tommy started his PhD, Ken asks what made Tommy want to focus on studying hypothermia further during his PhD. 24:45: Dawns asks Tommy how he would research the optimization of hypothermia treatment in humans? 28:29: Ken asks Tommy how he became a senior fellow in the Pediatrics Department at the University of Washington. 29:53: Tommy’s postdoc work at the University of Washington involves developing a ferret model of brain injury in premature babies. Ken asks Tommy why he chose ferrets. 32:52: Ken talks about Xenon, a noble gas that has many applications from headlights to spacecraft propulsion to biological aspects. Dawn points out that while Ken was at NASA, that Xenon was used as a fuel for a spacecraft called Deep Space 1. Ken then asks Tommy to talk about the use of Xenon in helping people suffering hypoxic-ischemic brain injuries. 36:12: Ken points out that Xenon’s activation of HIF-1alpha makes Xenon potentially ergogenic and, in some circles, regarded as a performance-enhancing substance. The Russians admitted to using Xenon in their athletes up until WADA banned it and Argon. Ken asks Tommy for his thoughts on Xenon’s effectiveness in enhancing performance. 40:06: Dawn mentions that Xenon has been shown to increase heart and lung capacity, reduce muscle fatigue, boost testosterone and cause an improvement in mood. 40:32: Dawn talks about how Tommy has been involved in collaborative w

Today’s guest on STEM-Talk is Dr. Chris McKay, a leading astrobiologist and planetary scientist with the Space Science Division of the NASA Ames Research Center in California’s Silicon Valley. Chris’s interview covers a diverse range of topics ranging from the origins of life to the possibility of manned missions to Mars. For the past 30 years, Chris has been advancing our understanding of planetary science. He graduated from Florida Atlantic University in 1975 with a degree in physics and earned a doctorate in astrogeophysics at the University of Colorado in 1982. He was a co-investigator on the Huygens probe to Saturn’s moon Titan in 2005, the Mars Phoenix lander mission in 2008, and the current Mars Science Laboratory mission. His research at NASA has focused on the evolution of the solar system and the origin of life. He also has been heavily involved in NASA’s Mars missions including the current Mars rover — Curiosity. In addition, Chris has thought deeply about the human exploration of Mars. He has spent considerable time studying polar and desert environments to better understand how humans might survive in Mars-like environments. His research has taken him to the Antarctic Dry Valleys, the Atacama Desert, the Arctic, and the Namib Desert. In 2015, the Desert Research Institute named Chris the Nevada Medalist, which is the highest scientific honor in the state. Links: STEM-Talk Episode 33, interview with NASA’s Natalie Batalha – http://www.ihmc.us/stemtalk/episode-33/ Chris McKay’s NASA profile page – https://spacescience.arc.nasa.gov/staff/chris-mckay/ Show Notes 3:53: Ken and Dawn welcome Chris to the show. 4:05: Dawn asks Chris if it is true that the television series Star Trek inspired him to take up science and start studying planets as a kid. 4:34: Dawn comments on how Apollo happened almost 50 years ago when Chris was a teenager and asks him where he was for Apollo 11 and what it meant to him. 5:24: Ken asks Chris how he learned about Florida Atlantic University, as it was a relatively new university at the time, and asks Chris why he chose it. 6:54: Dawn asks Chris if he was thinking about becoming an astronaut when he decided to major in physics. 7:27: Ken asks Chris what it was like to be a summer intern in the Planetary Biology program at the NASA Ames Research Center around 1980. 8:52: Dawn asks Chris how he chose the University of Colorado, where he earned a PhD in astrogeophysics. 10:42: Dawn asks Chris to discuss his transition from mechanical engineering to astrogeophysics. 12:11: Ken discusses how Chris ended up back at NASA Ames as an astrobiologist and planetary scientist after graduate school. 13:53: Dawn comments how Chris’s research is taking him to extreme places, and asks him to explain what extremophiles are and what their relevance is in the search for life beyond Earth. 17:26: Dawn comments on her experiences searching for extremophiles while working on cave diving projects. 18:12: Dawn asks Chris what his most recent search experience for extremophiles on our planet was. 19:49: Dawn asks Chris what he takes to be the most exciting extremophile discovery out of all of the work he has done. 22:40: Dawn asks Chris to talk about his favorite and least favorite aspects of field research. 24:06: Ken asks Chris to define some terms related to the search for life beyond Earth. Specifically, whether we have a definition for life itself and if not, what exactly we are searching for when we say we are searching for life. He also asks Chris to talk about alien life and how it differs from life on Earth. 26:21: Ken asks Chris how tough it would be to recognize alien life if it is based on fundamentally different chemistry than life on Earth. 29:16: Ken asks Chris where NASA’s secret alien life storage room is. 31:03: Ken asks Chris what the scientific importance of discovering life in another world is. 32:49: Dawn asks Chris where the most likely environment to hold life beyond Earth in our solar system is. 33:47: Dawn asks Chris what makes Mars an ideal candidate for life beyond Earth. 36:47: Ken discusses how we have been searching for life on Mars for decades, but how Chris questions the way we have been going about this. Chris was quoted to say, “If we are going to search for life, let’s search for life.” Ken asks Chris to explain what he means by this. 39:07: Dawn asks Chris what he thinks would happen if we did discovered life on Mars, and whether he thinks there would be a profound societal reaction. 40:57: Ken asks Chris if it is likely that life on Earth may have seeded life on Mars, or perhaps vice versa. 42:57: Dawn asks Chris what motivated his interest in the atmospheres of Titan. 45:14: STEMTALK BLURB 45:39: Ken asks Chris to talk about the search for life on Europa. 47:06: Ken comments that Chris has noted that life chooses, chemistry does not. He then asks Chris when we will be able to send capable robots to examine the chemistry of Titan or the other frigid

Today’s interview features one of the nation’s foremost hypnotists who is also the associate chair of psychiatry and behavioral sciences at the Stanford University Medical School. In this episode, Dr. David Spiegel talks about how hypnosis can help people not only quit smoking and lose weight, but also relieve chronic pain and reduce people’s dependency on medications. David earned his Bachelor’s at Yale College and graduated from Harvard Medical School in 1971. His mother and father were psychiatrists and his father started practicing hypnosis just before World War II. David now has more than 45 years of clinical and research experience studying psycho-oncology, stress and health, pain control and hypnosis. In addition to his role as the Willson Professor and associate chair of psychiatry and behavioral sciences at the Stanford, he is also the director of the Center on Stress and Health and the medical director of the Center for Integrative Medicine at the Stanford University School of Medicine. David has published 12 books, including one with his father. He has written more than 380 scientific journal articles and 167 book chapters on topics ranging from hypnosis to psychosocial oncology to trauma to psychotherapy. Last year David was featured in Time magazine about the therapeutic uses of hypnosis. In terms of the nation’s escalating opiate problem, David has gone on record saying that hypnosis can and should be used instead of painkillers in many cases. “There are things we could be doing that are a lot safer, cheaper and more effective,” said David, “but we’re not because as a society we have the prejudice that hypnosis is voodoo and pharmacology is science.” David’s research has been supported by the National Institute of Mental Health, the National Cancer Institute, the National Institute on Aging, the National Center for Complementary and Integrative Health, the John D. and Catherine T. MacArthur Foundation and the Dana Foundation for Brain Sciences. David is the past president of the American College of Psychiatrists and the Society for Clinical and Experimental Hypnosis, and is a member of the National Academy of Medicine. Links: David Spiegel Stanford profile page “Group Therapy for Cancer Patients” — http://amzn.to/2wd7c39 “Living Beyond Limits” — http://amzn.to/2vlTzzZ Show Notes 3:42: Ken and Dawn welcome David to the show. 3:56: Dawn comments on how both of David’s parents were psychiatrists, and how his father started practicing hypnosis just before WWII. She then asks David if it was always his plan to follow in his parents’ footsteps. 4:53: Dawn discusses how David got his Bachelor of Arts in Philosophy and then decided to attend Harvard Medical School. She asks David why he decided to specialize in hypnosis. 7:26: After graduating from medical school, David made news for refusing pain medication after his operation. Ken asks David to describe what he did. 8:51: Dawn asks David to give an overview of hypnosis. 11:48: David talks about how hypnosis and mindfulness are similar and different. 13:48: Ken asks David if people who are easily hypnotized are also more likely to be able to successfully practice meditation or mindfulness. 14:44: Dawn discusses how she has colleagues that are interested in studying mindfulness for conditions such as PTSD or pain management, but they have had trouble finding funding on these topics. She then asks David who typically funds the work that he does. 15:31: Dawn comments on how David has written about how hypnosis is the oldest western conception of psychotherapies and asks him to give a short historical tour of hypnosis. 20:35: Dawn discusses how David has had more than 40 years of clinical and research experience studying hypnosis, psycho oncology, pain control, psychoneuroendocrinology, and the use of hypnosis in the treatment of PTSD. Specifically, David was involved in two studies that showed that Vietnam veterans with PTSD had higher than normal tendencies to be hypnotized. Dawn then asks David to discuss these studies and the utility of hypnosis as a treatment for stress and physical trauma. 24:09: Ken asks David if he has found hypnosis to be an effective treatment for PTSD. 24:35: Ken asks David about using hypnosis to treat phobias. 26:32: Ken asks David if hypnotherapy can be used to reveal suppressed or impaired eyewitness memories and whether the courts raise questions about it. 29:17: Ken discusses a landmark study, published in the late 1990s by Pierre Rainville, looking at hypnotized people who placed their hands in really hot water. Many have said that this study changed the whole landscape of hypnosis. Ken then asks David to discuss this study and its importance. 31:06: Ken comments on how not everyone can be hypnotized, and how David has used functional MRI scans to figure out why some people are not susceptible to hypnosis. In 2012, David shared results of a study that showed hypnosis changes the way b